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Abstract 
ABSTRACT 
Fluorescence enzyme inhibition assays have been established for a number of 
years as valuable methods of analysis in clinical chemistry and other fields. Those 
in common use are normally single analyte assays. However, in many cases (e.g. 
drug screening) dual or multiplex assays would be much more valuable, with the 
advantages of increased information content, saving in time and costs, and the 
elimination of some sources of sampling variance. 
This project has investigated single and dual screening assays of enzyme 
inhibitors, namely 3-nitrophenylboronic acid (3-NPBA), phenylethyl /3-0-
thiogalactopyranoside (PETG) and sodium vanadate (VI), using flow injection 
fluorescence spectroscopy and chemometric methods to resolve strongly 
overlapping fluorescence spectra. The single and dual screening assays have 
been based on flow injection analysis methodology, with immobilised enzymes on 
solid phase reactors to investigate the enzyme inhibitors. The assays were rapid, 
allowing around 15-25 measurements to be made per hour. The inhibitions of 
alkaline protease, alkaline phosphatase and /3-galactosidase with their inhibitors at 
flg/ml levels were achieved. An alternative approach to these dual assays has 
been investigated by the use of multivariate techniques. Such techniques allow 
accurate and reliable results to be obtained even from spectra that contain 
extremely overlapping signals. Moreover, preliminary investigation of three 
fluorophores which gave strongly overlapping spectra, using flow injection 
fluorescence spectroscopy and partial least squares (PLS-1) model has been 
successful. 
By combination of this flow injection fluorescence spectroscopy with the use of 
chemometrics, many applications can be envisaged in biochemical, clinical, and 
pharmaceutical industries. With the findings of this research the system described 
here can be developed for use in high throughput screening of candidate drug 
molecules and many screening processes throughout the different industries. 
ii 
Research aims and scope of the thesis 
RESEARCH AIMS 
The object of this investigation was to develop new fluorescence methods for the 
multiplex determination of enzyme inhibitors, in a format suitable for the rapid 
screening of candidate drug molecules. The methods used immobilised enzyme 
reactors in flow injection analysis systems. Multiplexing was achieved by 
incorporating time-dependent manifolds in the flow systems, and by using 
chemometric methods for the resolution of overlapping fluorescence spectra. 
SCOPE AND OUTLINE OF THE THESIS 
The thesis reports in seven chapters the work carried out to achieve the above 
aims. 
Chapter 1 gives a brief overview of the subjects pertinent to the investigation, 
while Chapter 2 covers the area of chemometrics, emphasising the important 
methods of multivariate calibration. 
Chapter 3 summarises the materials, instruments, and general procedures used 
during the research. Lists of suppliers are given in the appendices. 
Chapters 4 and 5 describe the use of fluorescence spectroscopy with labelled 
proteins as enzyme substrates. The use of these substrates with immobilised 
enzyme reactors and a time-dependent flow injection analysis system for the dual 
determination of inhibitors is demonstrated. 
Chapter 6 shows that these methods can be extended by the application of 
chemometric techniques such as partial least squares to the determination of 
fluorophores with strongly overlapping emission spectra. 
Finally Chapter 7 summarises and comments on the work carried out and offer 
ideas for its further development. References and appendices complete the thesis. 
iii 
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1.1 MULTIPLEX SCREENING IN DRUG DISCOVERY 
1.1.1 The drug discovery process 
The discovery of a new drug is a long and expensive process. From the synthesis 
of a compound to its approval can take 10-20 years, with an estimated average of 
about 12-15 years of development, including the cost and time to discover 
potential biological targets. 1 Out of the around 15 years in development time of a 
successful compound about 6 years are devoted to the drug discovery and the 
preclinical phase 2 (figure 1.1). There are numerous references on drug discovery 
and development.3-7 
• 
o 2 4 
Post-marketing testing 
FDA review & approval 
Clinical phase III 
Clinical phase 11 
Clinical phase I 
Preclinical testing 
Drug discovery (1-5 years, 
6 S 
Years 
10 12 14 16 
Fiaure 1.1 Average periods for steps in the drug discovery and development procedure 
A recent survey of 68 randomly selected new drugs yielded a total pre-approval 
cost estimate of 802 million US dollars for the research and development costs 
when unsuccessful projects were also included.s 
Traditionally, pharmaceutical analysis referred to the chemical analysiS of drug 
molecules. However, over the years, modern pharmaceutical analysis has evolved 
beyond this to encompass combination techniques, high-throughput screening, 
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chemometrics, miniaturization and nanotechnology. Figure 1.2 shows the applied 
fields of modern pharmaceutical analysis in drug discovery.9 
The progress made in biochemistry, genomic sciences, combinatorial chemistry, 
etc. gave rise to the establishment of high-throughput screening (HTS) 
technologies. The demand for higher productivity has increased the need to 
screen more targets with higher throughput and lower costs. 
A comprehensive analysis of the drug targets underlying current drug therapy 
showed that present-day therapy address only 500 molecular targets and as 
shown in figure 1.3, cell membrane receptors, largely heterotrimeric GTP-binding 
protein - coupled receptors, constitute the largest subgroup with 45% of all targets, 
and enzymes and inhibitors account for 28% of all current drug targets.s 
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Figure 1.2 Applied fields of modem pharmaceutical analysis in drug discovery 
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o Receptors (45%) 
• Enzymes and inhibitors (28%) 
III Hormones and factors (11%) 
o Unknown (7%) 
11 Ion channels (5%) 
III Nuclear receptors (2%) 
III DNA (2%) 
Figure 1.3 Biochemical classes of drug targets of current therapies 
1.1.2 Concept of high-throughput screening 
In the past decade the world of high-throughput screening (HTS), which targets 
lead discovery for pharmaceutical applications, is in a highly rapid developmental 
stage. For an effective HTS infrastructure the fundamental working fields of target 
discovery and validation, screen design, assay technology, detection method, 
sample generation and handling, laboratory automation and robotics, as well as of 
data management have to be integrated, coordinated and optimized. At present, 
latest technology and laboratory automation in all parts of the early stages of drug 
discovery play crucial roles in the success of HTS strategies.10 Nearly all drug 
discovery research projects in the pharmaceutical industry employ HTS assays as 
initial steps to discover the chemical leads. The primary role of the technology is to 
detect lead compounds and supply directions for their optimisation using other 
techniques. 
Enabling technologies that characterize HTS 11 are: 
• Increase in compound library diversity and size 
• Exponential increase in targets from genomicsl proteomics 
• Miniaturization 
• Integrated systems 
• Automation 
4 
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• More sensitive and efficient assay and detection systems 
• Cellular assay system improvements 
• Sensitive alternatives to radioactive assays 
• Computational methods for assay simUlation 
• Data management improvements and innovations 
• Outsourcing and customization 
• Lead optimization tools 
However, drug discovery is extremely complex and the goals, company resources, 
products portfolio, as well as future expectations of the different players vary 
widely. 
A number of assay formats have been developed or modified over the past few 
years to conform to the constraints imposed by HTS. Several of the more 
developed or exploited assay protocols for HTS have been the focus of several 
papers. 12-15 
1.1.3 Multiplex assays 
The development of multiplex assays has been gaining in importance over the 
years due to the increasing demands being placed upon the speed and complexity 
of analysis. Such assays are widely used by many of the different industries 
including pharmaceutical industries and medical sciences. This is mainly due to 
the many advantages that these assays bring over single analyte assays such as 
a reduction in cost, time and reagent as well as sample consumption. 
Multiplex determinations usually require an extra step, which normally involves the 
separation of the analytes prior to their detection. The most classical separation 
techniques include chromatography or some form of extraction. However, due to 
the ever-increasing need for more rapid screening assay throughput, separation 
methods such as chromatography are very time consuming and give relatively low 
sample turnovers. Many authors have looked at combining the technique of flow 
injection analysis with multiplex assays. 
5 
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1.1.3.1 Multiplex immunoassays 
Immunoassays traditionally are performed as discrete tests, i.e., each assay is 
only able to analyse one analyte. An alternative option is multi-analyte 
immunoassays, in which two or more analytes are measured simultaneously in a 
single assay. Generally, the multi-analyte immunoassays can be classified into two 
main formats: 
• Assays based on more than one label 
• The assay based on spatially separated test zones 
These are shown in table 1.1 and figure 1.4 
There are numerous sources of dual and multiplex immunoassays.l6-23 
Table 1.1 Diagnostically related groups of test suitable for the multi-analyte immunoassays 
format'· 
.. Type of testing 
Allergen testing 
Blood banking 
Cardiac markers 
Dried blood spot analysis 
Drugs of abuse testing 
Dual and triple testing 
Fertility testing 
Example 
IgE and IgG antibodies 
Antibodies to HIV and hepatitis B 
Troponin and myoglobin 
Thyrotropin and immunoreactive trypsin 
Cocaine and amphetamines 
Alpha fetoprotein 
Lutropin, follitropin and prolactin 
6 
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Multiplex immunoassay system 
I 
Multiple label 
met ods 
Enzymes 
Radioisotopes 
Fluorophores 
Affinity labels 
Dyes 
Spatially resolved Separation based 
methods methods 
Test cardl mu~i strip 
Macro areas 
Micro areas 
Sequential 
detection 
Fiaure 1.4 Classification of multi-analyte immunoassays 11 
1.1.3.2 Multiplex determination in flow injection analysis 
A typical sample sometimes needs to be analysed for more than one species, 
which is important, for example, in food processing, in clinical and industrial 
analysiS and in process control. In order to eliminate the limitation of flow injection 
analysis (FIA) for the determination of only one species at a time many attempts to 
achieve multiplex analysis have been made with a variety of procedures and 
manifolds, for example by using a single injection with several detectors in series 
or parallel24 or by using a 16-way switching valve.25 Enzymatic assays have 
particular importance in clinical analysis. A number of enzyme reactors have been 
reported to be used for simultaneous determination of more than one component 
in a mixture.26 Moreover, an automated flow injection method was developed for 
the determination of six different analytes simultaneously, by using six enzyme 
reactors in parallel, with a Single detector and a single injection valve?7 
1.1.3.3. Multiplex determination with fluorescence spectroscopy 
Fluorescence spectroscopy has been extensively used as a detection method in a 
wide range from clinical chemistry to environmental monitoring on account of its 
_._--_._---------_._._------------_._--------------_.-. __ ._-_ ..... 
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high sensitivity and selectivity, and relatively low cost. However, spectra for 
complex mixtures often cannot be successfully resolved, mainly because the 
individual components of the mixture exhibit spectra with broad bands that tend to 
overlap; this necessitates combining spectrofluorimetry and a separation 
technique or using a highly specific method. This usually increases analysis costs; 
hence there is interest in improving the selectivity of the spectrofluorimetric 
technique in order to accomplish simultaneous multiplex analyses without the 
need for expensive or time-consuming procedures. 
There are various approaches to increasing the selectivity of spectrofluorimetry, 
including derivative spectroscopy28, synchronous spectroscopy29 and synchronous 
derivative spectroscopy30, in which the fluorescence intensity is a function of a 
single parameter (the excitation or emission wavelength or a constant difference 
between the two). 
1.1.3.4 Multiplex determination with chemometrics 
Due to the recent advances in computer technology and the development of 
statistical software packages, multiplex assays do not necessarily require multiple 
methods of detection. It is now possible to use only one method of detection for 
the quantification of various analytes simultaneously from just one sample. The 
highly sensitivity spectrofluorimetry and flexible multivariate calibration methods 
make a novel, effective combination for the simultaneous determination of several 
analytes in mixtures that cannot be resolved by conventional spectrofluorimetry. In 
studies by Lindberg et al.31 and Sjostrom et al.32 concentrations of two and three 
component synthetiC mixtures are successfully predicted from fluorescence 
emission spectra by the method of partial least-squares regression. There have 
been many publications that use f1uorometric method for the simultaneous 
determination of analytes (table 1.2). 
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Table 1.2 Simultaneous fluorescence spectrophotometric determinations using 
chemometrics 
Application 
Inorganic substances, i.e. ultratrace Niobium (V), Tantalum (V) 
and Zirconium (IV) 
Ternary micellar ion-association complexes; Zirconium (IV), 
Hafnium (IV) ions and quercetin 
Canrenone and spironolactone in Urine 
Naproxen and Salicylate in human serum 
Pesticides, i.e. carbaryl (CBl), fuberidazole (FBZ), 
thiabendazole (TBZ) and warfarin (W) 
Juvenile and mature eucalyptus wood samples 
Refined sugar samples 
Furosemide and Triamterene in pharmaceutical and urine 
samples 
(Acetyl) Salicylic acid, Codeine and Pyridoxine in 
pharmaceutical preparations 
Albumin and Immunoglobulin G 
1.2 FLUORESCENCE 
References . 
33 
34 
35 
36 
37 
36 
39 
40 
41 
42 
Fluorescence spectroscopy is an extremely powerful analytical tool that has seen 
a remarkable growth in its use over the past 20 years, in a wide range of areas 
from clinical chemistry to environmental monitoring. There are numerous sources 
of information on the theory of fluorescence and its applications.43-49 
1.2.1 Theory of fluorescence 
The sequence of events that occurs in fluorescence from a single molecule is 
shown in figure 1.5 and is as follOWS: 
• A quantum of light is absorbed by a dipole (a) 
• Rapid radiation less relaxation (internal conversation) takes the dipole to the 
thermally relaxed S1 level (b) 
9 
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• The dipole retains this energy for a certain period of time, generally 
designated as the lifetime (1:) 
• The excess energy is dissipated through radiationless de-excitation (c, d, 
and e) caused predominantly through vibrational and rotational modes and 
collisions with solvent molecules, or by photon emission (f, g). When this 
photon emission is from a singlet electronic state, it is referred to as 
fluorescence (f). Conversely, when the emission is from a triplet state, 
phosphorescence is the result (g). 
Fluorescence differs from phosphorescence in that the electronic energy 
transitions responsible for the fluorescence do not involve a change in electron 
spin. As a consequence, fluorescence is short-lived, with luminescence ceasing 
almost immediately «10.5 S).44 
In nearly all cases, fluorescence arises from the lowest vibrational level of the 
ground state of a molecule to a higher vibrational level of the first excited singlet 
state. Upper vibrational levels quickly relax to the lowest vibrational level of the 
particular electronic level, since vibrational relaxation occurs in about 10.12 sec, 
much faster than other energy dissipation processes. On reversion to the ground 
electronic level fluorescence may result, with the molecule usually ending up in an 
excited vibrational level. Because the vibrational levels of both ground and excited 
states are similar, the fluorescence spectrum often is a sort of mirror image of the 
exciting absorption spectrum (figure 1.6). The lifetime of an excited singlet state is 
usually 10-9 - 10.6 sec and fluorescence lifetimes fall in this range. 
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Figure 1,5 Jablonski diagram showing absorption and emission processes of fluorescence 
and phosphorescence. 5 0 = ground singlet state, 5 , and 5 2 = first and second singlet levels 
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Figure 1.6 Excitation and emission spectra of Fluorescein Isothiocyanate 
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To ascertain the excitation and emission spectra (figure 1.6) the following 
procedure is commonly followed. The excitation monochromator is varied until 
fluorescence occurs; often this can simply be viewed visually. The excitation 
monochromator is then set at this wavelength (or at any point within the excitation 
wavelength band) and the emission monochromator is allowed to scan, recording 
the emission spectrum. The emission monochromator is then set at the 
wavelength at which maximum fluorescence occurred, the excitation 
monochromator is allowed to scan, and the excitation spectrum is recorded. In 
turn , setting the excitation wavelength and again scanning the emission 
monochromator gives the final emission spectrum.50 For analytical applications the 
emission spectrum is used. Often an excitation spectrum is first made to confirm 
the identity of the substance and to select the optimum excitation wavelength. 
1.2.2 Fluorescence intensity 
Fluorescence intensity (IF) in dilute solutions is directly proportional to the intensity 
of the excitation light source and solution concentration and is given by equation 
1.1. 
(Eq.1 .1) 
q> is the quantum efficiency, 10 is the incident radiant power at the wavelength of 
interest, e is the molar absorptivity at that wavelength, b is the cell path length and 
c is the molar concentrationS 1 
For a very dilute solution where A < 0.05 absorbance units, equation 1.1 
approximates to equation 1.2: 
Observed IF' = kq> loebc (Eq.1.2) 
k is an instrumental factor, it is a proportionality constant due to the fact that 
although fluorescence is emitted in all directions, only that of a limited aperture is 
measured. 
In order to emit radiation as fluorescence, a molecule must first absorb radiation. 
The higher the molar absorptivity (e), the more intensely fluorescent a compound 
will be. Because fluorescent emission in organic compounds comes predominately 
12 
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from the higher singlet state, it is often found that the quantum efficiency (<p) is 
independent of the excitation wavelengthS1 For highly fluorescent molecules, such 
as fluorescein, under some conditions <p approach one. 
In theory, the observed fluorescence intensity, which is only a fraction of IF 
because of instrumental factors, is proportional to both the solute concentration 
and to the intensity of the exciting light source at the absorption wavelength, 
suggesting the more intense the light source the greater the fluorescence. 
However, in practice a highly intensive radiation source can cause 
photodecomposition of the sample, therefore a moderate intensity is used. 
1.2.3 Advantages of fluorescence 
One of the most attractive features of fluorescence methods is their inherent 
sensitivity , with detection limits often being one to three orders of magnitude 
smaller than those encountered in absorption spectroscopy. Typical detection 
limits are in the parts-per-billion range. As fluorescence is measured at right 
angles to the incident beam, it is considered a zero background technique. 
Another advantage of fluorescence methods is their large linear concentration 
ranges, which are often significantly greater than those encountered in absorption 
methods. 
Finally, the selectivity of fluorescence procedures is often better than that of 
absorption methods. Fluorescence methods, however, are much less widely 
applicable than absorption methods because of the relatively limited number of 
chemical systems that can be made to produce luminescence. 44 
1.2.4 Limitations of fluorescence 51 
The principle disadvantage of fluorescence as an analytical tool is its serious 
dependence on the environment (temperature, pH, ionic strength, etc.). 
1.2.4.1 Photochemical decomposition 
The ultraviolet bright light used for excitation may cause photochemical changes 
in, or destruction of, the fluorescent compound, giving a gradual decrease in the 
intensity reading. In a practical sense one can take three measures to avoid 
13 
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photochemical decomposition: (a) always use the longest wavelength radiation for 
excitation; (b) measure the fluorescence of the sample immediately after 
excitation, not allowing the exciting radiation to strike the sample for long periods; 
(c) protect photochemically unstable standard solutions, such as quinine sulphate, 
from sunlight and ultraviolet laboratory light by storing in a black bottle. 
1.2.4.2 Quenching 
Quenching, the reduction of fluorescence by a competing deactivating process 
resulting from the specific interaction between a fluorophore and another 
substance present in the system, is also frequently a problem. 
The general mechanism for the quenching process can be denoted as follows: 
Sometimes also, 
or 
M +hv ~ M* 
M* ~ M + hv 
M*+Q ~ Q*+M 
Q* ~ Q + energy 
M +Q ~ [MQ] 
M*+ M ~ [MM*] 
etc. 
(light absorption) 
(fluorescence emission) 
( quenching) 
Four common types of quenching are observed in luminescence processes: 
temperature, oxygen, concentration, and impurity quenching. One of the most 
notorious quenchers in organic solvents is dissolved oxygen, which causes a 
reduction in fluorescence intensity and a complete destruction of phosphorescent 
intensity; however, oxygen quenching is not usually serious in aqueous solutions. 
Small amounts of iodide and nitrogen oxides are very effective quenchers and 
interfere. 
Small amounts of highly absorbing substances like dichromate interfere by robbing 
the fluorescent species of the light available for excitation. For this reason most 
workers prefer not to wash their cuvettes with dichromate cleaning solution. 
14 
Chapter 1 Introduction 
Temperature quenching. As the temperature is increased, fluorescence 
decreases. The degree of temperature dependence varies from compound to 
compound. Tryptophan, quinine, and indoleacetic acid are compounds whose 
fluorescence varies greatly with temperature. The change in fluorescence is 
normally 1 % per 1°C; however, in some compounds, such as Tryptophan or 
Rhodamine B, it can be as high as 5%. Temperature effects on luminescence are 
a type of excited-state quenching by encounter. The fluorescence changes are 
mainly those of molecular activity with temperature, which suggests that increasing 
temperature increases molecular motion and collisions, and hence robs the 
molecule of energy. 
Concentration quenching. Absorption causes many problems during a 
f1uorometric assay, just as fluorescence causes a problem when the absorbance 
of a solution is measured. 
In order for fluorescence to be observed absorption must occur. The fluorescence 
intensity is proportional to the molar absorptivity: the more highly absorbing the 
substance, the greater its fluorescence. However, when the absorption is too 
large, no light can pass through to cause excitation. Thus, at low concentrations, 
when the absorbance is less than about 0.05, there is a linear relationship 
between fluorescence and concentration. At intermediate concentrations the light 
is not evenly distributed along the path of light. The portion of the solution nearest 
the light source absorbs so much radiation that less and less is available for the 
rest of the solution. As a result, considerable excitation occurs at the front of the 
solution, but less and less occurs throughout the rest of the cell. This type of 
concentration quenching causes a fluorescence loss that is called the inner-filter 
effect. 
1.2.5 Fluorophores 
Fluorophores can be broadly divided into two main classes: intrinsic and extrinsic. 
Intrinsic f1uorophores are those which occur naturally. They include the aromatic 
amino acids - tryptophan, tyrosine and phenylalanine in proteins, vitamin A and 
B2, NADH derivatives of pyridoxal and chlorophyll. Extrinsic f1uorophores are 
added to the sample to provide fluorescence when none exists or to change the 
15 
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spectral properties of the sample. Indeed, there are many instances when the 
molecule of interest is non-fluorescent or when the intrinsic fluorescence is not 
adequate for the desired experiment. For example, in the case of proteins, it is 
frequently desirable to label them with chromophores that have longer excitation 
and emission wavelengths than the aromatic amino acidss 2 
A variety of fluorophores have been used in this study, and the structure, and brief 
descriptions of each fluorophore are given below and in table 1.3. The energy 
capture efficiency of a fluorescent dye is expressed as the exti nction coefficient (E) 
and usually ranges from 10000 - 250000 cm-1M-1. The emission efficiency is 
expressed as the quantum yield or quantum efficiency (<p) , and usually ranges 
from 0.05 - 1.0. Quantum yield is strongly influenced by the local environment and 
so is not usually reported as a 'constant' like the extinction coefficient. The best 
fluorophores will have both a high extinction coefficient and high quantum yield. 
1.2.5.1 Fluorescein isothiocyanate 
A more detailed description of fluorescein isothiocyanate (FITC) can be found 
elsewhere.53 The structure and spectral characteristics of FITC are shown in figure 
1.7 and table 1.3. 
Advantages: high extinction coefficient, excellent fluorescence quantum yield 
(- 0.9) and good water solubility. 
Disadvantages: relative high rate of photobleaching and pH-sensitive 
fluorescence that is significantly reduced below pH 7.0 (pI<" -6.4). 
SCN 
HO o OH 
A..x = 494 nm, Aem = 520 nm, MW = 389.4 
Figure 1.7 Structure of FITC, Isomer I 
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1.2.5.2 BODIPY Dyes 
The BODIPY dyes are dibenzopyrrometheneboron difluoride compounds. All the 
BODIPY dyes have a difluoro-bora-diaza-indacene structure. Different substituents 
are then added onto this basic structure to produce different BODIPY dyes with 
different excitation and emission wavelengths. Numerous sources of information 
can be found on these fluorophores.54-56 The particular BODIPY dyes that have 
been used in this study are shown in figure 1.8 and 1.9, and their spectral 
characteristics can be seen in table 1.3. 
Advantages: high extinction coefficients, high fluorescence quantum yields (often 
approaching 1.0, even in water), greater photostability than fluorescein - they 
remain intensely fluorescent even when constantly illuminated. 
Disadvantages: expensive (- £188 per 5 mg) and small Stokes shift HO nm). 
H3C 
o 
11 0 
CH2CH2- C-NH(CH2),_! H3C 
\ O-N 
o 
A..x = 504 nm, "-em = 513 nm, MW = 502.32 
Figure 1.8 Structure of BODlPY " FL-X, SE 
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11 CH2-C-O-N I 
CH2 
o 
A.< = 500 nm, "-em = 509 nm, MW = 417.22 
Figure 1.9 Structure of BODlPY " 493/503, SE 
Table 1.3 Spectral characteristics of the dyes 57 
Dyes Aabs· "'em" 
BODlPY " FL-X, SE 504 513 
BODIPY " 493/503, SE 501 508 
FITC 494 518 
• Absorbance and fluorescence emission maxima in nm 
# Extinction coefficient at AMax in cm" M" 
• Correction factor (A2BO free dye 1 Am" free dye) 
e and CF,BO employed for calculating the final dye: protein ratio 
1.2.6 Fluorigenic substrates 
eH 
68000 
87000 
73000 
Introduction 
CF280 • 
0.04 
0.14 
0.20 
In this work two of fluorigenic substrates or fluorophores conjugates have been 
investigated and thus a brief description of each is given. 
1.2.6.1 Fluorescein digalactoside 58 
Fluorescein di-~-O-galactopyranoside (FOG) is a fluorigenic substrate for ~­
galactosidases W-gal). Nonfluorescent FOG is sequentially hydrolyzed by the 
enzyme, first to fluorescein monogalactoside (FMG) and then to highly fluorescent 
fluorescein (figure 1.10) 
18 
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FDG FMG Fluorescein 
Figure 1.10 Sequential hydrolysis of FOG to FMG and fluorescein by p-gal 
The Km for FOG conversion to FMG has been determined to be approximately 18 
~M , although much higher values (>600 ~M) have also been reported. The 
turnover rate for hydrolysis of FOG to FMG (1.9 ~mol min" mg") is much slower 
than for conversion of FMG to fluorescein (22.7 ~mol min" mg-'). Low levels of 13-
gal activity are readily detectable with FOG due to the superior spectral 
characteristics of fluorescein. 
1.2.6.2 Fluorescein diphosphate 59 
Fluorescein diphosphate (FOP) is a fluorigenic alkaline phosphatase substrate that 
was first described in 1963 and has been isolated in pure form and made 
commercially available by Molecular Probes. Molecular Probes' researchers have 
used the substrate in an alkaline phosphatase-based enzyme-linked 
immunosorbent assay (EL/SA), finding that it provided a detection limit 50 times 
lower than that obtained with the chromogenic substrate, p-nitrophenyl phosphate. 
The high pH used to monitor alkaline phosphatase activity is advantageous as it 
also produces optimal absorptivity and fluorescence of fluorescein. FOP is 
colourless and nonfluorescent. Sequential alkaline phosphatase mediated 
hydrolysis of the two phosphate substituents (figure 1.11 ) yields weakly 
fluorescent fluorescein monophosphate followed by strongly fluorescent 
fluorescein (excitationlemission - 4901518 nm).60 
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Figure 1.11 Structure of fluorescein diphosphate (FOP) 
1.3 FLOW INJECTION ANAL VSIS 
The theory, application and developments of flow injection analysis (FIA) are 
covered by many papers and books.61-65 The term 'flow injection analysis' was first 
used by Ruzica and Hansen in 1975,67 who described the use of sample injection 
directly into an unsegmented flowing stream for rapid continuous - flow analysis. 
FIA is now widely used and well characterized ; its simple basis, relatively 
inexpensive equipment and ease of result generation are excellent in view of the 
rapidity, accuracy and precision with which results are obtained. The critical 
features of FIA can be described as: unsegmented flow, direct injection, controlled 
partial dispersion and reproducible operational timing. 
The fundamental scheme of an FIA system is shown in figure 1.12. 
Carrier 
stream 
Pump 
Injection 
valve 
Reaction coil 
Detector 
Figure 1.12 Schematic diagram of a single line FIA manifold 
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Usually, a FIA system consists of four components: 
A propelling unit, which produces the flow of one or several solutions, either 
containing a dissolved reagent or merely acting as carriers. This function can be 
performed in various ways, for example by a pump, a gas-pressure system or 
even gravitation. 
An injection system, which allows the reproducible insertion or introduction of an 
accurately measured sample volume into the flow without stopping it. 
A length of tubing, along which the transport operation takes place, this is 
referred to as the reactor. Dispersion of the sample plug into the carrier or reagent 
takes place as the plug passes along the tube, also there may be chemical 
reactions occurring. 
A flow cell , accommodated in a detector (e.g. photometer, fluorimeter, 
colorimeter) which transduces some property of the analyte into a signal to a 
recorder or a PC with a data handling package. 
The flow emerging from the sensing system usually goes to waste, although it is 
sometimes recirculated through the peristaltic pump to achieve greater constancy 
of flow rate. The signal obtained from FIA techniques is transient. A typical FIA 
peak is shown in figure 1.13 . 
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Figure 1.13 A typical FIA peak 
Time 
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The parameters of the peak shape are affected by the flow rate of the carrier, the 
injected volume, the length and bore of the manifold, the viscosity of the sample 
and carrier and the detector and recording system time constant. 
In FIA, immediately after injection through the sampling valve, a sample zone is 
formed in the flow injection apparatus, which has a rectangular concentration 
profile. As it moves through the tubing, band broadening or dispersion takes place. 
If the sample dispersion is due to convection, the flow profile is characterised by a 
parabolic head and tail. This type of flow is characteristic of most flow injection 
systems. If this were the only mass transport process operating, the peak would 
have an infinitely long tail , as the velocity at the walls of the tubing is zero. Two 
additional mass transport processes are operating; molecular diffusion in the 
longitudinal direction (parallel to direction of flow). The longitudinal diffusion is 
small compared with the dispersion due to the flow velocity and can be ignored 
under the conditions of most flow injection experiments. Radial diffusion moves 
sample molecules to and from the tubing walls, where the radial flow velocity 
profile is zero towards the centre of the tube, where the mass flow velocity is at 
maximum. The net result of radial diffusion is that a peak with a finite peak width is 
obtained. Radial diffusion becomes more important as the residence time of the 
sample increases, at long residence times, primarily the radial diffusion process 
controls the dispersion product process and the peak shape assumes a 
symmetrical Gaussian shape. 
Dispersion (D) is defined by equation 
D = Co I C 
Where: Co is the analyte concentration of the injected sample. 
C is the peak concentration at the detector. 
Dispersion is readily measured by injecting a dye solution of known concentration 
(Co) and then measuring the absorbance in the flow cell . After calibration, C is 
calculated from Beer's law. Dispersion is influenced by the three interrelated and 
controllable variables: sample volume, tube length, and pumping rate. 
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1.4 ENZYMES 
1.4.1 Introduction to enzymes 
Enzymes are biological catalysts. They increase the rate of chemical reactions 
taking place within living cells without themselves suffering any overall change. 
The reactants of enzyme-catalysed reactions are termed substrates and each 
enzyme is quite specific in character, acting on a particular substrate or substrates 
to produce a particular product or products. 
Enzymes are proteins. However, without the presence of a non-protein component 
called a cofactor, many enzyme proteins lack catalytic activity. When this is the 
case, the inactive protein component of an enzyme is termed the apoenzyme, and 
the active enzyme, including cofactor, the holoenzyme. The cofactor may be an 
organic molecule, when it is known as a coenzyme, or it may be a metal ion. Some 
enzymes bind cofactors more tightly than others. When a cofactor is bound so 
tightly that it is difficult to remove without damaging the enzyme it is sometimes 
called a prosthetic group.68 
To summarize diagrammatically: 
/ORGAN1C MOLECULE 
/INACTIVE PROTEIN (APOENZYME) + COFACTOR (COENZYME) 
ENZYME \ .... (HOLOENZYME) .. \ 
METAL ION 
ACTIVE PROTEIN 
Enzymes are valuable analytical tools and offer sensitive and specific methods of 
quantitation for many substances. The increasing availability of highly purified 
enzyme preparations, both in solution and in immobilized forms permits the 
development of a wide range of methods. 
Many sources of literature covering the structure function and basic concepts of 
enzymes are available for a more detailed discussion.68-75 
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1.4.2 Factors affecting enzyme activity 
Several factors affect the rate at which enzymatic reactions proceed: temperature, 
pH, and the presence of any inhibitors or activators. 
Like most chemical reactions, the rate of an enzyme-catalysed reaction increases 
as the temperature is raised to a maximum level, known as the optimum 
temperature. Activity then abruptly declines with further increase of temperature, 
normally due to denaturation of the enzyme. 
Enzymes are affected by changes in pH. The most favourable pH - the point 
where the enzyme is most active - is known as the optimum pH. Extremes of pH 
generally result in complete loss of activity for most enzymes where activity may 
not be restored even after re-adjustment of the pH. 
Enzyme inhibitors are substances that alter the catalytic action of the enzyme and 
consequently slow down, or in some cases, stop catalysis. Enzyme inhibition is 
discussed in more detail in section 1.6. 
Activators are substances that increase the catalytic activity of an enzyme, are 
used in very small amounts and which, unlike coenzymes; do not participate in the 
enzyme reaction. 
1.4.3 Free enzymes 
Three different enzymes have been investigated in this work and thus a brief 
description of each is given below. An extremely comprehensive book covers 
data banks, name and history, activity and specificity, structural chemistry, 
preparation, biological aspects, and distinguishing features of enzymes known to 
date l6,77 
1.4.3.1 Alkaline proteases 
Alkaline proteases (AlkP, EC 3.4.24.31) are one of the most important groups of 
industrial enzymes produced commercially and are used in the detergent, protein , 
brewing, meat, photographic, leather, and dairy industries18 These enzymes offer 
advances over the use of conventional chemical catalysts for numerous reasons, 
for example they exhibit high catalytic activity, a high degree of substrate 
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specificity , can be produced in large amounts and are economically viable. One of 
the commercial applications of the enzymes is the possibility of using them to 
catalyse peptide synthesis and to resolve racemic mixtures of amino acidsJ9 AlkP 
can be obtained from different sources such as bacteria, fungi, or certain insects. 
Brief properties of the enzymes are: enzyme type: serine protease, MW: 50,000, 
specificity: broad, pH: maximal activity at pH 11 .0, additional information: type XXI 
proteasen AlkP is covered in more detail elsewhere.80-82 
1.4.3.2 Alkaline phosphatase 
Alkaline phosphatase (AP, EC 3.1.3.1) from bovine intestine mucosa is a 
homodimeric metalloenzyme, which hydrolyses non-specifically phosphate 
monoesters at alkaline pH with release of inorganic phosphate and alcohol.83 AP is 
found in a variety of tissues and is particularly associated with bone mineralization, 
but its function and natural substrate are still unknown.84 The increase in activity of 
AP can result in painful changes in the bones, hepatitis and tumerigenesis. 
Alternatively, it can be used as an indicator of normal physiological process such 
as pregnancy and bone growth. The enzyme is widely used in test systems used 
to diagnose various diseases, such as hyperparathyroidism, and productions of 
various therapeutic preparations.85 
1.4.3.3 ~-Galactosjdases 
~-Galactosidases (~-Gal , EC. 3.2.1.23) are widespread , in microorganisms, plants 
and animals tissues. This enzyme is responsible for degradation of galactosyl ~­
linkages in glycolipids, glycoproteins, polysaccharides, and such disaccharides as 
lactose. Several glycosidases have been purified and their specificities 
determined.- The enzyme from Escherichia coli (E.col i) is an ideal model 
enzyme for the study of glycosidases, which act on disaccharides.89 ~-Gal is a 
glycosidase enzyme with tetrameric structure and one active site per monomer, 
and its x-ray structure has been determined.oo The mechanism of action of ~-Gal 
has not been firmly established, but it is generally accepted that it involves a 
double displacement reaction in which the enzyme forms and hydrolyses a 
glycosyl enzyme intermediate via an oxocarbonium ion like transition state.89 
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Characteristics of p-Gal from E.coli 91 are MW: 540,000, composition: the enzyme 
is tetrameric, being composed of four identical subunits of 135000 daltons, each 
with an active site, which may be independently active. The enzyme is readily 
fragmented into small peptides. The amino acid analysis indicates approximately 
1170 residues per subunit, and optimum pH: 6-8. 
1.4.4 Enzyme kinetics 
Experimental evidence shows that for many single-substrate enzyme-catalysed 
reactions a hyperbolic relationship exists between the velocity of the reaction, V 
and the substrate concentration [S] as shown in figure 1.14. 
v 
Vmax 
----- - --- - -----------------
t 
Analytically useful region 
for enzyme determination 
Analytically useful region for substrate 
determination 
[5) 
Figure 1.14 Dependence of initial velocity on substrate concentration for a single-substrate 
enzyme-catalysed reaction 
The graph V versus [S] (figure 1.14) shows three distinct regions: 
• At low substrate concentration the velocity of the reaction is directly related 
to the substrate concentration; this is the region of first order kinetics. 
• At intermediate substrate concentration there is a big curve, where the 
velocity of the reaction increases more slowly with increase in the substrate 
concentration. 
26 
Chapter 1 Introduction 
• At high substrate concentration Vmax is attained and the observed velocity is 
independent of further addition of substrate; this is the region of zero order 
kinetics. 
Kinetic models to explain these findings were proposed by Henri (1903) and 
Michaelis and Menten (1913). These were essentially similar, but Michaelis and 
Menten did a great deal of experimental work to give their work a sounder basis. 
The critical feature in their treatment is that a specific enzyme - substrate (ES) 
complex is a necessary intermediate in catalysis. The model proposed, which is 
the simplest one that accounts for the kinetic properties of many enzymes, is: 
ES E+P 
where E :: enzyme, S :: substrate, ES = enzyme - substrate complex, and P = 
product E combines with S to form ES with a rate constant of k1. ES then has 
two fates. It can dissociate to E and S with a rate constant of k.l or proceed to 
form P with a rate constant of k2. 
V= 
v max[S] 
Km +[5] (Eq.1.3) 
The equation 1.3 is Michaelis-Menten equation. It is a statement of the quantitative 
relationship between the velocity of the reaction V, the maximum velocity Vmax, and 
the substrate concentration [S], all related through the Michaelis-Menten constant 
Km. 
The meaning of Km is evident from the Michaelis-Menten equation. When [S] = 
Km, then V = Vmax I 2. Thus Km is equal to a substrate concentration at which the 
reaction rate is half its maximal value. 
The Michaelis-Menten equation gives a hyperbolic curve as shown in figure 1.14. 
This is not entirely satisfactory for the determination of Vmax and Km. Unless, after 
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a series of experiments, there are at least three consistent points on the plateau of 
the curve at different [S] values, then an accurate value of Vmax, and hence of Km 
cannot be obtained. 
This problem was overcome by Lineweaver and 8urk (1934) without making any 
fresh assumptions. They simply inverted the Michaelis-Menten equation thereby 
conveniently transforming it into a straight-line plot: 
1 Km 1 1 
-=----+--
V Vmox [5] Vmsx (Eq.1.4) 
This is of the form y = mx + c, which is the equation of a straight line graph; a plot 
of y against x has a slope of m and intercept of c on the y-axis. As shown in figure 
1.15, Km and Vmax can be read directly from the Lineweaver-8urk plot. 
1N 
Slope = KmNmax 
Intercept = -1/Km 
1 Intercept = 1 N max 
1 I [S] 
Figure 1.15 The Lineweaver-Burk plot 
Numerous sources of literature are available that discuss enzyme kinetics in 
greater detail. 68,70 
1.4.5 Quenched over-labelled f1uorigenic assays for proteolytic enzymes 
Assays based on fluorigenic protein substrates, which are over-labelled by suitable 
fluorophores to such an extent that the dye is efficiently quenched by internal 
energy transfer in the protein conjugate, have also been employed in many 
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papers.92,93 As shown in figure 1.16, upon protease digestion this internal energy 
transfer is abolished and the virtually non-fluorescent substrates release highly 
fluorescent dye-labelled peptides, the fluorescence intensity increases being 
proportional to enzyme activity. This type of protease assay removes the necessity 
for the separation of substrate from degradation products. 
Intramolecularly 
quenched substrate 
Protease 
Fluorescent cleavage 
products 
Figure 1.16 Schematic principle of an intramolecularly quenched protein substrate 57 
1.5 IMMOBILISED ENZYMES 
The term 'immobilised enzyme' describes an enzyme that has been chemically or 
physically attached to a water-insoluble matrix, polymerised into a water-insoluble 
gel, or entrapped within a water-insoluble gel matrix or water-insoluble 
microcapsule resulting in reduced or complete loss of enzyme mobility. These 
immobilised enzymes retain their catalytic activity and can be used repeatedly and 
continuously.94 The usage of binding enzymes onto solid materials goes back to 
1916 when Nelson and Griffin 95 first immobilised invertase on charcoal and 
observed that the enzyme retained most of its activity over a long period of time. 
However, this work was largely ignored until the 1950s. Since then immobilisation 
of proteins in general and enzymes in particular, has been widely studied and the 
number of applications of immobilised enzymes is increasing. In addition, the 
application of immobilised enzymes to flow injection analysis systems allows the 
combination of immobilised enzymes in different arrangements to permit multi-
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determination. Many sources of information can be found on the preparation, 
characteristics, and application of immobilised enzymes for more detailed reading. 
96-102 
1.5.1 Why immobilise enzymes? 
Immobilised enzymes offer many advantages over their solution analogues, some 
of which are listed below: 103 
• Low cost, they are economical as they can be used repeatedly and 
continuously 
• Increased stability in storage and use against denaturing conditions such as 
high temperature, extreme pH, and extreme salt concentrations 
• Ease of use as no enzyme solution preparation is required 
• They do not contaminate the sample and insoluble enzymes can be easily 
recovered from the reaction medium in case of batch analysis, while in the 
case of continuous flow system; samples are made to pass through 
immobilised enzyme reactors, resulting in controlled product formation 
• Rapid termination of reactions, especially in flow systems 
• Less susceptibility to the normal activators and inhibitors of the enzyme, 
therefore much more useful , for complex analytical samples such as blood 
• The possibility of simultaneous determinations, due to the greater variety of 
designs available for the use of immobilised enzymes in flow systems 
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1.5.2 Methods of immobilisation 
Immobilised enzymes are classified by methods as given in figure 1.17. 
IMMOBILISED ENZYMES 
I 
Attachment to carriers Crosslinking 
(bio )affinity binding 
-- covalent binding 
ionic binding 
adsorptive binding 
metal binding 
direct crosslinking 
crystallisation+ 
crosslinking 
co-crosslinking 
copolymerization 
after chemical 
modification 
I 
Encapsulation 
microcapsules 
Membrane 
devices 
liposomesl 
reversed 
micelles 
Figure 1.17 Classification of methods employed for enzyme immobilisation" 
1.5.3 Immobilised enzyme support 94 
The support material can have a critical effect on the stability of the enzyme and 
the efficiency of enzyme immobilisation, although it is difficult to predict in advance 
which support will be most suitable for a particular enzyme. The most important 
requirements for a support material are that it must be insoluble in water, have a 
high capacity to bind enzyme, be chemically inert and be mechanically stable. The 
enzyme binding capacity is determined by the available surface area, both internal 
(pore size) and external (bead size or tube diameter), the ease with which the 
support can be activated and the resultant density of enzyme binding sites. The 
inertness refers to the degree of non-specific adsorption and the pH, pressure and 
temperature stability. In addition, the surface charge and hydrophilicity must be 
considered. The activity of the immobilised enzyme will also depend upon the bulk 
mass transfer and local diffusion properties of the system. 
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Due to the often-conflicting requirements of a good support, various materials 
have been used. At present there is not a universally recommended support, the 
final choice being a compromise for each particular enzyme and experimental 
system. The type of support can, however, be conveniently classified into one of 
three categories: 
• Hydrophilic biopolymers based on natural polysaccharides such as 
agarose, dextran and cellulose. 
• Lipophilic synthetic organic polymers such as nylon, polystyrene, 
polyacrylamide and bis-acrylamide/ azlactone copolymer. 
• Inorganic materials such as controlled pore glass and iron oxide. 
In this work UltraLink® Biosupport Medium was used and thus a brief description of 
it is given below. 
1.5.3.1 UltraLink® biosupport medium 104 
Pierce UltraLink® biosupport medium is a preactivated, ready-to-use bead 
designed for use in affinity chromatography. These beads are composed of a bis-
acrylamide/ azlactone copolymer that is slightly hydrophobic in its active forms and 
highly cross-linked. Because the azlactone functionality is copolymerised with the 
matrix material , the binding capacity is an integral part of the bead. This results in 
a high level of functionality throughout the porous bead matrix. 
The support is provided in dry form and reacts rapidly with nucleophiles, which 
allows coupling to a wide range of proteins and small molecules. The beads 
average 50-80 microns in diameter with a very open architecture that provides 
both high surface area and high pore volume. Due to the rigid polymeric nature of 
this support, it has excellent utility in medium-to-Iow pressure chromatography 
applications. 
The azlactone functionality of the UltraLink® biosupport medium couples 
nucleophiles on ligands via a ring reaction to attach the ligand to the support 
through stable covalent linkages (figure 1.18). For example, amino-functional 
byproduct as a result of the coupling reaction, therefore this coupling chemistry is 
extremely safe and easy to use. 
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Characteristics of UltraLink® biosupport medium are pH stability of matrix: 1-13, 
temperature stability: 4-40 °C, average particle size: 50-80 microns, pore size: 
1000 A, swell volume: 8 ml gellg beads 
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Figure1 .18 Reaction of azlactone ring on UltraLink"' Biosupport Medium with amine-
containing ligand. 
1.5.4 Changes in enzyme properties after immobilisation 
Immobilisation of an enzyme results in a change in many of the physical kinetic 
properties of the corresponding soluble counterparts. This may be due to a 
considerable change in the microenvironment of the enzyme. Among the changes 
in physical properties, the storage and temperature stabilities are prominent. 
Numerous enzymes have been reported with an increase in long-term storage and 
thermal stability. Sulphite oxidase, which in the soluble form loses its activity 
rapidly (20% after six hours) at room temperature, when immobilised on controlled 
pore glass (CPG) shown no loss in activity for months in spite of continuous use at 
25 oC.105,106 This increase in stability may be due to the stabilisation of the native 
structure of enzyme. Immobilisation also has profound effect on the optimal pH . 
Depending on the nature of the carrier, the pH may shift towards a higher or lower 
value. Goldstein et al. 107 studied this phenomenon in detail. If the carrier used for 
immobilisation is negatively charged , then more positively charged ions, mainly H+, 
will accumulate at the boundary layer between the carrier and surrounding 
solution. To compensate for that, the pH of the bulk solution has to be displaced 
towards more alkaline pH. If the carrier is positively charged the opposite may 
occur. 
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Enzyme kinetics and therefore reactivity are changed after immobilisation, possibly 
due to the placement of the enzyme in a new environment. The charge on the 
carrier may also contribute to change in the rate constants. Excellent discussions 
on this aspect are available.1os,1OO 
1.5.5 Analytical applications of immobilised enzymes 
Immobi lised enzymes have been used for a long time in industry for 
biotechnological purposes, and in clinical , food and environmental analysis. Many 
reviews 96,110 exist on their analytical applications. In a wide variety of applications, 
immobilised enzymes have been used in electrodes or in the form of enzyme 
reactors. A brief description of them is given below: 
1.5.5,1 Immobilised enzyme electrodes 
An immobilised enzyme electrode is an electrochemical sensor on whose surface 
is attached a thin layer of enzyme. The outer surface of the enzyme exposed to 
the analyte is covered with a semi permeable membrane to protect the enzyme 
and allow the passage of substrate and product. The electrode is dipped into the 
analyte solution, which is stirred continuously to speed up mass transfer and 
provide fast response. The principle of such an electrode is shown in figure 1.19. 
.ll 
TT 
s 
Analyte 
solution 
Electrochemical 
sensor 
Enzyme layer 
Figure 1.19 Principle of an immobilised enzyme electrode 
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When the enzyme electrode is immersed in a sample solution, the substrate 
diffuses into the enzyme layer, where it is converted into a product, which then 
diffuses out of the enzyme layer to the electrode. Since the conversion of 
substrate to product depletes the available concentration of substrate a 
concentration gradient of both substrate and product is formed. After some time 
(0.5-10 minI a steady state is reached where the rate of supply and rate of 
consumption of substrate and rate of transfer to the electrode becomes constant. 
Quantitative measurements either at steady state or during the initial stages of the 
reaction can be made. 
Enzyme electrodes have been used for analysis of an analyte alone105 or in a 
mixture.111 These electrodes are very handy, easy to use and are cheap, but the 
disadvantages associated with their use are their long response and recovery 
times and their poor reproducibility. 
1.5.5.2 Immobilised enzyme reactors 
The reactors are columns holding immobilised enzymes on appropriate supports. 
Solutions carrying analyte can be made to pass through and react with enzyme, 
the enzyme being retained, while the product is carried to the detector. The 
advantage of these reactors is that almost any detector system can be used which 
can record the concentration of substrate, a product or coenzyme. Principally there 
are two types of reactors, packed-bed and open-tubular, both of which have been 
used successfully in flow systems. Jurkiewicz and Alegret112 studied a comparison 
of flow injection analytical biosystems based on open-tube and packed-bed 
enzyme reactors with three different enzymes (urease, creatinin iminohydrolase 
and creatine aminohydrolase). 
a) Packed-bed reactors 
Packed-bed reactors are receiving much attention. Their use was previously 
avoided because of the pressure drop across the column, but nowadays with the 
introduction of inorganic supports like glass beads, that problem has disappeared. 
These supports do not swell on packing, so that the pressure drop is minimised. 
Such reactors are easily prepared by packing a column of fixed volume with 
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immobilised enzyme (figure1 .20a). The unique advantage of a packed-bed reactor 
is its large surface area, thus it has the potential of providing a relatively larger 
number of immobilised enzyme molecules, therefore making possible the almost 
complete conversion of substrate into product. 
b) Open-tubular reactors 
Such reactors are comparatively difficult to construct. They are prepared by 
covalently immobilising enzymes onto the inner wall of tubing made of nylon or 
polyacrylamide (figure 1.20b). The advantages of open-tubular reactors are: 
• Low pressure drop 
• They are well suited for air-segmented analysers (autoanalysers) . 
• Blood samples do not block the reactors. 
• Their commercial availability. 
The problem associated with these reactors is the small amount of enzyme that 
can be attached to the inner wall of the tube owing to small surface area. Thus to 
achieve reasonable conversion of the substrate to product, a very long reactor 
would be required, which in turn would increase the dispersion.113 Also radial mass 
transfers to the walls in an open tube with a flowing liquid may be prohibitively 
slow. 
(a) 
;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;:;: 
:::::::;:;:::;:::;:::;:;:;:;:;:::::;:;:;:::;:::;:;:;:;:::;:;:;:::;:;:; 
(b) 
Figure 1.20 Immobilised enzyme reactors (a) packed-bed (b) open-tubular 
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1.5.6 Immobilised enzymes in FIA 
Immobilised enzymes were introduced in a continuous flow system around 
1974.114 Since that time a variety of FIA methods using immobilised enzymes 
appeared, which shows their usefulness in many areas of application especially for 
the determination of enzyme substrates.115.116 
Until 1988, of publications that appeared for the determination of substrates 30% 
of them dealt with glucose determination. This may be due to its clinical 
importance, as it is most frequently determined in clinical laboratories, or it may be 
due to the availability and cost of glucose oxidase, and perhaps also due to the 
high stability of this enzyme after immobilisation. Both areas (clinical and food) 
take advantage of high enzyme selectivity, so that enzymatic reactions can be 
applied to complex matrices like whole blood, serum, urine and all types of food 
and drinks. 
As the knowledge of FIA is developing more interesting applications of 
immobilised enzymes appear. Starting from the determination of a single analyte 
by using a single immobilised column, and progressing towards the determination 
of five or six analytes 117 in a sample demonstrates the advances in enzymatic 
methods in FIA. Analysis of more than one analyte is made possible by placing 
more than one reactor in series or parallel like determination of ethanol and 
aldehyde by immobilised alcohol dehydrogenase and aldehyde dehydrogenase, 
placed parallel to each other and determination of glucose and sucrose by 
immobilised invertase and mutarotase placed in series. 118,119 A plug of analyte 
mixture is split into sub-plugs before transfer to enzyme reactors. 
In spite of the high selectivity of enzymes for their substrates, sometimes 
interferences appear from the real samples e.g. blood and urine, in which ascorbic 
acid, uric acid and NH3 may reduce the system applicability. 
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However, a system's selectivity can be increased in several ways: 
• By the application of dialyser units or liquid chromatographic columns.119 
• By using appropriate reactors, this can eliminate the interfering species. It 
may be enzyme reactors (e .g. use of immobilised ascorbate oxidase to 
eliminate interference of ascorbic acid in the determination of fructose) . 120 
After the exploitation of the advantages of immobilised enzymes in conjunction 
with FIA for chemical analysis, the technique has also been extended to process 
analysis. Conventionally, most industrial analyses are carried out off-line and face 
problems like limited reliability, time consumption and extra labour to deal with 
large number of samples for analysis. FIA with immobilised enzyme reactors can 
give reliable determinations of analytes in media originating from food and 
fermentation. 
The use of immobilised enzymes In FIA is not limited to the determination of 
enzyme substrates, but is also gaining attention for the determination of many 
enzyme inhibitors. 
1.6 ENZYME INHIBITION 
There are a variety of natural and synthetic compounds, which have the ability to 
inhibit specific enzymes and reduce or eliminate their catalytic activity. Drugs, 
metal ions and many other substrates are among such inhibitors. 
Enzyme inhibiting processes may be divided into two main classes, reversible and 
irreversible, depending upon the manner in which the inhibitor (or inhibitor residue) 
is attached to the enzyme. Reversible inhibitors bind to an enzyme in a reversible 
fashion and can be removed by dialysis (or simply dilution) to restore full enzyme 
activity whereas irreversible inhibitors cannot be removed from an enzyme by 
dialysis. Sometimes it may be possible to remove an irreversible inhibitor from an 
enzyme by introducing another component to the reaction mixture, but this would 
not affect the classification of the original interaction. 
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1.6.1 Reversible inhibition 
Reversible inhibition occurs if an inhibitor is bound non-covalently at the active site 
of the enzyme. Three distinct mechanisms of reversible inhibition are known and 
are recognized by the effect of substrate concentration on inhibition. 
1.6.1.1 Competitive inhibition 
In competitive inhibition, the inhibitor (I) mayor may not be similar to the substrate, 
and attacks at the active site or close to the active site of the enzyme in a 
reversible fashion: 
•• ===:::::f>P ES ------+. E + P 
El 
As shown above El and ES complexes are formed and no ESI complex appears in 
this type of inhibition. A high concentration of substrate can overcome this 
inhibition by making the reaction process towards ES and then product formation. 
The physical interpretation of competitive inhibition is that the inhibitor can 
reversibly bind with enzyme and compete with substrate for the binding site. 
Inhibitor can only bind with the free enzyme and not with the ES complex. By 
increasing the substrate concentration, inhibition decreases. From the kinetic 
expression it can be seen in figure 1.21 a that in the presence of a competitive 
inhibitor the reaction reaches half of its maximum velocity at high substrate 
concentration i.e. the y-intercept of the Lineweaver-Burk plot remains the same 
and the value of Km is increased, which is the characteristic of competitive 
inhibition. 
1.6.1.2 Uncompetitive inhibition 
E + S +~ ===='.~ ES -----~ E + P ~+I 
ESI 
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In uncompetitive inhibition, inhibitors only bind with the ES complex and not with 
the free enzyme. In this case a high concentration of substrate cannot reverse the 
inhibition, but increased substrate concentration increases the inhibition. In this 
case the rate of reaction cannot reach half of its maximum velocity i.e. the 
intercept and the value of Km are decreased (figure 1.21 b). 
1.6.1.3 Noncompetitive inhibition 
E + S '4'====~' ES -----+~ E + P 
H +1 H +1 
El + S ESI 
Noncompetitive inhibitors decrease the catalytic activity of an enzyme without 
influencing the binding relationship between the substrate and enzyme. It means 
that inhibitor and substrate can bind at the same site to an enzyme to form ES, El 
and ESI complexes. Noncompetitive inhibition completely depends on the inhibitor 
concentration and is unaffected by the substrate concentration. 
The Lineweaver-Burk plot is one way of visualizing the effect of inhibitors and 
determining the Michaelis-Menten constant, Km and the maximum velocity, Vmax 
from a set of measurements of velocity at different substrate concentrations. If 1 N 
is plotted against 1/[S), a straight line is obtained where the slope is equal to 
KmNmax and the y-intercept is equal to 1 N max. This method is usually used for 
distinguishing the type of inhibition. This information is used to select the 
appropriate type of plot needed to calculate the inhibition constant, ~. The 
Lineweaver-Burk plots of three modes of reversible inhibition are shown in figure 
1.21 a, b, and c. 
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Figure 1.21 Lineweaver-Burk plot for different modes of reversible inhibition 
where a, b, and c show competitive, uncompetitive and noncompetitive inhibition 
respectively 
1.6.2 Irreversible inhibition 
/' 
Irreversible inhibition occurs when an inhibitor binds to active site of the enzyme 
by an irreversible reaction and cannot subsequently dissociate from it. A covalent 
bond is usually formed and the inhibitor may act by preventing substrate binding or 
it may destroy some component of the catalytic site. In such type of inhibition the 
enzymatic activity cannot be reversed by dilution on dialysis.121 
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1.7 ENZYME INHIBITORS 
In setting out to find new inhibitors of a particular enzyme, an early decision that 
must be made is where to look. Chemical synthesis of new compounds designed 
to be inhibitors of the enzyme probably is the most common approach. Random or 
selective screening of existing synthetic compounds can be a source of leads to 
new structural types of inhibitors. Extraction of naturally occurring inhibitors from 
animal tissues or plants has been another source. 122 
In this work some of inhibitors have been investigated and thus a brief description 
of each is given. Comprehensive accounts of different enzyme inhibitors can be 
found in excellent references.123-125 
1.7.1 3-Nitrophenylboronic acid 
3-nitrophenylboronic acid (3-NPBA) is a reversible competitive serine protease 
inhibitor with a molecular weight of 166.93 and acts as a transition state analogue. 
Saccharides have been shown to act as a 'co-inhibitor' in the boronic acid 
inhibition system.126 Raghavendra and Prakash investigated the kinetics of 
inhibition of lipase by phenylboronic acid .m Investigation into the mechanism of 
binding of peptide boronic acids to proteases has been carried OUt.1 2B.129 
1.7.2 Vanadate 
Vanadate has a wide variety of effects in biological systems. Vanadate has 
multiple biologic effects, including inhibition of alkaline phosphatases and protein 
tyrosine phosphatases. The biologic effects of vanadate are very diverse, 
depending on the target cell and the concentration of vanadate. Vanadate has 
been shown to activate certain signal transduction mechanisms.13o In vitro 
vanadate has been shown to be a reversible inhibitor of phosphatases with a 
micromolellitre affinity.131 This may arise because of the ability of vanadate to 
adopt a trigonal bipyramidal structure that mimics the transition state in phosphoryl 
transfer reactions. m 
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1.7.3 Phenylethyl I3-D-thiogalactopyranoside 
Phenylethyl ~-O-thiogalactopyranoside (PETG) is a potent competitive inhibitor of 
~-galactosidase with K; ranging from 0.94 - 2.5 IJM .133 PETG has a thiol group 
substituted for the hydroxyl linkage present in compounds that ~-galactosidase 
normally hydrolyzes (figure 1.22).134 PETG when present in a reaction would be 
expected to occupy the enzyme and thus inhibit its action on hydrolysable 
substrates such as FOG. 
OH 
Figure 1.22 Molecular structure of phenylethyl Jl-D-thiogalactopyranoside 
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2.1 WHAT IS CHEMOMETRICS? 
A general definition of chemometrics is "the use of statistical and mathematical 
techniques to analyze chemical data".135 The development of the discipline 
chemometrics is strongly connected with the use of computers in chemistry. The 
term chemometrics was introduced in 1972 by the Swede Svante Wold and the 
American Bruce R. Kowalski. The foundation of the International Chemometrics 
Society in 1974 led to the first description of this discipline. In the following years 
several conference series were organized, e.g. COMPANA (Computer 
applications in analytics) , COBAC (Computer-based analytical chemistry) or CAC 
(Chemometrics in analytical chemistry). Some journals devoted special sections to 
papers on chemometric subjects. Later on novel chemometric journals were 
started, such as the Journal of Chemometrics (Wiley) and Chemometrics and 
Intelligent Laboratory Systems (Elsevier).136 
The relationship of chemometrics to different disciplines is indicated in figure 2.1. 
On the left are the enabling sciences, mainly quite mathematical and not 
laboratory based. Statistics, of course, plays a major role in chemometrics. 
Computing is important as much of chemometrics rel ies on software. On the right 
are the main disciplines of chemistry that benefit from chemometrics. Analytical 
chemistry is probably the most significant area. Environmental chemists, 
biologists, food chemists as well as geochemists, chemical archaeologists, 
forensic scientists and so on depend on good analytical chemistry measurements 
and many routinely use multivariate approaches, and so need chemometrics to 
help interpret their data. 
Statistics Chemometrics 
Engineering 
Organic 
Chemistry 
Analytical 
Chemistry 
Theoretical 
and Physical 
Chemistry 
/BiOI09y 
- Industrial 
~ Food 
Applications 
among 
others 
Figure 2.1 How chemometrics relates to other disciplines 137 
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Chemometrics has been used to: 
• Remove as much noise as possible from the data. 
• Extract as much information as possible from the data. 
• Use the information to learn how to make accurate predictions about 
unknown samples. 
In order for this to work, two essential conditions must be met: 
• The data must have information content. 
• The information in the data must have some relationship with the property 
or properties which we are trying to predict. 
The areas where chemometrics has been most successful, both in industry and in 
academia, according to all measures are the following: 
• Mu ltivariate cal ibration . 
• Structure-(re)activity modelling. 
• Pattern recognition , classification, and discriminant analysis. 
• Multivariate process modelling and monitoring. 
There are numerous sources of information on the theory of chemometrics and its 
applications. 135-140 Here only multivariate calibration will be considered in detail. 
2.2 MULTIVARIATE CALIBRATION 
The use of computers in the laboratory has enabled the adoption of a new 
approach to multi component determinations in complex samples by allowing the 
simultaneous processing of the vast amount of information provided by currently 
available instruments. Multivariate calibration methods, which rely on various 
mathematical algorithms, are being increasingly used to circumvent the problems 
posed by the presence of interferences, or spectral overlap. 
Multivariate calibration is a general selectivity and reliability enhancement tool. It is 
applicable to the determination of major constituents as well as microcomponents 
and other qualities, and for a very wide range of instrument types. With 
multivariate calibration the need for sample preparation is greatly reduced. The 
reason is that selective input measurements are no longer needed - it is the 
output results that must be selective. 
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Multivariate calibration can thus stimulate the development of new analytical 
instruments and increase their analytical capacity and reliability. This extends the 
usefulness of quantitative methods in on-line industrial process control, analysis of 
intact biological or medical samples, etc. 
2.2.1 Multivariate calibration decision tree 135 
The multivariate calibration decision tree (figure 2.2) is a guide to the selection of 
the appropriate multivariate calibration tool for a particular problem. Before 
discussing this tree, it is important to understand the distinction between linear and 
non linear approaches. In this chapter, only methods that estimate models that are 
linear in the parameters are discussed. Fortunately, these methods also tolerate 
some degree of non linear behaviour in the data. 
In figure 2.2 there are two main branches for the multivariate methods: classical 
least squares (CLS) and inverse least squares (ILS). Deciding which method to 
employ is not always straightforward. The question posed is "Is the system simple 
and are all of the analytes known?" If the answer to this question is yes, CLS may 
be the best approach. If the answer is no, ILS is the best (or only) choice. The 
difficulty in applying the CLS approach is knowing if the system meets the 
assumptions inherent to the methods. CLS is applicable when all of the analytes 
are known and pure spectra can be obtained using either the direct or indirect 
methods. These systems typically have relatively few major components, few 
factors that affect the instrument response other than the concentration of the 
analytes of interest, and no significant interferences. It also must be possible to 
represent the mixture spectra as combinations of the pure spectra. If all these 
conditions hold, CLS has an advantage over the ILS methods in that it is generally 
easier to construct a calibration model. All that is required for the model are 
spectra of the pure components of interest. 
Two CLS methods are available, direct (DCLS) and indirect (ICLS), where the 
difference is in how the pure spectra are obtained. If it is possible to isolate the 
pure analytes and directly measure the pure spectra, the DCLS method can be 
used. If the pure analytes cannot be isolated, it may be 
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Yes Is the system simple and are all 
of the analytes known? 
Classical Least Squares (CLS) 
Explicitly account for all sources 
of variation. (Need pure spectra 
of all components) 
Are the pure spectra 
readily available? 
No 
Yes 
Inverse Least Squares (ILS) 
Implicitly account for all sources 
of variation. (Do not need pure 
spectra of all components) 
Direct CLS (DCLS) 
Pure spectra 
measured directly 
Indirect CLS (ICLS) 
Pure spectra estimated 
using mixtures 
r-----Yes---<' 
s the number 0 
variables small or is the 
goal t o reduce the 
umber of variables 
Multiple Linear Regression (MLR) 
Principal Components 
Regression (PCR) 
Transform to stabilize the 
regression using only the 
spectral (R) data 
No 
Partial Least Squares (PLS) 
Transfonn to stabilize the 
regression using concentration 
(C) and spectral (R) data 
Figure 2.2 Multivariate calibration decision tree 135 
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possible to obtain the pure spectra mathematically by using spectra of mixtures 
and the ICLS approach. 
If the system is not simple, an inverse calibration method can be employed where 
it is not necessary to obtain the spectra of the pure analytes. The three inverse 
methods discussed later in this chapter include: multiple linear regression (MLR), 
principal components regression (PCR), and partial least squares (PLS) . When 
using MLR on data sets found in analytical chemistry, variable selection is often 
required to make the matrix calculations possible and/or improve the stability of 
the calculations. It is therefore appropriate to use MLR when the number of 
variables is small, or in situations where a subset of measurement variables is 
desired. An example of the latter is when a full-wavelength instrument is used to 
perform a feasibility study, but where a filter instrument is to be purchased for 
economic or other reasons. It must be borne in mind that reducing the number of 
variables will almost always result in poorer error detection ability and less precise 
estimates. However, this may be outweighed by other factors. 
Unlike MLR, PCR and PLS are methods that can be used without explicitly 
selecting variables. This is accomplished by transforming the measured variables 
(e.g. fluorescence spectra at many wavelengths) into new variables (often referred 
to as factors) that are used in the matrix calculations. The difference between PCR 
and PLS is in how this variable transformation is performed. Both PCR and PLS 
have good diagnostic tools and in general the results are similar. These methods 
are often preferred over MLR unless the number of variables is small or 
circumstances dictate the explicit reduction in the number of variables. 
The basic questions that must be answered in deciding between these methods 
are found in the decision tree. The information found throughout this chapter also 
helps to reveal how these questions are best answered. 
Quantification is an important task in fluorescence spectroscopy. Since 
fluorescence spectroscopy is an indirect measurement technique, calibration is 
usually required. Moreover, calibration is a fundamental step in the calculation of 
the unknown concentrations of compounds in spectroscopy. In calibration, indirect 
measurements are made from samples where the amount of analyte has been 
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pre-determined, usually by an independent assay or technique. These 
measurements, along with the pre-determined analyte concentrations, comprise a 
group known as the 'calibration set'. This set is then used to develop a model, 
albeit absolute or relative, that relates the concentration of analyte (y), to the 
measurements made by the instrument (x), via some evaluation function fO . 
y = f(x) (Eq.2.1 ) 
However, as with all chemical measurements there will always be some degree of 
systematic or random error, hence the calculated concentration is said to be an 
estimate of the actual concentration y, and is usually denoted y (the symbol • 
above the term denotes its an estimate of the true value). So equation 2.1 should 
be correctly written as: 
y = f( x) (Eq.2.2) 
Once the model has been constructed, it can then be used to predict the 
concentration of the analytes based on the measurements made from the new 
samples usually termed 'the new data set' . For absolute calibration methods, there 
tends to be a mathematical formula that relates x to y. 
If the relationship between x and y is not obvious then determining the model can 
be very time consuming, and sometimes almost impossible to figure out. In these 
circumstances relative calibration methods can be used. Such calibration methods 
make assumptions on the underlying relationship between x and y. This is 
achieved by using some given examples of the x and y variables (calibration set), 
to estimate the parameters of the relationship.141 
Univariate calibration is based on a single measurement. There are two possible 
approaches to univariate calibration. The first involves predicting a single 
concentration from absorbance at a single wavelength. The weakness of this is 
that it will fail if there are unknown interferences or completely overlapping spectra. 
An alternative is to predict the concentrations using a matrix of all concentrations. 
When there are more samples than variables, the approach is referred to as 
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multiple linear regression (MLR). If the number of variables is larger than the 
number of samples and the variables are linearly dependent or if they are highly 
correlated , the matrix is singular or nearly singular, which means that the 
computed regression coefficients are relatively imprecise. This collinearity can 
cause MLR to fail when applied to data sets containing highly correlated 
variables.142 Another two common methods of calibrations include partial least 
squares (PLS) and principle component regression (PCR). Graphical 
representation of matrices of calibrations used in analytical chemistry is shown in 
figure 2.3. 
1 1 
.G .G 
K 1 
EJ ,G 
1 
.8 
K 
,Cv] 
J 
X 
J 
X 
Univariate 
MLR 
PCR 
PLS-1 
PLS-2 
Figure 2.3 Graphical representation of matrices of calibrations used in analytical 
chemistry'42 
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2.2.2 Principal component regression 
The idea of principal component regression (PCR) is to form a model between a 
concentration of a compound and the principal components (PCs) of a data matrix, 
e.g. spectra. It differs from MLR in that the spectra are first reduced to a few 
orthogonal PCs. This means that even if there is a high correlation between 
wavelengths, PCR is nevertheless effective. PCR is performed using only one 
concentration vector at a time. When there is more than one concentration of 
interest, PCR is applied to each concentration vector separately.137 The PCR can 
be implemented as a full spectrum calibration method. However, with PCR the 
spectral decomposition is performed slightly differently. PCR is a two-step 
multivariate calibration method in which the first step involves principal component 
analysis (PCA) being carried out on the data matrix, followed by a multiple linear 
regression (MLR) step. 
There is plenty of literature on the methods of PCA and MLR. l43,l44 Hotelling 145 
first described PCA in 1933; however, Malinowski first introduced it into chemistry 
around the 1960's under the name of principal factor analysis. After 1970 a large 
number of chemical applications have been published and PCR has been 
successfully applied to the quantitative analysis of ultraviolet,146,147 
fluorescence,l46 near infrared,149 and chromatographic 150 data. 
The core of PCR is the PCA of the data matrix, and several algorithms for PCA are 
available. One of the most commonly used algorithms is the non-linear iterative 
partial least squares algorithm (NIPALS) and it computes sequentially the 
eigenvectors by order of explained variance. The algorithm has been described by 
manyauthors.144,151 
2.2.3 Partial least squares 
One of the most promising multivariate statistical methods to find application in 
chemistry is partial least squares (PLS) developed by WOld.152 Certain 
Scandinavian and North American groups have based much of their development 
over the past two decades primarily on applications of the PLS algorithm. Since its 
introduction into chemometrics as a tool for solving regression problems with 
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linearly dependent predictor variables, PLS has become a common, if not 
standard regression method. It has been successfully applied to the quantitative 
analysis of ultraviolet,l53 fluorescence ,34,41 near infrared,l54 and chromatographic 
155,156 data. Much work has gone into making clear its mathematical and statistical 
properties,157-160 and several altemative algorithms have been proposed.161,162 All 
these effects have helped to clarify the diverse aspects of PLS and shed light on 
what was once, by definition, only an algorithm. 
Like PCR, the PLS algorithm can be implemented as a full spectrum calibration 
method which gives it many advantages such as; (1) potentially significant 
improvements in precision for estimating sample concentrations or properties from 
calibration spectral data, (2) useful information (contained in the loading vectors) 
that allows quantitative chemical interpretation of spectral features, and (3) the 
ability to calculate spectral residuals that can be used for efficient outlier detection 
diagnostics and further qualitative interpretation. 
PLS is often presented as the major regression technique for multivariate data. An 
important feature of PLS is that it takes into account errors in both the 
concentration estimates and the spectra. A method such as peR assumes that the 
concentration estimates are error free. Much traditional statistics rests on this 
assumption, which all errors are of the variables (spectra). If in medicine it is 
decided to determine the concentration of a compound in the urine of patients as a 
function of age, it is assumed that age can be estimated exactly, the statistical 
variation being in the concentration of a compound and the nature of the urine 
sample. Yet in chemistry there are often significant errors in sample preparation, 
for example accuracy of weighings and dilutions, and so the independent variable 
in itself also contains errors. Classical and inverse calibration force the user to 
choose which variable contains the error, whereas PLS assumes that it is equally 
distributed in both the x and c blocks.137 
There are two main PLS algorithms, usually termed PLS-1 and PLS-2. The most 
widespread approach is often called PLS-1 . Although there are several algorithms, 
the main ones due to Wold and Martens, the overall principles are fairly 
straightforward. An extension to PLS-1 was suggested some 20 years ago, often 
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called PLS-2. In PLS-1 one compound is modelled at a time, whereas in PLS-2 all 
known compounds can be included in the model simultaneously. 
The concentration estimates are different when using PLS-2 compared with PLS-
1. In this way PLS differs from PCR where it does not matter if each variable is 
modelled separately or all together. The reasons are rather complex but relate to 
the fact that for PCR the principal components are calculated independently of the 
c variables, whereas the PLS components are also influenced by both blocks of 
variables. 137 
In some cases PLS-2 is helpful , especially since it is easier to perform 
computationally if there are several c variables compared with PLS-1 . Instead of 
obtaining many independent models, it can analyse all the data in one go. 
However, in many situations PLS-2 concentration estimates are, in fact, worse 
than PLS-1 estimates, so a good strategy might be to perform PLS-2 as a first 
step, which could provide further information such as which wavelengths are 
significant and which concentrations can be determined with a high degree of 
confidence, and then perform PLS-1 individually for the most appropriate 
compounds.137 
The aim of this research is to quantify the individual components from a series of 
mixtures, thus the algorithm PLS-1 will only be discussed in detail here. The 
orthogonal PLS-1 method presented is that used by Marten and Nces,163 and is 
used by the Unscrambler® software which was used throughout this research. 
2.2.4 Orthogonal PLS-1 algorithm 
To calculate the estimates of the model parameters, the number of relevant 
principal factors needs to be determined (factors that significantly affect the 
results, i.e. the number of components in the mixture, noise, etc.). It has been 
suggested that the number of factors should be higher than the number of 
phenomena expected, and those that do not contribute to the model should be 
removed later, thus allowing any unexpected phenomena to be modelled. The 
total number of factors used here will be denoted a (a = 1, 2 ... A). 
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To make the calculations easier, the calibration data is mean-centred. This is 
achieved by calculating the variance for each of the individual x and y variables. 
(Eq.2.3) 
yo= y-w (Eq.2A) 
where X is a matrix containing the instrument response variables j for i samples 
{Xij i =1 ,2 .. .. 1 j = 1 ,2 .. .. J} and vector y contains the concentrations of a particular 
analyte in the samples {Yi} 
For each of the variables in Xo its projection in the X-space has direction and 
length. These two parameters are usually known as spectral loadings and scores 
and are denoted p and t respectively. So theoretically, 
(Eq .2.5) 
where E is the X-residual error matrix. However, in PLS the t scores tend to be 
orthogonal to each other, whereas the spectral loadings p, tend to be non-
orthogonal.39 Hence, there is no guarantee that the spectralloadings (or rather the 
scores formed by the projection) are suitable for predicting y. To solve this 
problem a set of loading weights are used (denoted Wi) that are orthogonal to each 
other. They express how the information in each X-variable relates to the variation 
in y. The loading weights also can be used to calculate the t scores from the X 
matrix so that the decomposition of the data is orthogonal. So equation 2.5 can be 
rewritten as: 
X._1 = t . w . '+E (Eq.2.6) 
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However, the loading weights are usually scaled to a length of 1 to avoid any 
scaling ambiguities, using the scaling factor s, where: 
(Eq.2.7) 
This is so their lengths can be interpreted as well as their direction. The variables 
with large loading weights are of importance when it comes to predicting y. 
Therefore the loading weights need to maximize the scaled covariance between 
X.-l and Ya- l such that: 
(Eq.2.8) 
The loading weights can be estimated using the following formula: 
. X' 
w a = S a-I Y •. l (Eq.2.9) 
Now that the loading weights have been estimated, the t scores can be estimated 
using equation 2.6. The least squares solution is: 
(Eq.2.10) 
Substituting la back into equation 2.6 gives, 
X a-I = X a-I IN a • IN a + E (Eq.2.11 ) 
which is equivalent to, 
Xa_1 = Xa_1 + E (Eq.2.12) 
since IN;IN. is equal to 1. 
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...........................................................................................•...•.................. , .................................. -.................................................................. . 
The spectralloadings can now be estimated using equation 2.5. The least squares 
solution is (where P. is an estimate of p): 
• X. t. P. = a-l -. - .-
t ; t . 
(Eq.2.13) 
Substituting Pa back into equation 2.5 gives: 
X X i.i; E a-1 = a.1 -· -· -+ 
tata' 
(Eq.2.14) 
which is equivalent to equation 2.12 because: 
Vector Ya-l. can also be broken down in to chemical loadings and scores. The 
chemical loading is usually denoted q and is a scalar because only one y variable 
is calculated in this PLS-1 algorithm. So Ya-l can be written as: 
Ya-l = t aqa + f (Eq.2.15) 
So using the least squares solution (where Cia is an estimate of qa): 
(Eq.2.16) 
Substituting back into equation 2.15 gives: 
Y.-1 = Y a-,' + f (Eq.2.17) 
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So from equations 2.5 and 2.15 the X and y residual matrix and vector can now be 
estimated respectively. 
(Eq.2.18) 
(Eq.2.19) 
If a equals A then the model parameters c and Co can be estimated. However, if 
a does not equal A, then a should be increased by one and the values for 
ta' Pa, wa and qa should be re-calculated using the new values for Xa-1 and Ya-1 
where: 
X 8-' = E and Ya-' = f 
Once the number of relevant factors has been determined the model parameters 
c and Co can be estimated using the following formulas: 
(Eq.2.20) 
and (Eq.2.21 ) 
The matrices Wand P represent the combined loading weights and spectral 
loading vectors respectively, estimated from each of the relevant factors, i.e. 
W = {w" W 2' ... W A} and P = p" P2,···PA}. The vector Cl represents the combined 
chemical loadings for all the relevant factors, i.e. Cl = {q" q2'····· .qA}. 
Once the model parameters c and Co have been estimated any further Xj 
variables from the new data set can be used to predict y using the formula: 
"" , " y = Co + x c (Eq.2.22) 
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2.3 UNSCRAMBLER SOFTWARE 
The Unscrambler is developed and published by CAMO ASA, created in the mid-
1980's. Harald Martens and the Norwegian Food Research Institute originally 
developed the software and tailor-made it for the modelling, prediction and 
classification of multivariate data. It has been used for chemometrics and process 
analysis within the food and drink industries, chemical industries, pharmaceutical 
industries, process industries and research and development. The software is a 
general software package for multivariate calibration and prediction by use of the 
PLS-1 , PLS-2, PCR and MLR algorithms. It also carries out statistical tests on the 
models generated, to check their validity. The methods give adequate solutions 
where traditional multiple regression fails owing to multi-colinearity problems.164 
The following are the five basic types of problems which can be solved using the 
software: 
• Design experiments, analyze effects and find optima. 
• Find relevant variation in one data matrix. 
• Find relationships between two data matrices. 
• Predict the unknown values of a response variable. 
• Classify unknown samples into various possible categories. 
There is much literature on various aspects of the Unscrambler software. 164-170 
2.4 VALIDATION 
When generating a calibration model it is very important to carry out validation 
tests on the data set to ensure that any future predictions made from it are 
accurate and reliable. In general to validate a model means to see how well it will 
perform on any new data and estimate the uncertainty of predictions made upon 
that data. If the uncertainty is reasonably low, then the calibration model can be 
considered to be valid. 
The best way of evaluating a model is prediction testing, or test set validation, with 
an independent data set that is not used in the calibration model . Test set 
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validation tends to be used on large numbers of samples (usually 50 or more) and 
divides the data set into two global sets called the calibration set and the test set. 
The calibration set contains the samples used to compute the calibration model 
and the samples in the test set are predicted from this model and compared to 
their actual values. However, this method is very inefficient with regards to 
samples (usually the test set contains 25% to 50% of the total data set) and the 
test samples are not used for calibration. 
Other alternative methods of validation that have been widely used include cross 
validation and leverage correction. 
2.4.1 Cross validation 
Cross validation has been referred to as a cunning technique to make up for the 
shortage of data and permits the testing of a calibration model without having a 
test set. There are a number of cross validation methods including full cross 
validation and segmented cross validation. 
Full cross validation (FCV) is a method that leaves out one sample at a time, the 
concentration of this sample being calculated from the calibration model generated 
by the other samples. This method improves the relevance and power of the 
analysis because all the samples are tested individually. However, using this 
method does have its drawbacks because it can be very time consuming and 
sensitive to unique samples (outliers), which would give a validation model 
significantly different from that of the calibration model. However, such findings 
could be useful in detecting outlying samples in the calibration set. 
An altemative method is segmented cross validation, which leaves out a whole 
group of samples at a time. This method is faster but the segments must contain 
unique information i.e. samples that are considered replicates of each other should 
not be present in different segments. This method is also sensitive to clusters in 
the calibration set e.g. if all the samples in the segment are very different from the 
others then there will be an excessive prediction error for this segment. 
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So how is the uncertainty of a calibration model measured when using the different 
cross validation methods? The simplest way and most efficient measure of 
uncertainty on future predictions is the root mean squared error of prediction 
(RMSEP) and is calculated using the following formula: 
RMSEP = 
N 
(Eq.2.23) 
where Yn is the predicted concentration of sample n, Yn is the actual concentration 
of sample n, and N is the total number of samples (minus the omitted sample) . 
This value gives the average uncertainty that can be expected when predicting the 
concentration of the samples, and because the square root is taken the units are 
the same as y. The lower the RMSEP value the more valid the model (zero being 
the ideal value) . 
2.4.2 Leverage correction 
Leverage correction (LC) can be used for projection methods such as PLS and 
PCR, but should only be used in early stages of analysis. This is because for such 
methods it gives more 'optimistic' results than the other validation methods. It 
especially affects the PLS algorithm because of the way in which the scores are 
estimated. The PLS components are more dependent upon the information in y 
thus the residuals fn (equation 2.26) for the calibration samples are much too small 
and cannot be fully corrected by the denominator 1-hn. The leverage (hn) is 
calculated in the space spanned by the correct number of relevant factors. Thus, 
(Eq.2.24) 
where Sa are the orthogonal score vectors, Cns is the regression factor for 
prediction sample n, N is the total number of calibration samples, and a is the 
factor number. The leverage of a sample describes its actual contribution to the 
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calibration model. A leverage value close to zero indicates that the corresponding 
sample had very little influence on the calibration model. 
The equation for calculating RMSEP for LC is based on an equation that is valid 
for multiple linear regression, thus can only give an approximation for PLS and 
PCR. Leverage correction is an approximation to cross val idation that enables 
prediction residuals to be estimated without actually performing any prediction. 
The predicted residuals in full cross validation 164 are equal to: 
f =~ 
n(cv) 1- h 
n 
(Eq.2.25) 
where fn is the predicted residual for sample nand hn is the leverage for sample n. 
Thus, the equation to calculate the RMSEP (LC) is equal to, 
RMSEP(LC) = f f ~ /(1 - hn ) ' 
n N 
(Eq.2.26) 
where N is the number of samples. The lower the RMSEP the more valid the 
model (zero being the ideal value). 
2.4.3 Residual variance 
The residual variance can be calculated for both x and y data (x being the spectral 
data and y being the concentration of the analyte that the spectral data represent) ; 
however, it is the residual y variance that is of interest here. The Unscrambler 
software calculates the residual variance for each factor in one of two ways, 
depending upon which validation method was chosen, 
Leverage Correction 
(Eq.2.27) 
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Cross Validation 
(Eq.2.28) 
where d is the number of degrees of freedom, n is the number of samples and hn is 
the leverage value. The Unscrambler also calculates the total residual variance 
(TRV) (usually termed factor 0): 
(Eq.2.29) 
where a is the factor number and N is the total number of calibration samples. 
Using the TRV value, the percentage of explained variance can be calculated and 
is a good way of seeing how much of the variance in y is explained by the model. 
There are two kinds of residual variances that can be observed using the 
Unscrambler and these are the calibration variance and the validation variance. 
The calibration variance is based on fitting the calibration data to the calibration 
model , whereas the validation variance is obtained by testing the data that have 
not been used to build the model. From these two variances it is possible to see if 
the model describes the new data well. 
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3.1 MATERIALS AND INSTRUMENTATION 
3.1.1 Reagents 
Table 3.1 Reagents and Suppliers 
Substance 
Buffer reagents 
10X Phosphate buffer 
Sodium carbonate, anhydrous 
Sodium dihydrogen orthophosphate 
Sodium hydrogen carbonate 
Sodium phosphate, dibasic anhydrous 
Trizma base 
Trizma hydrochloride 
Enzymes 
~-galactosidase grade VI : from Escherichia coli 
Protease type XXI: from Streptomyces griseus 
Supplier 
Molecular Probes 
Sigma 
Fisher Scientific UK 
Fisher Scientific UK 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Alkaline phosphatase type I-S: from Bovine Sigma 
intestine mucosa 
Fluorophores and f1uorigenic substrates 
BOOIP~493/503 , SE 
BOOIP~FL , SE 
Fluorescein isothiocyanate isomer I 
Fluorescein di-~-O-galactopyranoside (FOG) 
Fluorescein di-phosphate (FOP) 
Molecular Probes 
Molecular Probes 
Sigma 
Molecular Probes 
Molecular Probes 
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Substance Supplier 
Immobilisation supports 
UltraLink<ll> Biosupport Medium 
Inhibitors 
Phenyl ethyl thiogalactoside (PETG) 
3-Nitrophenylboronic acid 
Sodium orthovanadate 
Other reagents 
Bicinchoninic acid 
Copper (\I) sulphate pentahydrate 98% 
Dimethyl sulphoxide (DMSO), anhydrous 
Ethanolamine 
Sodium chloride 
Sodium azide 
N, N-D i methylformam ide 
Ethanol 
Methanol 
Protein 
a-Casein : from bovine milk 
All chemicals were analytical reagent grade 
3.1.2 Balances 
Pierce 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Fisher Scientific UK 
Sigma 
Sigma 
Fluka 
Fluka 
Fluka 
Sigma 
Electronic balance, Precisa 620C, two decimal places ... ", .......... .. ........... Precisa 
Electronic balance, Precisa 40SM-200A, four decimal places ........ " ..... .... . Precisa 
Electronic balance, Adventurer, four decimal places ... .. ....... " ... .... ...... ...... Ohaus 
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3.1.3 Cells 
Quartz fluorescence cell (3500 ~I volume, 1 cm light path) ...... ..... .. ... .. ' .... Hellma 
Quartz UV cell (3500 ~I volume, 1 cm light path) ... ... ..... ................. . ...... Hellma 
Flow cell UV and fluorescence, 25 ~I volume ............. ............... .............. Hellma 
1.5 mm X 1.5 mm light path 
3.1.4 Chromatographic columns and frits 
PD-1O column .......................... . ................ Amersham Pharmacia Biotech UK 
Glass column 3.0 x 1.5 cm (105 mm bed volume) .............. .. ............... .. .. Omnifit 
Glass column 3.0 x 2.5 cm (170 mm bed volume) .................. .... ..... .. ...... Omnifit 
Glass column 3.0 x 5.0 cm (350 mm bed volume) ................................... Omnifit 
Frits (2 micron) ........ .. .... ... ... .. . .. . ... .. ...... . ...... .. . .. . .. ........ ...... ............. Omnifit 
3.1.5 Flow system equipment 
Injection valves (manual with 25 ~I , 50 ~I and 75 ~I sample loop) .. ............. Omnifit 
Peristaltic pump (Gilson minipuls 3) .. ........... ...... .. . ... .. .... '" .... .. .. AD Instruments 
Pump tubing 0.8 mm I.D ................. . ... .. .................. . ............................ Elkay 
Sterile Syringe, 1 ml (BD Plastipak) ............. .. ............ ... ..... . .... ... Fisher Scientific 
3.1.6 Pipettes 
Automatic adjustable pipettes: P100, 200, 1000, and 5000 .... .... .... .. ..... Anachem 
3.1.7 pH Meter 
Bench pH meter model PHA 230 .............. .. .. ..... ............. .. ........... .. .. Whatman 
pH meter model 220 ... .. ......................................................... .......... Corning 
3.1.8 Spectrometers 
Model F-4500 Fluorescence Spectrophotometer ... .. . .. ....... .. . .. ...... . .......... Hitachi 
UVNisible Spectrometer ........................ .. .............. Unicam Analytical Systems 
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3.1.9 Temperature control 
Water bath (0 - 99 °C, ± 0.1 °C) ........ . ......... ....... ................... . .... ....... Grant 
3.1.10 Other equipments 
Centrifuge, model Z 2000A. ....................................... ......................... Hermle 
Micro centrifuge, model 320 ............ ................................ ... ........... . .... Quickfit 
Roller bed, model Spiramix 10 .............................................. ..... . ...... .. Denley 
3.2 GENERAL PROCEDURES 
3.2.1 Water purification 
All solutions were prepared using triply deionised water (18.2 MQ), purified by a 
Maxima ultra pure water system (USF Elga Ltd.). 
3.2.2 Buffer preparation 
Buffers were prepared in triply deion ised water throughout. Tris-HCI , carbonate 
and phosphate buffers have been used during the experimental work. 
3.2.3 pH measurement 
pH measurements were carried out using the pH meter, with a pH range of 0.00 to 
14.00 and an accuracy of ± 0.01 pH. The instrument was calibrated with high-
resolution buffer solutions at pH 4.00, 7.00, and 10.00, ± 0.005, before use. 
3.2.4 Mass determination 
Weighing measurements were carried out on three balances depending on the 
weighing range needed. 
3.2.5 Pipetting 
Pipetting was carried out using Gilson (supplied by Anachem) variable volume 
automatic pipettes. 
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3.2.6 Fluorescence measurement 
The Hitachi F-4500 Fluorescence Spectrophotometer was used in this study. The 
spectrophotometer mainframe has a xenon lamp light source, the beam of which is 
incident on the excitation monochromator. The beam after wavelength selection 
with the excitation monochromator (Aex) is irradiated onto the sample cell. Light 
emitted from the sample in the form of fluorescence (A..m) then passes through the 
emission monochromator (which is at right angles to the incident light) to remove 
any light that is not at the emission wavelength. The intensity of fluorescence is 
detected via a red-sensitive photomultiplier tube (R928F). Instrument parameters 
are shown in appendix C. 
3.2.7 Absorbance measurement 
Absorbance measurements were carried out on a Unicam 8700 Series UVI Visible 
spectrometer using buffer solution to obtain a baseline. 
3.2.8 Flow system measurement 
Flow system measurements were made using the basic set-up shown in figure 
4.10, and variations thereof. Buffer solution was pumped using a peristaltic pump, 
and injections of substrate and enzyme inhibitor into the flowing stream were 
made using a manual sample injection valve fitted with 25, 50 or 75 IJI sample 
loops. A manual 6-port rotary valve was used to direct the main flow stream into a 
reactor where assay components were captured. The reactor was situated in a 
thermostatted water bath to enable the reactions to occur at a defined 
temperature. The rotary valve was then again switched to direct the assay 
components back into the main stream. This flowed through a fluorescence flow 
cell situated in the Hitachi F-4500 fluorescence detector to measure the 
fluorescence intensity and then through to waste. 
3.2.9 General dye: protein conjugation procedure 
Dye-protein conjugation procedures varied depending on the reaction conjugation 
times, concentrations of dye and protein, conjugation buffer, stop solution, 
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separation column/methods, etc. The following are the procedures, according to 
the Molecular Probes guideliness7 
3.2.9.1 FITC- a-casein and BODIPy4l' 493/503- a-casein conjugates 
FITC- a-casein and BODIPY® 493/503- a-casein conjugates were prepared 
according to the following method. 
• 2 mg/ml a-casein was prepared by dissolving 2 mg a-casein in 1 ml 0.1 M 
carbonate buffer pH 8.4. 
• 1 mg FITC and BODIPY® 493/503 were dissolved each dye in DMSO at 10 
mg/ml. 
• The FITC and BODIPY® 493/503 solutions were added to 2 mg/ml a-casein 
solutions. The total volume for each dye was made up to 2.5 ml with 0.1 M 
carbonate buffer pH 8.4. 
• The solutions were incubated for 2 hours In dark vials with continuous 
stirring at room temperature. 
• Two PD-10 Sephadex G25 columns were equilibrated with 25 ml 0.1 M 
phosphate buffer pH 7.2. Each conjugate was passed through the PD-1O 
column in order to remove unconjugated dye from the conjugate. 
• For each reaction conjugate, 3.5 ml 0.1 M phosphate buffer pH 7.2 was 
added to the PD-1O column in order to elute the conjugate. Aliquots of 
conjugate were stored in black vials in the freezer. 
3.2.9.2 BODIPy4l' FL- a -casein conjugates 
BODIPY® FL- a-casein conjugates were prepared according to the following 
method. 
• 2 mg/ml a -casein was prepared by dissolving 2 mg a-casein in 1 ml 0.1 M 
carbonate buffer pH 8.4. 
• Amount of BODIPY® FL required for 5: 1, 10: 1, 20: 1 and 40: 1 reaction 
mixture ratios of BODIPY® FL- a-casein were calculated by multiplying the 
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number of moles of a-casein by the molecular weight of BODIPY® FL 
followed by multiplying by the ratio. 
• The BODIPY® FL solution was made up by dissolving the require amount of 
BODIPY® FL in DMSO at 10 mg/ml. 
• For each reaction mixture ratio conjugate , the BODIPY® FL solution was 
added to a 2 mg/ml a-casein solution. The total volume was made up to 2.5 
ml with 0.1 M carbonate buffer pH 8.4. 
• The solutions were incubated for 2 hours in dark vials with continuous 
stirring at room temperature. 
• PD-1O Sephadex G25 columns were equilibrated with 25 ml 0.1 M 
phosphate buffer pH 7.2. The conjugates were passed through the columns 
in order to remove unconjugated dyes from the conjugates. 
• Elution buffer was prepared by diluting the 10X PBS stock pH 7.2, which 
contains 2 mM sodium azide, and 10 fold in deionised water. 
• For each reaction conjugate, 3.5 ml of the elut ion buffer was added slowly 
until the conjugate had been eluted. Aliquots of the conjugate were stored 
in black vials in the freezer. 
3.2.9.3 Final dye: protein ratio or degree of labelling calculations 
• A portion of the conjugates was diluted so that the maximum absorbance 
was 0.5 to 1.5 AU. The absorbance of the conjugate solution at 280 nm and 
at the dye maximum wavelength (A 280 and Ama. ) was measured in a cuvette 
with a 1 cm pathlength . 
• The concentration of protein in mg/ml was determined; 
A protein = A 280 - Ama. (CF) 
C F = A280 free dyel Ama. free dye 
CF is a correction factor, and the CF values for used f1uorophores are listed 
in table 1.3. 
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• The protein concentration was calculated assuming 1.4 A protein units = 1 
mg/ml (this may not be true for all proteins) . 
• Final dye: protein (0: P) ratios or degree of labelling (DOL) were calculated. 
The ratios were the average numbers of dye molecules coupled to each 
protein molecules. 
0 : P = (Amex x MW) I ([protein) x E dye) 
MW = the molecular weight of the protein 
E dye = the extinction coefficient of the dye at its absorbance maximum and 
protein concentration is in mg/ml 
Calculation of dye: protein ratio assumes that the absorption properties (A, E) of 
both the dye and the protein were not changed when they combine (this may not 
be true). 
3.2.10 Immobilisation of enzyme onto Pierce UltraLink biosupport medium 
The enzymes were immobilised onto Pierce UltraLink biosupport medium 
according to the manufacturer's instructions.'04 0.125 g of UltraLink were weighed 
out. A solution of enzyme in 2 ml cold (4°C) 0.1 M phosphate buffer pH 7.2 with 
0.6 M Sodium citrate was added to the dry beads and the solution vortexed, 
followed by gentle rotation on a roller bed for 2 hours at room temperature. The 
solution was then filtered to remove unbound enzyme from the beads and this 
filtrate was kept in order to determine the amount of enzyme not coupled to the 
beads, using the BCA assay. A quench solution of 2.5 ml 3.0 M ethanolamine pH 
9.0 was then added to the beads to block unreacted azlactone sites, vortexed and 
gently rotated on a roller bed for 2.5 hours at room temperature. The beads were 
then separated from the quench solution by filtration and resuspended in 2.5 ml 
0.1 M phosphate buffer pH 7.2 followed by vortexing and gentle rotation for 15 
minutes. Buffer was removed and the beads were resuspended in 2.5 ml 1.0 M 
NaCI to remove non-specifically attached protein. The solution was vortexed and 
rotated for 15 minutes after which the NaCI was removed and the beads 
resuspended in 0.1 M phosphate buffer pH 7.2, the solution vortexed and gently 
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rotated for 15 minutes followed by removing the buffer. This last step was 
repeated and the beads stored in 0.1 M phosphate buffer pH 7.2 at 4°C. 
3.2.11 Bicinchoninic acid (BeA) assay for determination of protein 
concentration 
The BCA assay 171 was used to determine the amount of enzyme immobilised on 
to the UltraLink biosupport medium. This method was used to determine the 
protein concentration in solution before and after the immobil isation. It was 
adopted as the use of Triton® X-100 surfactant in the bead production may have 
interfered with an assay using absorbance at 280 nm for the measurement of 
uncoupled enzyme. Both the standard protocol (room temperature for 2 hours, 
working range 20-200 j.Jg/ml ) and the enhanced protocol (60 °C for 30 minutes, 
working range 5-250 j.Jg/ml ) were used according to the PIERCE BCA reagent 
manufacturer's instructions.172 
3.2.12 Preparation of Fluorescein di-galactoside (FOG) solution 
FOG was prepared according to the following method. 58 FOG is susceptible to 
hydrolysis and only minimally soluble in aqueous solutions. To minimize hydrolysis 
and facilitate solution preparation, first the FOG was added to a 1: 1 mixture of 
OMSO/ethanol - the FOG should readily dissolve. Then the resulting FOG solution 
was gradually added to an appropriate volume of ice-cold water to make an 8: 1: 1 
water/OMSO/ethanol solution. This stock solution was faint yellow in colour. The 
20 nM stock solution was divided into aliquots containing sufficient substrate for a 
single set of experiments and stored in brown vials in the freezer. 
3.2.13 Preparation of Fluorescein di-phosphate (FOP) solution 
FOP solution was prepared according to the following methodS9 A 5000 j.Jg/ml 
stock solution of FOP was prepared by dissolving the entire content of the bottle in 
0.1 M pH 7.8 Tris-HCI buffer. Background fluorescence of FOP samples is 
primarily due to fluorescein monophosphate. If not used immediately, the stock 
solution has to be promptly divided into aliquots containing sufficient substrate for 
a single set of experiments and stored in brown vials in the freezer. 
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4.1 INTRODUCTION 
During screening for promising drug candidates, hundreds of thousands of 
compounds need to be assayed. The aim of these experiments was therefore to 
develop a simple, sensitive and efficient method for assaying enzyme and enzyme 
inhibitor activity that would facilitate the testing of large numbers of samples using 
High Throughput Screening (HTS). 
The application of fluorogenic substrates, which are non- or weakly fluorescent but 
are converted by an appropriate enzyme to a highly fluorescent product, is 
widespread in biochemical analysis.173 Such methods combine the amplification 
effects of the catalytic enzyme action with the high sensitivity of fluorescence 
spectrometry. Some applications are straightforward enzyme assays, while in 
others the enzyme is a label through which other reactions such as immunoassays 
are monitored H 4 
4.2 SINGLE ENZYME SCREENING ASSAYS IN STATIC SYSTEM 
4.2.1 Determination of dye to protein ratios of conjugate substrates 
Four Bodipy FL-a-casein conjugates were prepared as described in section 3.2.9.2 
using fluorophore:protein reaction mixture molar ratios of 5:1, 10:1, 20:1 and 40:1. 
Reaction mixture ratios greater than these caused precipitation of the conjugates. 
Final D: P ratios were calculated using the method given in section 3.2.9.3. 
Reaction mixture ratios and calculated final dye: protein molar ratios are given in 
table 4.1. 
Table 4.1 Initial reaction mixture and calculated final dye: protein ratios for Bodipy FL- 0.-
casein conjugates 
Initial reaction mixture ratio of dye: protein Final dye: protein ratio 
5:1 1.05:1 
10:1 2.37:1 
20:1 5.72:1 
40:1 
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As would be expected, as the amount of dye in the reaction mixture was increased 
relative to the protein concentration, a concomitant increase was seen in the final 
0 : P ratio. As this ratio was increased, it might be expected that the suitability of 
the substrate as a quenched protease substrate would also have increased. 
Unfortunately due to the difference between the absorbance values of the 280nm 
and the maximum wavelength of the Bodipy FL- a-casein conjugates, it was 
impossible to strike a balance and obtain accurate absorbance values. Moreover, 
the 40: 1 ratio conjugates seemed to be less stable than others. Therefore, the 
20: 1 ratio was used in all subsequent work. 
4.2.2 Effect of excitation wavelength on the emission spectra of Bodipy FL-a-
casein-AlkP, FDG-~-Gal and FDP-AP 
Using excitation and emission bandwidths of 10 nm and solutions of Bodipy FL -a-
casein-AlkP, FDG-~-Gal and FDP-AP in a standard 3 ml quartz cuvette, emission 
spectra were taken using a variety of excitation wavelengths. Figure 4.1 shows 
that the optimum excitation wavelength of Bodipy FL-a-casein-AlkP, FDG-~-Gal 
and FDP-AP was 490 nm. The optimum emission wavelengths of Bodipy FL-a-
casein-AlkP, FDG-~-Gal and FDP-AP were around 512 nm, 515 nm and 516nm 
respectively, giving a Stokes shifts of just 22 nm, 25 nm and 26 nm respectivel y. 
76 
Chapter 4 Single labeled substrate enzyme and enzyme inhibition screening assays 
7000 
6000 (a) 
- 465nm 
» 6000 
- 470nm 
"" U) c: 475 nm Q) 
'E 4000 
- 480nm 
Q) 
<) 
- 485nm c: 
Q) 
<) 3000 - 490nm en 
l'! 
0 
::> 
u: 2000 
1000 
0 
490 500 510 520 530 540 550 560 570 560 590 
Wavelength (nm) 
3500 
3000 (b) - 465nm 
- 470nm 
:z:. 2500 475nm 
"Vi 
c: 
- 480nm Q) 
E 2000 
- 485nm 
Q) 
<) 
- 490nm c: 
Q) 
- 495nm <) 1500 en 
l'! 
0 
::> 
u: 1000 
500 
0 
490 510 530 550 570 590 
Wavelength (nml 
77 
Chapter 4 Single labeled substrate enzyme and enzyme inhibition screening assays 
~O r--------------------------------------------------. 
4000 
z:. 
'iij 
0:: 
- 465 
.'!l 3000 - 470 
.!: 
Q) 475 () 
0:: 
- 480 Q) 
() 
'" 2000 - 485 !!! 
0 
- 490 :0 
u: 
1000 
O~~~~~~~~==~ 
450 470 490 510 530 550 570 590 610 630 650 
Wavelength(nm) 
Figure 4.1 Effect of excitation wavelength on the emission spectrum of Bodipy FL.(l-casein-
AlkP (a), FDG-p-Gal (b) and FDP-AP (c) 
Figure 4.1 Illustrates the increasing interierence from the scatter peak on the 
emission peak as the excitation wavelength was increased to the optimum 
excitation wavelength . The use of the optimal excitation wavelengths of 490 nm for 
Bodipy FL-a-casein-AlkP, FDG-~-Gal and FDP-AP was therefore not practical 
because the Stokes shift was so small. Although a loss in fluorescence intensity 
was seen with lower excitation wavelengths, decreasing the sensitivity of the 
enzyme assays, a balance between sensitivity and interierence was required and 
a sub-optimal wavelength of 480 nm was chosen for use in all subsequent 
experiments. 
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4.2.3 Enzyme assays in a static system 
4.2.3.1 Optimisation of Enzyme assay conditions 
Fluorescence measurements were made for the enzyme assays using a Hitachi F-
4500 fluorescence spectrophotometer with excitation and emission bandwidths of 
10 nm and an excitation wavelength of 480 nm. The F-4500 was switched on and 
allowed to stabilise for 1 hour before fluorescence readings were taken. Static 
measurements were carried out in a standard quartz fluorescence cuvette. 
Descriptions of Bodipy FL, FDG, FDP, AlkP, j3-Gal and AP are given in chapter 1. 
The substrates were subjected to enzyme digestion, the fluorescence intensity of 
the digested substrates then being compared with that of the undigested 
substrates (blank) . Incubation time, buffer concentration, enzyme concentration, 
temperature, pH and concentration of substrate were optimised univariately. 
The assay parameters studied and optimum conditions found for Bodipy FL-a-
casein-AlkP, FDG-j3-Gal and FDP-AP are shown in table 4.2 
Table 4.2 Assay parameters studied and optimum conditions for various enzyme and 
substrates in a static system 
Bodipy FL.(]- FDG-Jl-Gal FDP-AP 
Assay parameters casein-AlkP 
Range Optimum Range Optimum Range Optimum 
studied studied studied 
Incubation time, 0-35 5 0-35 10 0-35 5 
minutes 
[Enzyme], ~g/ml 0-10 8 0-20 15 0-10 8 
[Substrate], ~g/ml 0-5 4 0-1 .5 1.5 0-1 0.5 
Temperature, QC 25-40 37 25-40 37 25-40 37 
pH 7.5-9.5 8.5 5.0-9.0 7.5 8.0-9.5 9.0 
Buffer PBS,CA PBS PBS,CA PBS PBS,CA CA 
[Buffer], mM 10-100 10 10-100 10 10-100 10 
CA = Carbonate and PBS = Phosphate 
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The effect of assay parameters will be shown in detail only for the FOG-I3-Gal as it 
was found that similar trends were observed with all three substrate-enzyme pairs. 
As optimisation experiments will be discussed in detail for the assays carried out in 
a flowing system, the optimisation experiments for the assay conditions for FOG-j3-
Gal are only summarised. The results are shown below in figure 4.2 -
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Under the optimised conditions given in table 4.2, Bodipy FL-a-casein, FOG and 
FOP were incubated with AlkP, ~-Gal and AP, respectively. As shown in figure 4.7-
4.9, the fluorescence of Bodipy FL-a-casein, FOG and FOP increases dramatically 
after enzymatic digestion, indicating that Bodipy FL-a-casein, FOG and FOP are 
promis ing as fluorigenic substrates. 
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Figure 4.7 Fluorescence emission spectra showing enhancement seen upon incubation of 
Bodipy FL~-casein with AlkP 
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4.3 ENZYME IMMOBILISATION ON UL TRAlINK BIOSUPPORT MEDIUM 
Enzymes were immobilised on UltraLink biosupport medium. The immobilisation 
procedure is given in 3.2.10. The immobilised enzymes were packed in enzyme 
columns and incorporated into the flow injection system (figure 4.10). The 
hydrolysis products of Bodipy FL-a-casein, FDG and FDP reacted with AlkP , [3-Gal 
and AP, respectively were monitored fluorimetrically at 514 nm, using the F-4500 
detector. The immobilised enzymes were stored in PBS buffer (0.1 M, pH 7.2) at 4 
°C when not in use. When the stability of the immobilised enzymes on UltraLink 
was tested it was found that the immobilised enzymes could be used for over 500 
injections with around 90% capacity, and that the enzyme reactors preserved their 
activity for at least two months. 
Enzyme concentrations and sodium citrate concentrations for immobilisation of 
AlkP, f3-Gal and AP were optimised univariately. 
D 
c 
B 
A 
E F G 
Figure 4.10 Manifold for flow injection enzyme and enzyme inhibition assays 
(A = Buffer, B = Peristaltic pump, C = Injection valve, 0 = Enzyme reactor, E = Thennostatted 
water bath, F = Fluorescence detector and G = waste) 
As it was found that similar trends were observed with all three conjugate-enzyme 
pairs, only the effect of assay parameters on the FOG-[3-Gal will be described in 
detail here. 
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4.3.1 Effect of enzyme concentration 
The effect of enzyme concentration on the immobilisation of J3-Gal was examined 
over the range 10-80 mg/g of dry beads. As shown in figure 4.11 , the percentage 
coupling efficiency of J3-Gal was around 80% over the whole range of 
concentrations studied. 
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Figure 4.11 Influence of j}-Gal concentration on immobilisation on UltraLink Biosupport 
Medium 
4.3.2 Effect of salt concentration in the coupling buffer 
The addition of salts to the coupl ing buffer mayor may not enhance the amount of 
ligand covalently attached to the UltraLink biosupport medium, regardless of the 
pH of the coupling buffer. Salts could be added to the coupling buffer if they were 
compatible with the ligand. ~-Gal was coupled to the Ultra Link beads in PBS 
buffers pH 7.5. To the buffer were added different salt (sodium citrate) 
concentrations. The most efficient coupling for this enzyme was found to be at 0.6 
M Sodium citrate or greater (figure 4.12). 
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Figure 4.12 Effect of sodium citrate concentration on coupling for B-Gal 
4.4 ENZYME ASSAYS IN A FLOWING SYSTEM 
Fluorescence measurements were made using an F-4500 fluorescence 
spectrophotometer with excitation and emission bandwidths of 10 nm and time 
scans were performed with excitation and emission wavelengths of 480 nm and 
514 nm respectively. Flow system measurements were carried out using the set -
up shown in figure 4.10 
Assay conditions for Bodipy FL-a-casein-AlkP, FDG-~-Gal and FDP-AP were 
optimised. The effects of the following parameters on the enzyme assays were 
studied: 
• pH 
• Buffer 
• Buffer concentration 
• Temperature 
• Enzyme concentration 
• Flow rate 
• Enzyme reactor volume 
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• Substrate volume 
The assay parameters studied, and optimum conditions found, for each conjugate-
enzyme pair is shown below in table 4.3. 
Table 4.3 Assay parameters studied and optimum conditions for various enzymes and 
substrates in a flow system 
Bodipy FL-a- FDG-Il-Gal FDP-AP 
Assay parameters casein-AlkP 
Range Optimum Range Optimum Range Optimum 
studied studied studied 
pH 7.0-9.5 9.0 7.0-9.0 8.0 7.5-9.5 8.5 
Buffer PBS, CA PBS PBS, CA PBS PBS, CA CA 
[Buffer], flM 10-100 20 10-100 20 10-100 20 
Temperature ,OC 25-45 37 25·45 37 25-45 37 
[Enzyme], mg/g 5-100 100 5·40 20 5-100 80 
Flow rate, ml/min 0.5-3.0 1.0 0.5-3.0 1.0 0.5-3.0 1.0 
Enzyme reactor 150-350 170 150-350 170 150-350 170 
volume, fll 
Substrate volume, 25-75 50 25-75 50 25-75 50 
fll 
4.4.1 Effect of pH 
The effect of pH on the activity of FDG-p-Gal was investigated. A pH range from 
7.0 - 9.0 in 0.5 increments was investigated using PBS buffer. As shown in figure 
4.13, pH affected the reaction rate insignificantly. However, a pH optimum of 8.0 
was seen for FDG-p-Gal. Soluble p-Gal shown pH optimum at 7.5 (figure 4.6) , 
which is shifted to 8.0 when the enzyme was immobilised. This may be attributed 
to the new environment for the enzyme and changes in its kinetic properties after it 
was immobilised. 
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Figure 4.13 Effect of pH on the activity of FDG-f3-Gal 
4.4.2 Effect of buffer concentration 
The effect of PBS buffer concentration on the extent of product formation was 
optimised. A concentration range of 10 mM - 100 mM was studied and as shown 
in figure 4.14, the buffer concentration had little effect on the activity of 13-Gal on 
FOG. The greatest increase in intensity was observed with 10 mM PBS buffer. At 
higher buffer concentrations a gradual drop in the reaction rate occurred. A 20 mM 
PBS buffer concentration was chosen as a compromise between sensitivity and 
maximum buffering capacity. 
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Figure 4.14 Effect of buffer concentration on the activity of f3-Gal 
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4.4.3 Effect of temperature 
The effect of temperature on the activity of FDG-~-Gal was examined over the 
range 25 - 45°C using a thermostatted water bath. As shown in figure 4.15, there 
was an increase in the reaction rate as the temperature was increased from 25°C 
to 40°C. Above 40°C an irreversible fall in the activity due to the denaturation of 
the immobilised enzyme was observed. As a result, subsequent investigations 
were carried out at 37°C in order to ensure a long lifetime for the enzyme reactor. 
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Figure 4.15 Effect of temperature on the activity of f3-Gal 
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4.4.4 Effect of enzyme concentration on the reaction rate 
Due to the high level of azlactone functionality, proteins couple with high coupling 
efficiency (around 80%) to the UltraLink biosupport medium over a wide range of 
concentrations. p-Gal concentration was varied between 10 and 40 mg/g dry 
beads. It can be seen from figure 4.16 that there was some increase in the 
reaction rate as the enzyme concentration was substantially increased. However, 
it was only slightly increased from 20 to 40 mg/g dry beads. Probably, the 
maximum coupling capacity has been reached at 40 mg p-Gal bound per gram of 
dry beads. 
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Figure 4.16 Influence of ~-Gal concentrations on the formation of product 
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4.4.5 Influence of the enzyme reactor volume 
The sensitivity of the ~-Gal for FOG was investigated by using a set of three 
columns (150, 170 and 350 JlI bed volume). As can be seen in figure 4.17, enzyme 
reactor volume did not greatly affect the sensitivity for using peak height, perhaps 
because of the higher dispersion effect of longer reactors. Measuring the peak 
area, the enzyme reactor volume had a marked effect on the sensitivity of ~-Gal 
for FOG. In practice, however, using peak height was more convenient and less 
time consuming. Therefore the 170 JlI bed volume was used for further studies. 
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4.4.6 Effect of flow rate 
The flow rate effect was also examined for the optimum response from 0.5 - 3.0 
ml/min It was observed that increasing the flow rate from 0.5 - 1 ml/min slightly 
increases the fluorescence signal peak height, probably due to dispersion effect. 
However, flow rates above 1.0 mllmin resulted in a gradual fall in the enzymatic 
activity because of the decreased residence time of the sample in the system 
(figure 4.18). Therefore, a flow rate of 1.0 ml/min was used. 
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Figure 4.18 Effect of flow rate on the response of FDG-~-Gal 
4.4.7 Effect of substrate volume 
-
3 
The effect of substrate volume was investigated for the optimum response from 25 
- 75 1-11. From figure 4.19, it was observed that increasing the substrate volume 
from 25 to 50 1-11 the fluorescence signal peak height dramatically increases. 
However, a substrate volume at 75 1-11 produced only a slight further increase in 
fluorescence. Thus, a substrate volume of 50 III was used for further experiments. 
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4.4.8 Calibration graphs for Bodipy FL-a-casein-AlkP, FDG-13-Gal and FDP-
AP 
To evaluate the quantitative range, various concentrations of Bodipy FL-a-casein , 
FOG and FOP were injected into the flow injection system (figure 4.10), under the 
optimal conditions in table 4.3. The fluorescence intensity of the products of the 
enzymatic reaction increased with increasing concentration of the substrates 
indicating that the enzymatic system appeared to be working . Typical calibration 
graphs for Bodipy FL-a-casein, FOG and FOP was shown in figure 4.20. A linear 
relationship between fluorescence intensity, and Bodipy FL-a-casein, FOG and 
FOP concentrations was in the range of 0.5-8 ~g/ml , 0.1-10 Ilg/ml and 0.02-10 
~g/ml , respectively. The coefficient of determination was 0.9995 for Bodipy FL-a-
casein, 0.9989 for FOG and. 0.9993 for FOP. 
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Figure 4.20 Influence of substrate concentration on the production of Bodipy FL-a-casein-
AlkP (a), FDG-Jl-Gal (b) and FDP-AP (c) in a flow system 
4.5 ENZYME INHIBITION ASSAYS 
The inhibition of immobilised AlkP, ~-Gal and AP by 3-nitrophenyl boronic acid (3-
NPBA), phenylethyl thiogalactoside (PETG) and sodium vanadate (VI) respectively 
was investigated. The percent inhibition (%1) was calculated as follows: 
%1 = 100 (Aa - AI ) I Aa 
where Aa and AI are the responses in the absence and presence of the inhibitor, 
respectively. 
4.5.1 Enzyme reactivation 
Along with the optimization process to obtain a sensitive method for enzyme 
inhibitor determination, attention must also be given to the rapid recovery of the 
enzyme activity so that the reactors can be reused. As a first step, the possibility of 
continuously passing buffer solution through the column to displace the inhibitor 
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was studied. Then the activity of the column was checked by injecting the 
substrate. It was found that 3-NPBA, PETG and VI could be displaced by the 
buffer and enzyme activity regenerated, around 1-3 min being required for 100% 
reactivation. The rate of reactivation after 3-NPBA, PTEG and VI inhibition actually 
depended on the degree of inhibition. 80% inhibited enzyme was fully reactivated 
in 2-3 min, which was checked by consecutive injections of the substrate after 
treatment with the inhibitor. 
4.5.2 Inhibition of J3-Gal by PETG 
There are numerous sources of information on the inhibition of J3_Gal. 175,176 In the 
present work attempts were made to evaluate the inhibitory effect of PETG on 
immobilised J3-Gal in a flow system. The previously optimised conditions were 
checked. In addition the volume and concentrations of inhibitor were also 
examined. An increase in the volume and concentration of PETG increased the 
rate of inhibition of p-Gal (table 4.4). No significant change in the level of inhibition 
was observed by varying the other conditions. Therefore, all the conditions used 
for the inhibition of the enzyme were as previously described, with the exception of 
the volume of PETG (50 ~I ) . The mixtures (inhibitor and substrate) were injected 
into the flowing system containing the enzyme reactor and then the response was 
measured. The results are shown in figure 4.21 . The effect of PETG on the 
inhibition of J3-Gal was evaluated by varying the inhibitor concentration with 
constant substrate concentration. As can be seen in figure 4.21 , 80% inhibition 
was obtained with 20 Ilg/ml PETG. 
Table 4.4 Effect of the volume and concentration of PETG on % inhibition of l3-Gal 
Volume of PETG, j.1l 25 50 
% Inhibition 59 68 
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Figure 4.21 Inhibition of fl-Gal by PETG detenmined with FOG at 37 C 
4.5.3 Inhibition of AlkP by 3-NPBA 
Trigonal boron compounds contain a vacant 2p orbital which easily reacts as a 
Lewis acid with nucleophiles such as alkoxides and imidazoles to give a 
tetrahedral adduct. m The extended boronic acids are among the most potent 
reversible protease inhibitors yet developed. These compounds are similar to the 
peptide aldehydes in their apparent function as transition state analogues, but they 
appear to be very selective for serine proteases. In the current study attempts to 
develop an inhibition based assay for AlkP by 3-NPBA using Bodipy FL-a-casein 
as a substrate were made. This assay was performed in the same conditions as 
described earlier. 
Standard solutions of 3-NPBA were mixed with the substrate prior to injection into 
the flow system. The concentrations of the inhibitor were between 0-5 ~g/ml. As 
shown in figure 4.22, 3-NPBA efficiently inactivated the enzyme between 0.5 and 
5.0 ~g/ml 
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Figure 4.22 Inhibition of AlkP by 3-NPBA determined with Bodipy FL-a-casein at 37 C 
4.5.4 Inhibition of AP by VI 
6 
Vanadate (VOl ') is a reversible phosphatase inhibitor. Vanadate is a phosphate 
analog and is generally thought to bind as a transition state analog to the 
phosphoryl transfer enzymes that it inhibits, since it can easily adopt a trigonal 
bipyramidal structure.131 In the present study attempts to develop an inhibition 
based assay for AP by VI using FDP as a substrate were made. This assay was 
performed under the same condition as described earlier. The mixtures (inhibitor 
and substrate) were injected in the flowing system through the enzyme reactor and 
then the response was measured. The results are shown in figure 4.23. The effect 
of VI on the inhibition of AP was evaluated by varying the inhibitor concentration 
with constant substrate concentration. As can be seen in figure 4.23, 80% 
inhibition was obtained with 2.0 I!g/ml VI. 
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Figure 4.23 Inhibition of AP by VI determined with FOP at 37 C 
4.6 CONCLUSIONS AND DISCUSSION 
Fluorimetric methods have proven to be safe, rapid and sensitive techniques to 
determine enzyme activity. The availability of a suitable f1uorigenic substrate is 
critical to the success of f1uorimetric determination of enzyme activities. Fluorigenic 
substrates usually practical convenience, and higher sensitive in enzymatic assays 
than their chromogenic counterparts.17B Such methods combine the amplification 
effects of the catalytic enzyme action with the high sensitivity of fluorescence 
spectrometry and flow injection analysis. The procedure does not require any 
process such as separation, precipitation or centrifugation . 
In this work the enzymes AP, AlkP and ~-Gal were immobilised on UltraLink 
media. The enzyme reactor was placed in a flow injection system (figure 4.10). In 
order that an assay with optimum sensitivity could be constructed, the 
experimental conditions such as buffer (type, pH and concentration), temperature, 
flow rate, enzyme concentration, volume of substrate and volume of enzyme 
reactors, under which enzyme activities could be achieved were investigated 
(figure 4.13-4.19). The results obtained show identical trends for all the enzymes. 
100 
Chapter 4 Single labeled substrate enzyme and enzyme inhibition screening assays 
Increasing temperature had a positive influence on the enzymatic reaction ; 
however, temperatures over 40 cC produced denaturation of the biocatalyst. The 
flow rate finally selected (1 .0 mllmin) was appropriate for the reaction. Higher flow 
rates decreased the analytical signal due to a shorter on line substrate-enzyme 
contact time. 
The enzymes exhibited a maximum response at pH 8.0-9.0 in flow systems. All the 
soluble enzymes showed pH optima which were shifted by 0.5pH units when the 
enzymes were immobilised. This may be attributed to the new environment for the 
enzymes and change in their kinetic properties after they were immobilised. Using 
enzymes with optimum activities at alkaline pH is ideal for the detection of the 
fluorescent products, especially fluorescein (pKa = 7.9). 
The activities of enzymes gradually decreased with increasing buffer concentration 
(10-100 mM), probably due to an increase in ionic strength. 
In the optimum conditions (table 4.3) it was possible to obtain good calibration 
linearity over the range 0.5-8 I!g/ml, 0.1-1 0 ~g/ml and 0.02-1 0 ~g/ml for Bodipy FL-
a-casein (y = 164.42x + 29.27, ~ = 0.9995), FDG (y = 520.13x - 30.09, ~ = 
0.9989) and FDP (y = 432.61 x + 287.65, ~ = 0.9993), respectively (figure 4.20). 
The relative standard deviation for 10 successive injections was 1.07-2.39%. 
3-NPBA, PETG and VI , in this work were determined by their inhibitory effect on 
immobilised, AlkP, ~-Gal and AP, respectively in a flow injection system and 
continuous reuse of the immobilised enzymes with little loss of enzyme activity. 
The previously optimised conditions were used for this investigation. The method 
is rapid (allowing around 15-25 measurements to be made per hour) and 
economic. The inhibition of AP, AlkP and ~-Gal with the inhibitors at ~g/ml levels 
was achieved. 
This approach offers the potential to determine the concentration of two or more 
analytes in a single sample which could be used for the simultaneous detection. In 
addition, it may be possible to extend this concept to the development of more 
rapid simultaneous assays. 
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5.1 INTRODUCTION 
The aim of these experiments was to investigate multiplex screening enzyme 
inhibition assays in a flow injection analysis system based on the use of 
immobil ised enzyme reactors, such that the system would allow the determination 
of more than one inhibitor in the same assay. 
The need to improve productivity is imperative for drug discovery companies. One 
strategy is: test more discover more. The availability therefore of a simple, 
sensitive, and efficient method for the simultaneous determination of immobilised 
enzymes and their inhibitors would be of much use in the high throughput 
screening of candidate drug molecules. This set-up would allow a much higher 
throughput accompanied by cost advantages. 
An excellent review discusses the determination of two or more species in the 
same sample with a single flow injection analysis system.179 
5.2 FLUORESCENCE SPECTRA OF BODIPY FL-a-CASEIN, FOP AND FOG 
A comparison of the fluorescence spectra of Bodipy FL-a-casein-AlkP, FDP-AP 
and FDG-~-Gal are shown in figure 5.1. 
100 
80 
20 
510 520 530 
- Bodipy FL-a-casein 
- FDG 
- FOP 
540 550 580 
Wavelength (nm) 
570 580 590 600 
Figure 5.1 Emission spectra of Bodipy FL-o.-casein-AlkP, FOP-AP and FOG-Il-Gal 
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From the result it can be seen that the emission spectra of Bodipy FL-a-casein-
AlkP, FOP-AP and FOG-~-Gal are extremely overlapped, their fluorescence 
spectra are similar, especially when they are at the same intensity. Therefore, it is 
difficult to analyse these two or three analytes using conventional fluorescence 
spectroscopy. However, the problem of overlapping spectra can be overcome by 
using chemometric techniques (in chapter 6) or using time-dependent separation 
of flow injection analysis. Here the latter method was investigated. 
5.3 INVESTIGATION OF SIMULTANEOUS ASSAYS BY A FLOW-INJECTION 
METHOD BASED ON THE USE OF IMMOBILISED ENZYME REACTORS 
Fluorescence measurements were made using a F-4500 fluorescence 
spectrophotometer with excitation and emission bandwidths of 10 nm. Time scans 
were performed with excitation and emission wavelengths of 480 nm and 514 nm 
respectively for FOG and FOP as well as Bodipy FL-a-casein . All optimised 
conditions previously described in chapter 4 were used. 
As a starting point for the assays, it was decided that the simplest approach would 
be a dual assay using one buffer system. As was shown in table 4.3, the optimum 
pHs and buffers for AlkP, ~-Gal and AP were different. However, the best 
compromise of pH for FOG-~-Gal and Bodipy FL-a-casein-AlkP in a dual assay 
system is PBS, pH 8.0 , for FDG-~-Gal and FDP-AP is CA, pH 8.0 , and for Bodipy 
FL-a-casein-AlkP and FDP-AP is CA, pH 8.5. 
The ideal set-up for a simple assay was to flow buffer slowly through two enzyme 
reactors, each containing a different immobilised enzyme, as shown in figure 5.2. 
A substrates solution would be injected and the fluorescence detected through the 
time-dependent separation of the peaks emerging from each of the reactors by 
having different lengths of flow tubing between the enzyme reactors and the 
detector. 
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D 
C 
B 
E 
G 
H 
A 
Figure 5.2 Schematic of flow injection analysis system for dual assay 
(A = buffer, B = peristaltic pump, C = injection valve, D = enzyme reactor 1, E = enzyme 
reactor 2, F = thermostatted water bath, G = fluorescence detector and H = waste 
Immobilised enzyme was packed into Omnifit glass columns with a bore of 3 mm, 
and a length of 2.5 cm corresponding to reactor volume of 175 ~I. Aluminium frits 
with 2 ~m pores were used at both ends to prevent leakage of the UltraLink media. 
The appearance of the enzyme reactors is shown in figure 5.3. Columns were 
packed by mounting the columns vertically, and connecting the bottom of the 
column to a peristaltic pump that allowed suction of loaded UltraLink through the 
top end of the column downwards. The glass column was then incorporated into 
the flowing system and clamped vertically in the water bath. Buffer was flowed 
upwards through the column, which was opposite to the direction of packing. This 
ensured maximum contact of the buffer with the Ultra Link and tighter packing. 
Figure 5.3 Appearance of the enzyme reactors 
(top - packed glass column, bottom - empty glass column) 
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5.3.1 Investigation of interference between the substrates and enzymes 
Interference caused between components in the system is an important 
consideration in a mixture for simultaneous assays. To determine the interference 
the following methods were used: 
In a static system, dual assays of Bodipy FL-a-casein-AlkP and FDG-~-Gal , FDP-
AP and FDG-~-Gal , as well as Bodipy FL-a-casein-AlkP and FDP-AP were 
investigated. The concentrations of chemicals were kept constant, but the 
combinations of the components were varied. The resulting changes in 
fluorescence intensities were considered. The results showed that there was no 
interference amongst the components in the experiments. Only the result of the 
experiment for Bodipy FL-a-casein-AlkP and FDG-~-Gal was shown in figure 5.4. 
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BFL 
- BFL- Il-Gal 
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- FDG- [}Gal+AlkP 
- BFL-AlkP+FDG-[}Gal(exp.) 
BFL-AlkP+FDG-[}Gal (ca l.) 
o ~:==;:=::::;=~~~~;:;J 
500 510 520 530 540 550 560 570 560 590 600 
Wavelength (nm) 
Figure 5_4 Interference of Bodipy FL-<1-casein-AlkP and FDG-Il-Gal 
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5.3.2 Determination of length of flow tubing required for separation of peaks 
As the principle behind the dual-determination assay was to inject two substrates 
with or without inhibitors and detect the two peaks of products by time-dependent 
separation, it was important to determine the length of tubing required to cause 
such a separation. The tubing that was used for the experiments was Omnifit 
Teflon tubing with an internal diameter of 0.8 mm. A minimum length of tubing was 
required for the shorter length section so that the fluorescence spectra (which 
appear as a rapid pulse) actually recorded would be as sharp as possible. The 
appearance of actual layout and the length of flow tubing used are shown in figure 
5.5 (b). A length of 15 cm. was used between the first Y junction to both reactors. 
This was chosen so that the assay components would flow through the 
thermostatted water bath. For the shorter length section, a 5 cm. length was used 
between the reactor and the second Y junction as this was the minimize distance. 
Using this length of tubing, the time between injection and detection of the first 
peak was around 9 seconds at flow rate 1.2 mllmin. 
A longer length of tubing of 50 cm. for the second reactor was firstly added. 
However, using this length was too short for peak separation. In order for a 
separation of the peaks to occur the first peak has to return to the baseline first, so 
sufficient time must be allowed for this to occur. A length of 200 cm. was then 
added. This length was long enough to separate the two peaks which were 
properly resolved. 
Photos are shown in figure 5.5 (a) and (b) depicting the actual set-up of this flow 
system in our laboratory 
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Figure 5.5 (a) and (b) - Actual layout and equipment used for flow analysis enzyme and 
enzyme inhibition assays 
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5.3.3 Effect of flow rate 
The flow velocities of the buffer stream should be considered so that in the 
complete system there would be sufficient residence time for the sample in the 
enzyme reactors and any risk that tight packing of the column material might lead 
to increased back-pressure would be minimized. 
The effect of the flow rate on the response to Bodipy FL-AlkP and FDP-AP were 
investigated in the range of 0.5-1 .5 mllmin. The result showed that the response 
decreased with increasing flow rate up to 1.5 mllmin. The choice of flow rate 
involves a compromise between sensitivity and sample output rate as well as a 
risk of tight packing. A flow rate of 1.2 mllmin was chosen for further experiments, 
considering its relatively high response and the short sample output time. 
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Figure 5.6 Effect of flow rate on dual Bodipy FL-AlkP and FDP-AP assay 
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5.3.4 Simultaneous FOG and Bodipy Fl-a-casein using immobilized ~-Gal 
and AlkP reactors 
In order to establish a simple dual enzyme assay standard mixtures of Bodipy FL-
a-casein (0-10 Ilg/ml) and FDG (0-5 Ilg/ml) were injected through a manual 
injection valve (50 III each) into the flow system shown in figure 5.2 and figure 5.5. 
The sample was split into two parts using a V-connector and then passed into the 
AlkP and [3-Gal reactors. Product from the enzyme reactor with the shorter 
distance to the F-4500 was detected first. Then product from the enzyme reactor 
with the longer distance to the F-4500 was detected second. 
A typical flow injection analysis response of the products obtained by the two 
enzyme system was shown in figure 5.7. The calibration graphs obtained for FOG 
(y = 182.1 x - 1.1489, r" = 0.9962) and for Bodipy FL-a-casein (y = 72.504x + 
9.1279, r" = 0.9990) showed good linearity in the range investigated as shown in 
figure 5.B. These results demonstrate that the system can successfully be used for 
dual-analyte assays. 
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Figure 5.7 Typical flow injection analyses obtained by Bodipy FL-a-casein and FOG using a 
dual enzyme system, (a) AlkP and (b) fl-Gal 
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Figure 5.8 Calibration graph for (a) FOG and (b) Bodipy FL-a-casein using a dual enzyme 
system 
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5.3.5 Simultaneous FOG and FOP using immobilized j3-Gal and AP reactors 
Standard mixtures of FOG (0-5 Ilgfml ) and FOP (0-5 Ilgfml) were injected. The 
typical flow injection analysis responses of the products was obtained by the 
immobilized ~-Gal and AP enzyme reactor system (figure 5.9). The good 
calibration linearity was shown over the range investigated as shown in figure 
5.10. For FOG, y = 149.86x - 4.076, r = 0.9984, and for FOP, y = 227.21x + 
75.172, r = 0.9978. Therefore, the system can be used for dual-analyte assays 
successfully. 
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Figure 5.9 Typical flow injection analyses obtained by FOG and FOP using a dual enzyme 
system, (a) ~-Gal and (b) AP 
112 
Chapter 5 Multiplex screening enzyme inhibition assays 
1400 
1200 
~ 1000 
c 
~ 
Q) 800 
" c 
Q) 
" 800 (/l Q) 
~ 
0 
:::> 400 u:: 
200 
0 
0 
(b) 
y; 149.86x - 4.076 
R' ; 0.9984 
• 
2 
y ; 227.21 x + 75.172 
R' = 0.9978 
2 
3 
FDG Iug/ml) 
3 
FDP(ug/ml) 
4 
4 5 
5 6 
Figure 5.10 Calibration graph for (a) FOG and (b) FOP using a dual enzyme system 
5.3.6 Simultaneous Bodipy FL-a-casein and FOP using AlkP and AP 
6 
Standard mixtures Df Bodipy FL-c-casein (O. 5-10~g1ml ) and FDP (O . 01 -5~g/m l) 
were injected. The typical flow injection analysis responses of the products was 
obtained by the immobilized AlkP and AP enzyme reactor system (figure 5.11 ), 
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and calibration graphs, which gave the good linearity in the range investigated, are 
shown in figure 5.12. For Bodipy FL-a-casein, y = 33.909x + 1.46, r2 = 0.9985, and 
for FDP, y = 284.92x + 104.84, r2 = 0.9997. Therefore, the system can be used for 
dual-analyte assays successfully. 
300 
.i!:' 250 (a) 
.0; 
c 
2l 200 
.s 
" 
" 
150 c 
~ 
"' 
" 
100 ~
0 
::l 
u: 
50 
0 
0 50 100 150 
(b) 
200 
Time (sec.) 
250 300 350 400 
Figure 5.11 Typical flow injection analyses obtained by Bodipy FL·iH:asein and FOP using 
a dual enzyme system, (a) AlkP and (b) AP 
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Figure 5.12 Calibration graph for (a) Bodipy FL.(J~asein and (b) FOP using a dual enzyme 
system 
5.4 INVESTIGATION OF SIMULTANEOUS SCREENING FOR DUAL ENZYME 
INHIBITORS BY USING IMMOBILISED ENZYME REACTORS 
Fluorescence measurements were made using a F-4500 fluorescence 
spectrophotometer with excitation and emission bandwidths of 10 nm. Time scans 
were performed with excitation and emission wavelengths of 480 nm and 514 nm 
respectively for FDG-p-Gal and FDP-AP as well as Bodipy FL-a-casein-AlkP. In 
chapter 4, the inhibition in all cases, using 3-NPBA, PETG and VI , was shown to 
be highly reversible. 
The set-up for a simple assay is shown in figure 5.2. All the conditions used for 
these experiments were as previously described. The buffer was flowed slowly 
through two enzyme reactors, each containing different immobilised enzyme, as 
substrates I inhibitors solution would be injected and the fluorescence detected 
through the time-dependent separation of the peaks emerging from each of the 
reactors by having different lengths of flow tubing between the enzyme reactors 
and the detector. For the complete displacement of the inhibitors the carrier buffer 
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was passed through the enzyme reactors for 2 minutes. Injecting the substrate 
solution at intervals checked the activity of the enzyme reactors. 
5.4.1 Effects of Dimethyl sulphoxide on components in the system 
Dimethyl sulphoxide (DMSO) is an important solvent for small molecule (MW. < 
500 Da) studies as it provides a nearly universal approach for the solubilisation of 
small molecules. Because of its physicochemical properties, high solvent power, 
low chemical reactivity and relatively low toxicity, DMSO has become the solvent 
of choice for sample storage and handling in the pharmaceutical industry, 
particularly in the initial stages of high-throughput screening where storage of 
candidate molecules in DMSO is routine. 
The effects of OMSO on protein structure and function are extremely varied . When 
used as a co-solvent at high concentration OMSO has great potential to give 
misleading results in bioavailability measurements, by acting as a permeation 
enhancer, or even an inhibitor.l80 
The effect of OMSO on substrates (Bodipy FL-a-casein, FOG and FOP), enzymes 
(AlkP, ~-Gal and AP) and inhibitors (3-NPBA, PETG and VI) for the simultaneous 
determination of dual enzyme inhibitors by using immobilised enzyme reactors 
was investigated in static system. Similar trends were observed with all 
experiments, so only the effect of DMSO on FOP-AP with I without VI inhibitor is 
shown here (figure 5.13). Addition of DMSO (0-5%) had relatively little effect, but 
at 10% had great effect. However, OM SO had similar effects whether the inhibitor 
was present or not. 
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Figure 5.13 Effect of DMSO on FDP-AP withl without VI 
5.4.2 Investigation of simultaneous screening for PETG and 3-NPBA by 
using immobilised ~-Gal and AlkP enzyme reactors 
Based on prelim inary investigations, a model assay for measuring the inhibitory 
effect of PETG and 3-NPBA on ~-Gal and AlkP reactors respectively was studied. 
The standard solutions of PETG and 3-NPBA, mixed with the substrate solutions 
(Bodipy FL-a-casein and FOG) were injected into the flow system (figure 5.2). 
The result (figure 5.14) shown that there were interactions in the system, probably 
because boronic acids have a covalent and reversible interaction with 
monosaccharides in water.181 The interaction of the boronic acids with diols is 
illustrated in figure 5.15. Therefore this system is not suitable for simultaneous 
enzyme inhibitors assay with the 20 mM PBS buffer, pH 8.0. 
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Figure 5.15 Interaction between phenyl boronic acid and sugar at near neutral pH'·' 
5.4.3 Investigation of simultaneous screening for PETG and VI inhibitors by 
using immobilised ~-Gal and AP enzyme reactors 
A series of standard mixtures, which contain substrates (FDG and FDP) and 
inhibitors (PETG and VI) at various concentrations were treated under optimised 
conditions with ~-Gal and AP enzyme reactors in the flow system (figure 5.2). The 
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FIA response increased rapidly just after injection of the sample and returned to 
basel ine within about 2 min for the first peak and within 4 min for the second peak. 
Percentage inhibition against inhibitor concentration was plotted for each of the 
inhibitors. The calibration curves are given in figure 5.16. For PETG, the 
calibration graph showed good linearity over the range 0.02-0.5 jJg/ml with y :: 
76.689 + 13.55, r:: 0.9931 , and for VI , the linearity showed over the range 0.05-
0.3 jJg/ml with y :: 138.7 + 7.79680, r:: 0.9978. The limit of detection (OL) was 
calculated using the equation: OL :: 3S.0 .slm, where S.D.s is the standard 
deviation of the blank (pure substrates solution) and m is the slope of the 
calibration curve (obtained by IUPAC criterion). The limit of detection for these 
inhibitors was 0.02 jJg/ml (PETG) and 0.01 jJg/ml (VI). These results demonstrate 
that the system can successfully be used for multiplex screening assays. 
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5.4.4 Investigation of simultaneous screening for 3-NPBA and VI by using 
immobilised AlkP and AP enzyme reactors 
A series of standard mixtures, which contain a constant concentration of 
substrates (Bodipy FL-a-casein and FDP) mixed with 3-NPBA and VI at various 
concentrations were treated under optimised conditions with AlkP and AP enzyme 
reactors in the flow system (figure 5.2). The calibration curves are given in figure 
5.17. The good linearity shown over the range 0.01-0.2 IJgJml (y = 226.56x + 
5.3469, r2 = 0.9954) for VI , and 1-5 IJg/ml (y = 8.7081 x + 3.6727, r2 0.9956) for 3-
NPBA. The limit of detection for VI was 0.02 IJg/ml, and for 3-NPBA was 0.78 
IJg/ml. These results demonstrate that the system can successfully be used for 
multiplex screening assays. 
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5.5 CONCLUSIONS AND DISCUSSION 
6 
The suitability of applying the f1uorigenic substrates to multiplex enzyme inhibitor 
assays, using flow injection analysis and immobilised enzyme reactors in parallel , 
has been investigated. 
From a comparison of the fluorescence spectra of Bodipy FL-a-casein-AlkP, FDP-
AP and FDG-f3-Gal (figure 5.1) can be seen that all three emission spectra are 
strongly overlapped. Therefore, using time-dependent separation of flow injection 
analysiS method was used to overcome the problem. 
The interference amongst components (substrates and enzymes) in the system 
was also investigated. The results (figure 5A) showed that there was no 
interference among these components. Therefore all these components could be 
used in the mixtures for dual simultaneous assays. 
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A simple flow-injection system for dual assays, using one buffer is described that 
incorporates small glass reactors each containing different immobilised enzymes 
as shown in figure 5.2 and 5.5. Two-substrate I inhibitor solution would be injected 
and the fluorescence detected through the time-dependent separation of the 
fluorescence peaks by having different lengths of flow tubing between the enzyme 
reactors and the F-4500 detector. 
For optimisation of the total FIA system, one of the parameters would be the flow 
rate of the buffer stream because this affects the residence time of the sample in 
the enzyme reactors and thus the amplification as well as compression of the 
supports in the reactors. From the result shown in figure 5.6, a flow rate of 1.2 
ml/min was chosen for all experiments. 
Another important parameter for optimisation based on the dual-determination 
assay, using the flow injection system (figure 5.2) is the length of flow tubing 
required for separation of peaks. The length of flow tubing should be a judicious 
compromise between efficient separations and acceptable dispersion of the 
injected sample solution. The optimal lengths of flow tubing are shown in figure 
5.5(b). 
However, the minimal length of tubing that was required for a good separation of 
the two peaks was not ideal. The length of 200 cm. had to be coiled for placement 
in the water bath. This set-up would be much more applicable to a miniaturised 
system where such long lengths would not be needed. 
Based on these studies, a model assay was developed to demonstrate the dual 
simultaneous assay concept. 
The suitability of Bodipy FL-a-casein, FDP and FDG as substrates in the dual 
enzyme inhibition assays has also been demonstrated. The inhibition of AlkP, AP 
and p-Gal with 3-NPBA, VI and PETG, respectively at Jlg/ml levels was achieved. 
However, based on the preliminary investigations, an assay for measuring the 
inhibitory effect of PETG and 3-NPBA on p-Gal and AlkP reactor showed the result 
that the approach was not suitable for dual simultaneous enzyme inhibition assay 
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since there were some interactions amongst the components. Probably due to 3-
NPBA interacted with galactoses from FOG and PETG. 
The dual fluorogenic assays that have been described here took at most 2 minutes 
for the first analyte and around 4 minutes for the second inhibitor. 
Using the optimal conditions, the calibration graphs for VI and 3-NPBA or PETG 
were constructed with AP and AlkP or ~-Gal immobilised reactors (figure 5.16 -
5.17). The limits of detection were also determined for each of the inhibitors. The 
calculated limits of detection for each inhibitor using the substrates (Bodipy FL-a-
casein and FOP) and immobilised AlkP and AP enzyme reactors were 0.78 IJg/ml 
for 3-NPBA and 0.02 IJg/ml for VI. For the system using the substrates (FOG and 
FOP) and immobilised ~-Gal and AP enzyme reactors, the calculated limits of 
detection for each inhibitor were 0.02 IJg/ml for PETG and 0.01 (..Ig/ml for VI 
inhibitor. 
In conclusion, the application of the dual enzyme inhibition assays in the FIA 
system, using immobilised enzyme reactors is a rapid, simple (does not require 
any process such as separation, precipitation or centrifugation) and sensitive 
method for the assay of enzyme inhibitors, essential requirements for screening 
assays. 
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CHAPTER 6 
MULTIPLEX SCREENING ENZYME 
INHIBITION ASSAYS USING 
CHEMOMETRICS 
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6.1 INTRODUCTION 
Spectrofluorimetry has been widely used to determine analytes in such disparate 
fields as clinical , biomedical and environmental analysis on account of its high 
selectivity, sensitivity and relatively low cost. However, the analytes usually exhibit 
broad spectral bands that tend to overlap when the sample contains several 
components; this entails the use of prior separation procedures or highly specific 
methods, both of which result in increased analysis times and cost. There is thus a 
continuing need to improve existing methods, not only to improve their selectivity 
and detection limits, but also to expedite analysis. This challenge has been met by 
using many techniques, such as variable-angle fluorescence spectroscopy182 and 
synchronous fluorescence spectroscopy.183.184 Nevertheless, assays of complex 
mixtures by spectrofluorimetry are practically impossible in many cases. This is 
due to the high number of sample components and extensive spectral overlapping. 
From the system described in chapter 5 it is possible to quantify two enzyme 
inhibitors with dye-protein labelled substrates which have strongly overlapping 
spectra, using flow injection fluorimetry and time-dependent separation of the 
peaks, with different lengths of flow tubing between the enzyme reactors and the 
detector. However, problems may arise when using peak height or peak area to 
quantify more than two components using this system. 
The problem of overlapping spectra can be overcome by using multivariate 
calibration techniques as described in chapter 2. Such techniques would enable a 
reliable and accurate prediction of the analytes concentration without using either 
peak height or peak area. Recently, muitivariate calibration methods seem to be 
the techniques showing the best performance in terms of complex mixture 
resolution. Spectrofluorimetry has benefited from their introduction and several 
applications to pharmaceutical preparations, containing many active compounds 
and excipients having spectra in the same region, have been reported.185,188 The 
application of these techniques to spectral data offers the advantage of speeding 
up complex system resolution, without tedious preliminary separation steps. 
Among the various multivariate approaches applied to multicomponent analysis, 
principal component regression (peR) and partial least-squares regression (PLS) 
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have been successfully adopted in many applications. peR and PLS are factor 
analysis methods which establish a relationship between matrices of chemical 
data. PLS-1 and peR have been found to give very similar results when used for 
concentration predictions in some mixtures.187,188 However, in contrast to this De 
Jong 159 and Ragno 189 discovered that PLS-1 gave better predictions than peR, 
especially in the case of an extensive spectral overlap. Therefore, in this work only 
PLS-1 was employed. 
Multivariate calibration methods, however, do depend on the quality of the 
samples and variables obtained from the samples. This is because there needs to 
be an accurate and reliable interpretation of the calibration results before any 
predictions can be made. Thus validation methods need to be employed to check 
the validity of the calibration model. If the validation model differs Significantly from 
the calibration model then any predictions from it may be unreliable. Also, in order 
to optimise the calibration model further, selection of the correct number of 
relevant principal factors, variables and removing any outlying samples, all need to 
be carried out first. 
The aim of this work was to evaluate the potential of PLS-1 for the analysis of dual 
enzyme inhibitors by a flow-injection fluorimetry method with immobilised enzyme 
reactors, and also to use the method to study ternary mixtures with strongly 
overlapping spectra 
6.2 THE INVESTIGATION OF DUAL SCREENING ENZYME INHIBITIONS 
USING A FLOW-INJECTION METHOD AND CHEMOMETRIC METHODS 
6.2.1 Procedure 
Fluorescence measurements were made using a F-4500 fluorescence 
spectrophotometer with excitation and emission bandwidths of 10 nm. Time scans 
were performed with excitation and emission wavelengths of 480 nm and 514 nm 
respectively for Bodipy FL-a-casein-AlkP and FDP-AP. The single-channel 
manifold set-up for a simple assay as shown in figure 4.10 was used. All the 
conditions used for these experiments were as previously described in section 
129 
Chapter 6 Multiplex screening enzyme inhibition assays using chemometrics 
5.4.4. The buffer (CA at pH 8.5) was flowed at a rate of 1.2 mllmin through two 
enzyme reactors containing AlkP and AP in series (figure 6.1). Samples 
(substrates/inhibitors, containing Bodipy FL-a-casein 4 ~g/ml , FOP 0.5 ~g/ml , 3-
NPBA between 1 and 5 ~g/ml , and VI between 0.05 and 0.45 ~g/ml) were injected 
and the fluorescence measured. Full spectra (495 to 594 nm) were recorded 22 
seconds after injection, the flow being stopped manually. Spectral data were 
saved in ASCII files and then converted to Excel® files before analysis using the 
Unscrambler software. All plots obtained from the software show calibration data 
in red and validation data in green. The concentration ranges were selected from 
the established linear calibration range for each compound. The optimised 
calibration models, calculated using PLS-1 and full cross validation (FCV) were 
applied to analyze the spectra of the samples, and calculate the concentrations of 
3-NPBA and VI in the mixtures. 
Figure 6.1 AlkP and AP enzyme reactors in series 
6.2.2 Results and discussion 
6.2.2.1 PLS treatment of spectrofluorimetric data 
A calibration set of 13 samples was studied at wavelengths between 495 and 594 
nm at 1 nm interval (100 data points). In table 6.1 the compositions of binary 
mixtures used in the calibration matrices are summarized, and a diagrammatic 
representation of the mixture design is shown in figure 6.2. 
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Table 6.1 Concentration data used in the calibration set for determination of 3-NPBA and VI 
Sample Concentration of 3-NPBA. Concentration of VI. lIg/ml 
119/ml 
1 3 0.25 
2 5 0.45 
3 4 0.15 
4 0.05 
5 5 0.25 
6 1 0.45 
7 5 0.05 
8 3 0.45 
9 3 0.05 
10 2 0.15 
11 1 0.25 
12 2 0.35 
13 4 0.35 
5 
7 
• 5 2· 
3 13 
[3-NPBA]. 
119/ml 3 
9 1 8 
10 12 
4 11 6 
0.05 0.25 0.45 
[VI]. 119/ml 
Figure 6.2 Mixture design for the binary mixtures used in the data set for the PLS-1 method. 
The concentrations of the different mixtures are given in table 6.1 
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An appropriate choice of the number of principal components, or factors, is 
necessary for the correct performance of PLS-1 . The number of factors should be 
properly selected in order to avoid both over-fitting - which would result in 
accurate calibration but poor predictions - and under-fitting, which would lead to 
increased robustness but again, at the expense of impaired predictions: several 
criteria have been recommended for selecting the optimum number.163 Here the 
residual Y variance value was employed to select the optimum number of principal 
components (pes). Full cross validation consists of systematically removing each 
of the observations in turn and using the remaining observations for construction 
of latent factors and their regression . PLS calibration was performed on the 13 
calibration spectra: 12 spectra were used and the concentrations of the analytes in 
the sample left out were predicted. This process was repeated 13 times until each 
calibration sample had been left out once. The plots of scores, the root mean 
square error (RMSE), residual Y validation variance, and the correlation coefficient 
(r) obtained when plotting predicted versus measured concentrations for each 
component are included to give an indication both of the average error in the 
analysis and the quality of fit of all the data. (figure 6.3 and 6.4). 
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From figure 6.3, the score plots for the VI calibration set using PLS-1 and FCV 
show that all the samples fell within the average pattern for the x data. The 
residual Y validation variance plot showed the optimum number of PCs is three, so 
this was used for prediction. The RMSE plot at 3 PCs is fairly small (0.006 for 
RMSE of calibration, RMSEC, and 0.02 for RMSE of validation, RMSEP) . The r-
value was 0.998771 . Therefore the calibration set gave a good PLS-1 model ; no 
outlying samples had to be removed . 
However, figure 6.4 showed that for the 3-NPBA the r-value was only 0.97394. 
From the plot of predicted versus measured concentrations sample 13 in the 
calibration set was rather far away from the straight line. Moreover the RMSE plot 
showed quite high values (0.29 for RMSEC and 0.44 for RMSEP). From figure 6.5, 
it is clear that the residual Y variance of sample 13 differed significantly from the 
other samples. This sample could be classed as influential outlier, so it was 
removed from the calibration set. When the plots were recalculated (figure 6.6), 
the score plots showed that all the samples fell within the average pattern for the x 
data. The residual Y validation variance plot showed that the optimum number of 
PCs was two, so this was used for prediction. The RMSE plot at 2 PCs was also 
better (0.17 for RMSEC and 0.26 for RMSEP). Moreover, the r-value was higher 
(0.990833). This means that the corrected calibration set gave a satisfactory PLS-
1 model for the predictions, with no further outlying samples to be considered. 
1.5 -
1 .0 
0 .5 -
o 
o 2 4 6 B 10 12 14 
3-NF'BA PLS FCV .•. , pc: 2 2 
Figure 6.5 The residual sample variance plot for outlier checking of 3·NPBA calibration set 
using PLS·1 and FCV 
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6.2.2.2 Prediction and deviations 
In order to test the performance of the proposed method, it was applied to the 
determination of artificial mixtures containing various concentrations of the two 
compounds at IJg/ml levels. The above-mentioned model was used to predict the 
concentration of the analytes in 10 synthetic mixtures (new data set in table 6.2). 
Table 6.2 Concentration data used in the new data set for determination of 3·NPBA and VI 
Sample 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Concentration of 3-NPBA, 
I'g/ml 
3 
5 
4 
5 
2 
5 
4 
2 
4 
Concentration of VI, l'g1ml 
0.25 
0.45 
0.15 
0.25 
0.45 
0.35 
0 .05 
0.35 
0.25 
0.45 
A full analysis of the results can be seen in table 6.3. Results are summarized in 
figure 6.7. As can be seen, the actual and predicted values were consistent for 
most of the mixtures tested. All the predicted concentrations were 98-113% and 
90-105% of their actual concentrations for 3-NPBA and VI respectively. A large 
deviation value might suggest that the predicted sample is different from those that 
were used to make the calibration model . The deviation values were within 10% 
for 3-NPBA, except sample 5 (23%) and within 10% for VI , except sample 7 
(34%). The large deviation value might be due to signals from components in 
considerable excess, which tend to engulf the other peaks, making it difficult for 
the software to predict the concentrations. The multivariate calibration techniques 
look for changes in the x-data matrix and if one of the analyte peaks is much 
bigger than another or others, no significant spectral change may be observed. 
Hence it would be hard for the PLS-1 to predict the amount of the engulfed peak. 
The results can be considered satisfactory keeping in mind the strong spectral 
137 
Chapter 6 Multiplex screening enzyme inhibition assays using chemometrics 
overlap between Bodipy FL-a-casein-AlkP and FDP-AP (figure 5.1), and given that 
the aim of this research is to develop screening methods. 
Table 6.3 A full analysis for 3-NPBA and VI with FCV for the PLS-1 model 
Sample [Actual], !lg/ml [Predicted], % Deviation % Recovery 
!lg/ml 
3-NPBA VI 3-NPBA VI 3-NPBA VI 3-NPBA VI 
3.00 0.25 2.97 0.25 9.2 7.5 99 .0 100.8 
2 5.00 0.45 4.94 0.46 4.5 3.6 98.8 102.2 
3 4.00 0.15 3.99 0.15 5.9 10.1 99 .9 99.3 
4 5.00 0.25 4.91 0.26 4 .3 6.3 98 .3 105.2 
5 1.00 0.45 1.13 0.44 23.1 3.7 113.4 100.4 
6 2.00 0 .35 1.96 0.35 10.2 5.0 98.0 100.3 
7 5.00 0.05 5.09 0.04 4.7 34.4 101 .8 89.8 
8 4.00 0.35 4.09 0.36 5.4 4.4 102.3 103.1 
9 2.00 0.25 2.06 0.25 9.9 8.6 102.9 100.8 
10 4.00 0.45 4.11 0.42 5.8 3.7 102.8 96.4 
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Figure 6.7 A comparison ofthe predicted results using PLS-1 and FCV with the actual 
results for the new data set: (a) 3-NPBA and (b) VI 
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6.2.2.3 Variable (data point) selection 
Many methods have been published that look at variable selection.190,191 Having 
uninformative variables in the data must lead to less precision (higher variance 
due to imbedded errorl92) and also a higher bias in the eigenvalues.193 Elimination 
of such variables in the data matrix must in theory improve the overall model and 
result in better predictions. However, from the findings in section 6.2.2.2 the 
problem of uninformative variables seems to be irrelevant because of the good 
predictions. The software suggests that only a small percentage «1 %) of the 293 
data points for each sample do not ideally fit the model , too few to have any 
significant effect on the overall calibration model. The spectra of the calibration 
standards cover the whole spectral range of interest, so the chances of there 
being any uninformative section of variables in this data are very small. Thus, no 
further data manipulation was carried out on these results. 
6.2.2.4 Noise addition 
Contrary to the other transformations in the software, adding noise to the data 
would decrease the precision of the analysis. This is exactly the purpose of the 
transformation: include some additive or multiplicative noise in the variables, see 
how this affects the model , and check how the model would perform if it was used 
for predictions based on noisier new data e.g. from real samples. In previous work 
(section 6.2.2.1), the PLS-1 model gave satisfactory predictions for the new data 
sets, but here we check how well the model predicts for samples which are noisier 
by 3% than the original sample sets. All the optimum conditions and the 
compositions of the calibration set and new data set in the previous work were 
used. The calibration set spectra with 3% noise added are shown in figure 6.8. 
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Figure 6.8 The calibration set spectra with 3% noise adding 
The plots of scores, the root mean square (RMSE), residual Y validation variance, 
and the correlation coefficient (r) obtained when plotting predicted versus 
measured concentration for each component are included to give an indication 
both of the average error in the analysis and the quality of fit of all data (figure 6.9 
and 6.10). 
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From figure 6.9, the score plots for the VI data showed that all the samples fell 
within the average pattern for the x data. The residual Y validation variance plot 
showed the optimum number of PCs at three, so this was used for prediction. The 
RMSE plot at 3 PCs was fairly small (0.01 for RMSEC and 0.03 for RMSEP). And 
the r-value was 0.997349. Thus the calibration set gave a good PLS-1 model , with 
no outlying samples to be removed. 
However, in figure 6.10 (3-NPBA data) the r-value was only 0.976680 and from the 
plot of predicted versus measured concentrations it can be seen that two samples 
(8 and 13 in the calibration set) were rather far away from the straight line. 
Moreover the RMSE plot showed quite high values (0.26 for RMSEC and 0.44 for 
RMSEP). From figure 6.11 , it is clear that the residual Y variance values of sample 
8 and 13 differ significantly from the other samples Also sample 9 obviously 
differs from the rest. These samples could therefore be classed as influential 
outliers, so they were removed from the calibration set and the plots were 
recalculated. The results were better (figure 6.12): the score plots showed that all 
of the samples fell within the average pattern for the x data. The residual Y 
validation variance plot showed the optimum number of PCs at two, so this was 
used for prediction: the RMSE plot was then much improved (0.11 for RMSEC and 
0.26 for RMSEP) and the r-value was higher (0.996724). So the corrected 
calibration set gave a satisfactory PLS-1 model for the prediction, and no further 
outlying samples were considered . 
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Figure 6.11 The residual sample variance plot for outlier checking of 3-NPBA calibration set 
with 3% noise adding using PLS-1 and FCV 
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In order to test the performance of the proposed method, it was applied to the 
determination of artificial mixtures containing various concentrations of the two 
compounds at j.Jg/ml levels. The above-mentioned model was used to predict the 
concentrations of the analytes in 10 synthetic mixtures (new data set in table 6.2). 
A full analysis of the results can be seen in table 6.4, and the results are 
summarized in figure 6.13. As can be seen, the amounts added and found were 
consistent for most of the mixtures tested. All the predicted concentrations were 
87-106% and 87-106% of their actual concentrations for 3-NPBA and VI 
respectively. A large deviation value might suggest that the predicted sample is 
different to those that were used to make the calibration model. The percentage 
deviations were within 13% for 3-NPBA, except sample 5 (24.5%) and within 16% 
for VI , except sample 7 (49.9%). This could be attributed to the fact that the 
concentration of 3-NPBA was the lowest level (1 j.Jg/ml), while the concentration of 
VI was the highest level (0.45 j.Jg/ml) for sample 5, but vice versa for sample 7. 
Thus the method may be difficult to apply if the target analyte peak is engulfed by 
another. 
Table 6.4 A full analysis for 3-NPBA and VI with FCV for the PLS-l model with 3% Noise 
adding 
Sample [Actual], Ilg/ml [Predicted], % Deviation % Recovery 
Ilg/ml 
3-NPBA VI 3-NPBA VI 3-NPBA VI 3-NPBA VI 
1 3.00 0.25 2.94 0.24 8.6 11 .1 97.8 97.2 
2 5.00 0.45 4.93 0.46 4.7 4.8 98.6 103.1 
3 4 .00 0.15 3.99 0.14 5.4 15.6 99.8 95.3 
4 5.00 0.25 4.74 0.26 4.2 8.8 94.7 106.0 
5 1.00 0.45 0.87 0.44 24.5 5.6 87.2 98. 2 
6 2.00 0.35 2.05 0.37 11 .2 6.5 102.3 105.1 
7 5.00 0.05 4.69 0.04 7.8 49.9 93.8 87.4 
8 4.00 0.35 4.13 0.36 6.5 7.1 103.4 103.4 
9 2.00 0.25 2.11 0.26 13.0 11.0 105.5 103.6 
10 4.00 0.45 4.23 0.41 6.5 6.3 105.7 90.7 
146 
Chapter 6 
6 
E 
0,5 
:J 
« 
en 4 Cl. 
Z 
cl> 
-
3 0 
c: 
0 
~ 2 
-c: ID 
U 
c: 
0 
() 
0 
rt-
0.6 
E 0.5 
a, 
~ 
5" 0.4 
§ 0.3 
., 
~ 8 0.2 
c 
o 
() 0.1 
o 
rfr 
2 
~ 
2 
Multiplex screening enzyme inhibition assays using chemometrics 
(a) 
rf-
rh-
rh---
Fr 
3 4 5 6 
(b) 
~ 
rfI 
m-
3 4 5 6 
o Predicted 0 Actual 
rfr-
r!r 
7 8 
r.1r 
~ 
rIn 
7 8 9 
rh-
9 
a 
rh-
10 
Sample 
10 
Sample 
Figure 6.13 A comparison of the predicted results using the 3% noise adding, PLS-1 and 
FCV with the actual results for the validation set: (a) 3-NPBA and (b) VI 
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6.3 THE INVESTIGATION OF TERNARY ANAL YTE MIXTURES WITH 
STRONGLY OVERLAPPING SPECTRA FOR MULTIPLEX SCREENING 
The aim of this study was to demonstrate the practicability of the PLS-1 method for 
three strongly overlapping fluorescence spectra. The final aim could be multiplex 
screening enzyme inhibition assays using chemometric methods. The three 
conjugates used were Bodipy FL-a-casein conjugate, Bodipy 493/503-a-casein 
conjugate, and FITC-a-casein conjugate (hereafter referred to as Bodipy FL 
conjugate, Bodipy 493 conjugate, and FITC conjugate, respectively) . From figure 
6.14, the fluorescence emission maxima of Bodipy FL conjugate, Bodipy 493 
conjugate, and FITC conjugate are 511 nm, 512 nm and 519 nm respectively. It is 
clear that the emission peaks of the three conjugates overlap significantly, and a 
mixture of the three conjugates gave only one major peak. This is a preliminary 
study of the application of PLS-1 to such heavily overlapping spectra. 
350 ,------------------------------------------------, 
300 
" l; 150 
'" Qi
0:: 
lOO 
50 
495 505 515 
- FITC conjugate 
- Bodipy FL conjugate 
Bodipy 493 conjugate 
- Mixture of 3 conjugates 
525 535 545 
Wavelength (nm) 
555 565 575 
Figure 6.14 Fluorescence emission spectra of Bodipy FL conjugate, Bodipy 493 conjugate, 
FITC conjugate and a mixture of the three conjugates 
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6.3.1 Procedure 
PBS buffer (0.02 M, pH 9.0) was used throughout. The three conjugate solutions 
(Bodipy FL conjugate, Bodipy 493 conjugate, and FITC conjugate) were prepared 
by the methods given in section 3.2.9, then diluted to give similar fluorescence 
intensities and kept in dark bottles. 
Various samples were then prepared from the above solutions. The calibration set 
comprised 25 samples (table 6.5) and the new data set 20 samples (table 6.6). 
The samples were all selected within the linear calibration range for each 
compound. Fluorescence measurements were made using the F-4500 
fluorescence spectrometer with excitation and emission bandwidths of 10 nm. The 
time scan mode was used with excitation and emission wavelengths of 470 nm 
and 513 nm, respectively. The flow system in figure 4.10 was used. Each sample 
was injected (50 ).JI ) into a stream of buffer flowing at 1.2 ml/min. Once the flow 
was stopped (after 21 seconds), fluorescence spectra over the range 490 -584 nm 
were recorded with an excitation wavelength of 470 nm. Spectral data were saved 
in ASCII files and then converted to Excel<!> files before analysis using the 
Unscrambler software. The PLS-1 optimised model and FCV method were applied 
to analyze the spectra of the samples, and calculate the concentrations of the 3 
analytes in the mixtures. 
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Table 6.5 The composition ofthe calibration set for ternary mixtures 
Sample FITC conjugate, ml Bodipy FL conjugate, Bodipy493 
ml conjugate, ml 
1 0.6 0.2 0.2 
2 0.2 0.2 1.0 
3 0.2 1.0 0.4 
4 1.0 0.4 1.0 
5 0.4 1.0 0.6 
6 1.0 0.6 0.4 
7 0.6 0.4 0.4 
8 0.4 0.4 0.8 
9 0.4 0.8 1.0 
10 0.8 1.0 0.8 
11 1.0 0.8 0.6 
12 0.8 0.6 1.0 
13 0.6 1.0 1.0 
14 1.0 1.0 0.2 
15 1.0 0.2 0.8 
16 0.2 0.8 0.2 
17 0.8 0.2 0.6 
18 0.2 0.6 0.8 
19 0.6 0.8 0.8 
20 0.8 0.8 0.4 
21 O.S 0.4 0.2 
22 0.4 0.2 0.4 
23 0.2 0.4 0.6 
24 0.4 0.6 0.2 
25 0.6 0.6 0.6 
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Table 6.6 The composition of the new data set for ternary mixtures 
Sample FITC conjugate, ml Bodipy FL conjugate, Bodipy493 
ml conjugate, ml 
1 0.4 
2 0.4 1.0 0.6 
3 0.6 0.6 0.4 
4 0.2 1.0 1.0 
5 0.4 0.8 1.0 
6 0.8 1.0 0.8 
7 1.0 0.8 0.6 
8 0.6 1.0 1.0 
9 1.0 1.0 0.2 
10 0.2 0.8 0.2 
11 0.8 0.2 0.6 
12 0.2 0.6 0.8 
13 0.2 0.2 1.0 
14 0.6 0.8 0 .8 
15 0.8 0.8 0.4 
16 0.2 0.4 0.6 
17 1.0 1.0 1.0 
18 0.2 1.0 0.2 
19 1.0 0.2 0.2 
20 1.0 0.2 1.0 
6.3.2 Results and discussion 
6.3.2.1 PLS-1 treatment of fluorescence data 
A calibration set of 25 emission spectra was taken between 490 and 584 nm at 1 
nm intervals (95 data points). The plots of scores, the RMSE, the residual Y 
validation variance, and the correlation coefficient (r) obtained are shown in 
appendix E, figures E-1 to E-3, and a summary of the statistical parameters of the 
calibration set is shown in table 6.7. 
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Table 6.7 Summarisation of statistical parameters of 3 analytes with PLS-1 and FCV 
Optimum RMSE Correlation 
Analyte principal Slope Offset coefficient, component, RMSEC RMSEP r 
PC 
FITC 3 0.03 0.039 0.986411 0.008153 0.993182 
conjugate 
BFL 3 0.023 0.030 0.992044 0.004774 0.996014 
conjugate 
B493 4 0.028 0.040 0.988033 0.007180 0.993998 
conjugate 
From figure 6.15, it is clear that the residual Y variance of sample 8 (FITC 
conjugate calibration set) , sample 3 (BFL conjugate calibration set), and sample 3 
(B493 conjugate calibration set) differ significantly from the other samples. These 
samples could therefore be classed as influential outliers, so they were removed 
from the calibration set and the plots were recalculated. The improved results 
shown in appendix E, figures E-4 to E-B. The summary of the statistical 
parameters of the corrected calibration set is shown in table 6.8. It demonstrates 
that the modified calibration set gave a satisfactory PLS-1 model for the prediction. 
Table 6.8 Summarisation of statistical parameters of 3 analytes with PLS-1 and FCV without 
outliers 
Optimum RMSE Correlation 
Analyte principal Slope Offset coefficient, component, RMSEC RMSEP r 
PC 
FITC 3 0.018 0.024 0.995034 0.003021 0.997514 
conjugate 
BFL 3 0.016 0.022 0.995692 0.002513 0.997844 
conjugate 
B493 4 0.014 0.021 0.997013 0.001817 0.998505 
conjugate 
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Figure 6.15 The residual sample variance plot for outlier checking of 3 conjugates 
calibration set using PLS-1 and FCV: (a) FITC conjugate, (b) 8FL conjugate, and (c) 8493 
conjugate 
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6.3.2.2 Prediction and deviations 
In order to test the performance of the proposed method, it was applied to the 
determination of artificial mixtures containing various amounts of the three 
conjugates. The above-mentioned model was used to predict the concentration of 
the analytes in 20 synthetic mixtures (new data set in table 6.6). 
A full analysis of the results can be seen in table 6.9. Results are summarised in 
figure 6.1 6. As can be seen the actual and predicted amounts were consistent for 
most of the mixtures tested. All the predicted values were 91-106%, 90-108%, and 
91-110% of the actual amounts for FITC, 8FL, and 8493 conjugate respectively. 
The deviation values were within 10% for all conjugates. The results can be 
considered satisfactory for screening purposes. 
Table 6.9 A full analysis for 3 conjugates prediction set with FCV for the PLS-1 model 
Sample 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Actual, ml 
FITC BFL 8493 
1.0 
0.4 
0.6 
0.2 
0.4 
0.8 
1.0 
0.6 
1.0 
0.2 
0.8 
0.2 
0.2 
0.6 
0.8 
0.2 
1.0 
0.2 
1.0 
1.0 
0.4 
1.0 
0.4 
1.0 
0.8 
1.0 
0.8 
1.0 
1.0 
0.8 
0.2 
0.6 
0.2 
0.8 
0.8 
0.4 
1.0 
1.0 
0.2 
0.2 
1.0 
0.6 
0.4 
1.0 
1.0 
0.8 
0.6 
1.0 
0.2 
0.2 
0.6 
0.8 
1.0 
0.8 
0.4 
0.6 
1.0 
0.2 
1.0 
1.0 
Predicted, rnl 
FITC BFL 8493 
1.03 
0.42 
0.59 
0.18 
0.41 
0.82 
0.98 
0.61 
0.99 
0.2 
0.78 
0.2 
0.18 
0.57 
0.77 
0.18 
1.01 
0.19 
0.95 
0.98 
0.37 
0.98 
0.38 
0.97 
0.81 
0.99 
0.81 
0.99 
1.02 
0.80 
0.22 
0.59 
0.18 
0.81 
0.82 
0.4 
0.92 
1.00 
0.21 
0.21 
1.00 
0.61 
0.39 
1.01 
1.00 
0.8 
0.62 
0.99 
0.18 
0.20 
0.61 
0.81 
1.04 
0.82 
0.40 
0.62 
0.96 
0.22 
0.19 
1.01 
% Deviation 
FITC BFL B493 
2.9 
4.7 
2.8 
9.5 
4.2 
2.0 
1.6 
2.5 
2.0 
8.0 
2.6 
6.5 
7.5 
2.8 
2.8 
8.0 
3.7 
8.5 
3.3 
1.2 
6.7 
1.7 
3.7 
2.9 
1.8 
1.4 
1.7 
1.4 
1.8 
1.7 
9.5 
2.0 
6.0 
2.0 
2.6 
4.0 
1.5 
1.6 
4.0 
5.5 
1.8 
2.8 
3.5 
3.3 
1.8 
2.0 
3.1 
1.8 
9.0 
8.0 
3.0 
1.7 
3.6 
2.2 
4.2 
2.8 
3.6 
9.5 
6.2 
1.3 
% Recovery 
FITC BFL 8493 
103.2 92.0 
106.2 97.7 
99.2 96.2 
91 .0 96.6 
103.7 100.8 
102.0 99.0 
97.9 101 .2 
101 .0 99.4 
99.4 102.2 
99.5 100.6 
97.7 108.5 
98.5 98.3 
91.5 90.5 
94.5 100.7 
96.0 102.3 
92.0 100.0 
101.1 97.9 
95.0 100.3 
95.4 106.5 
97.9 106.5 
99.9 
101.1 
98.5 
101 .0 
99.7 
100.0 
104.0 
99.5 
91.0 
102.0 
101 .0 
101 .0 
104.3 
102.8 
100.7 
103.5 
96.4 
109.5 
93.5 
101.2 
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Figure 6.16 A comparison ofthe predicted results using PLS-1 and FCV with actual results 
for the new data set: (a) FllC conjugate, (b) BFL conjugate, and (c) B493 conjugate 
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6.4 CONCLUSIONS 
The system developed in this chapter is a simple design that could be dramatically 
improved with a flow system designed to be automatic rather than manual: this 
might reduce the experimental error considerably. Having an automatic injection 
and timing procedure to capture the spectral data would also improve the data 
analysis step because the input data would be more accurate, hence the output 
information will be better. 
However, despite all the technical problems, and taking into consideration any 
other experimental errors such as dilution errors etc., the multiplex screening 
systems using flow injection and multivariate calibration seem a promising 
approach. The predictions were relatively good for both dual and ternary analyte 
assays, suggesting that such a system could be used as part of a screening 
process for target analytes. Therefore, the findings of this chapter show that 
multiplex screening using enzyme inhibition, fluorescence detection and 
multivariate calibration is valid, and if improved further could bring many benefits in 
drug discovery applications. 
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7.1 CONCLUSIONS 
The application of flow injection fluorescence spectroscopic assays to the 
simultaneous determination of two or more components has been challenging for 
many years. Fluorescence enzyme assays are well known as analytical methods 
in clinical chemistry and other fields, being sensitive, safe, and easy to use and 
available in a variety of formats. The immunoassays normally used in industry or 
research now are still mostly single assays, i.e. each assay is only able to analyse 
one analyte. However, in many cases dual- or multi-analyte assays would be 
much more valuable with the advantages of increased information content, 
savings in time and costs, and the elimination of some sources of sampling 
variance. Amongst all the labels used in immunoassays, only fluorescent groups 
offer realistic prospects of practicable multi-analyte assays. 
Enzymes are being used to an ever-increasing extent in automated assays in 
analytical chemistry and biochemistry. This is clearly indicated by the dramatic 
increase in the number of papers being published in this area and by the large 
range of commercial instrumentation that has become available in recent years. 
The main advantage of enzymes as reagents in analytical chemistry is their 
specificity and extreme sensitivity. Disadvantages are their high cost especially 
when continuous flow, automated systems are employed and relative instability. 
These general limitations on enzymes as catalysts have been minimised to a great 
extent by the technique of immobilisation. 
The two main objectives of this investigation were to develop new fluorescence 
methods for the rapid and sensitive multi-analyte determinations of enzymes 
inhibitors using flow injection analysis, and to investigate the use of chemometric 
methods to determine whether it was feasibible to develop the simultaneous 
determination of the multiple analytes. These objectives were set with the intention 
that the final system could easily be reduced to a miniaturised scale (although 
miniaturisation was not one of the key objectives of this research). In addition, 
these assays were aimed at a high throughput screening application. 
To a large extent the aims of the project have been successfully fulfilled. 
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The use of a single excess-labelled substrate has been the successful 
fluorescence method for the determination of enzymes inhibitors. A substrate 
utilising a-casein labelled with BODIPY dye has been synthesised. This substrate 
has been shown to be a suitable intramolecularly quenched conjugate for the 
determination of enzymes inhibitors in flow-based screening programmes. The 
flow-based procedure that has been described is particularly well suited to the high 
throughput screening of candidate drug molecules. 
Pierce UltraLink biosupport medium was investigated and was shown to be 
extremely promising as a support in these assays. Enzymes, namely alkaline 
phosphatase (AP), alkaline protease (AlkP) and ~-galactosidase (~-Gal) were 
immobilised on UltraLink successfully. The enzyme reactor was placed in a flow 
injection system (figure 4.10). In order that an assay with optimum sensitivity could 
be constructed, the experimental conditions such as buffer (type, pH and 
concentration) , temperature , flow rate, enzyme concentration, volume of substrate 
and volume of enzyme reactors, under which enzyme activities could be achieved 
were investigated. 
The single and dual screening assays based on flow injection analysis 
methodology, with immobilised enzyme reactors to analyse enzyme inhibitors 
have been investigated successfully. 3-Nitrophenylboronic acid (3-NPBA), 
phenylethyl j3-D-thiogalactopyranoside (PETG) and sodium vanadate (VI), were 
determined by their inhibitory effect on immobilised, AlkP, ~-Gal and AP, 
respectively in a flow injection system, with continuous reuse of the immobilised 
enzymes. The previously optimised conditions were used for this investigation. 
The inhibition of AP, AlkP and ~-Gal with the inhibitors at Ilg/ml levels was 
achieved. 
The fluorescence spectra of Bodipy FL-a-casein-AlkP, FDP-AP and FDG-~-Gal 
(figure 5.1) are strongly overlapped. Therefore, a time-dependent flow injection 
analysis method was used to analyse them simultaneously. The flow-injection 
system for dual assays used one buffer and incorporated small glass reactors 
containing different immobilised enzymes as shown in figures 5.2 and 5.5. Two-
substrate I inhibitor solutions were injected and the fluorescence detected through 
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the time-dependent separation of the fluorescence peaks by having different 
lengths of flow tubing between the enzyme reactors and the detector. 
The suitability of Bodipy FL-a-casein, FDP and FDG as substrates in dual enzyme 
inhibition assays has also been demonstrated. The inhibition of AlkP, AP and 13-
Gal by 3-NPBA, VI and PETG, respectively at !-Ig/ml levels was achieved. But 
preliminary investigations of a dual assay for measuring the inhibitory effect of 
PETG and 3-NPBA on I3-Gal and AlkP respectively showed that there were 
difficulties because of some interactions between the two reaction systems. 
The application of the dual enzyme inhibition assays in the FIA system, using 
immobilised enzyme reactors provides a rapid, simple (does not require any 
process such as separation, precipitation or centrifugation) and sensitive method 
for the assay of enzyme inhibitors, essential requirements for screening assays. 
The dual determination capabilities of the system were even further enhanced by 
using the multivariate techniques partial least squares, PLS-1 . Analysis using 
three f1uorophores by flow injection fluorescence spectroscopy and a multivariate 
cal ibration method has been examined. However, the technique did have its 
problems when resolving significantly overlapping signals as seen in chapter 6. 
The system also suffered from reproducibility problems that were due to a variety 
of reasons. The main reason was the use of manual operations during the 
experimental procedures such as injecting the sample and collecting the data. This 
was a significant problem when trying to capture the whole spectrum at a 
particular time (one shot) because timing is vital in order to get the maximum 
signal : if the spectra are captured too early or too late this affected the statistical 
analysis of the data and therefore resulted in poor predictions. The technique of 
partial least squares looks for patterns in the spectral data and if any changes 
occur in the spectra that are not due solely to concentration it affects the overall 
calibration model : as always the output data is only as good as the input data. 
Overall; however, despite all these technical issues the predictions and deviation 
values of both dual and triple component analysis looked very promising and 
suggest such systems could be used as a major screening method. 
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7.2 FUTURE WORK 
Multi-determination allows a higher throughput and thus is extremely important in a 
future development of the labelled substrates for high throughput screening. The 
work that was carried out showed that UltraLink Biosupport Medium was extremely 
promising as a support for enzyme immobilisation. The enzyme reactor containing 
this support could be integrated into the dual inhibition assays described in section 
5. Using the enzymes and inhibitors from the assays described in chapter 5, 
numerous other set-ups are possible. Figure 7.1 illustrates just a couple of 
examples of possible set-ups out of the many combinations that are possible. 
Much more work can therefore be carried out in the area of multiplex 
determination. 
(a) 
S+ I Reactor 1 
~ Waste 
Buffer 1 Reactor 2 
S + I Detector 
~ Reactor 3 
Buffer 2 
(b) 
Reactor 1 
S+' Waste 
~ Reactor 2 
Buffer Detector 
Reactor 3 
Figure 7.1 Possible set-ups for multi-(jetennination assays 
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However, although parallel channels allow multi-determinations, which in turn 
produces a greater throughput of samples, the current macro-system has 
limitations. It would be impractical to keep paralleling up because of the amount of 
tubing that would be required. Space requirements would also increase, as well as 
the cost associated with high reagent consumption. This macro system therefore 
becomes limiting. The designs of such assays are much more suited to 
miniaturised assay formats, and hence a discussion of the transferral of these 
enzyme inhibition assays to a miniaturised system is given. Many discussions on 
the general concepts and techniques of the technology can be found .194-1 96 Using 
a chip-based system, the ability to manufacture a set-up with many parallel 
channels is much simpler than with a macro system. Many parallel channels of 
different lengths would be easily manufactured in such a system, allowing the 
determination of two or more activities in nanolitre volumes using time separation. 
The small amounts of sample and reagents required in such systems are much 
better suited to the small amounts of compounds synthesised by combinatorial 
methods, allowing a better connection of combinatorial chemistry to HTS. 
Modern microfabrication technology has had a great impact on the miniaturisation 
of analytical laboratory methods. Networks of coupled channels for sample 
concentration , mixing, dilution, reaction , etc. can be easily fabricated on a compact 
microchip.197-200 A simple method integrating an immobilised enzyme reactor into a 
microchip electrophoresis device was developed.194 Enzyme immobilisation was 
performed by drying a drop of dissolved nitrocellulose (NC) on a glass surface, 
and adsorbing enzyme on to the reconstituted NC membrane. The glass plate 
carrying the enzyme was incorporated into a polydimethylsiloxane chip on which 
the separation channel was fabricated (figure 7.2). 
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3 
Point of detection 
I 4 1 
Nitrocellulose membrane 
2 
Figure 7.2 Schematic diagram showing the set-up of the microchip 194 
Reservoirs: (1) sample, (2) buffer anode, (3) sample waste, and (4) buffer cathode 
The advantage of this method is the ability to change easily the position and size 
of the reactor within the device. A ~-galactosidase reaction was demonstrated with 
fluorescein di-~-galactopyranoside . Enzyme kinetics and inhibition of the ~­
galactosidase using fluorescein mono-~-galactopyranoside and 2-phenylethyl ~­
galactoside, respectively, were also studied. 
Microfabricated devices with integral heaters were described, which can be used 
for heterogeneous catalysis reactions.201 Banu et. al. 202 reported a device 
designed to permit the in situ packing of a section of channel with enzyme 
immobilised on to controiled pore glass (CPG). The chip design is shown in figure 
7.3. It was fabricated from glass and polydimethylsiloxane and to prevent dead 
volumes, had dedicated channels for packing the reactor. The device had the 
advantage of simplicity, the flow through enzyme reactor channel being just a 
widened section of the analyte channel. The system is suitable for both 
hydrodynamic and electro-osmotic pumping, and is designed such that when the 
packing is exhausted it can be repacked. The device was used with two enzymes 
of different molecular masses, alkaline phosphatase and xanthine oxidase for the 
assay of p-nitrophenyl phosphate and hypoxanthine with spectrophotometric 
detection at 405 and 470 nm, respectively. The limits of detection were 5 and 8 
jJM, respectively. 
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(A) 
2mm 
(8) 
10 mm 
(D) 
X 14~ • (C) 
1 mm 
3mm 9mm 
Figure 7.3 The chip design, showing the channel configuration202 
The four circles represent the location of the reservoirs. X is where the channel depth 
changes. The enzyme reactor where the CPG is packed is represented by the portion of 
thick black line along the channel A-D 
A potentially tricky part of the design of a miniaturised system would be the 
excitation of the fluorophore and subsequent detection. Detection of fluorescence 
on a chip is described briefly in many papers.203.205 These methods would require 
much thought and planning in order to develop multiplex miniaturised systems for 
the determination of enzymes and their inhibitors. 
For the chemometrics approach, future work should involve improving the flow 
injection system components to obtain more reliable and reproducible results, 
especially by automation of the sample injection and timing. Better software to 
capture and transform the data and the use of statistical software approaches to 
help resolve overlapping peaks more accurately should also be studied. In this 
work results were put into the Unscrambler software by initial data importation into 
Microsoft Excel<!i>, and then arranging them appropriately on the spreadsheet 
before transferring them to the Unscrambler. With large data matrices this was 
time consuming, and increased the possibility of introducing errors into the data. 
The Unscrambler does provide another mode which can import the data as ASCII 
fi les from any instrument directly into the software with little input from the user. 
This might save time and minimise errors from converting the data. Another 
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approach is to look more deeply into variable selection methods that remove 
irrelevant variables and therefore reduce the size of the data matrices. This in turn 
speeds up calculations and increases accuracy. 
The Unscrambler software also found it difficult to predict particular analytes when 
they were in the presence of other analytes that were in large molar excess. This 
was especially true when there was considerable overlap between the signals 
such that one of the peaks engulfed another. However th is problem may be 
difficult to solve when using PLS-1 algorithms in any software. Therefore, other 
multivariate methods need to be investigated such as neural networks 206.207 etc., 
to see if they give better predictions. Also, investigating other software packages 
such as SIMCA-p 208, Matlab 209, etc might be worthwhile. 
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APPENDIX A 
Supplier names and addresses 
Supplier name 
Amersham Pharmacia Biotech UK, Ltd. 
Anachem, Ltd. 
Elkay Laboratory Products (UK), Ltd . 
Fisher Scientific UK 
Grant Instruments (Cambridge), Ltd. 
Appendices 
Address 
Amersham Place 
Little Chalfont 
Buckinghamshire 
HP? 9NA,UK 
20 Charles Street 
Luton, Bedfordshire 
LU20EBG,UK 
Unit4, Marlborough Mews 
Crockford Lane 
Basingstoke, Hampshire 
RG24 8NA, UK 
Bishop Meadow Road 
Loughborough 
Leicestershire 
LE11 5RG, UK 
29 Station Road 
Shepreth, Royston 
Herefordshire 
SG86PZ, UK 
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Supplier name 
Hellma (England), Ltd. 
Hitachi Scientific Instruments 
Molecular Probes, Inc. 
Ohaus UK, Ltd. 
Omnifit, Ltd. 
Appendices 
Address 
Cumberland House 
24-28 Baxter Avenue 
Southend-on-Sea 
Essex 
SS26HZ, UK 
7 Ivanhoe Road 
Hogwood Industrial Estate 
Finchampstead 
Berkshire 
RG40400, UK 
Cambridge Bioscience 
24-25 Signet Court 
Newmarket Road 
Cambridge 
CB5 8LA, UK 
64 Boston Road 
Beaumont Leys 
Leicester 
LE41AW, UK 
2 College Park 
Coldhams Lane 
Cambridge 
CB13HD, UK 
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Supplier name Address 
Precisa Balances Ltd. 4 Vermont Place 
Tongwell , Milton Keynes, 
Buckinghamshire 
MK15 8JA, UK 
Sigma-Aldrich Company, Ltd. Fancy Road 
Poole 
Dorset 
BH12 4QH, UK 
Unicam Limited York Street 
Cambridge 
CB1 2PX, UK 
Whatman International Ltd. St leonard's Road 
20/20 Maidstone 
Kent 
ME16 OlS, UK 
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APPENDIX B 
Appearance of the model F-4500 fluorescence spectrophotometer (Hitachi) 
located in our laboratory 
Figure B-1 Appearance of the F-4500 in our laboratory 
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APPENDIXC 
Block diagram of the layout of the model F4500 fluorescence 
spectrophotometer (Hitachi) 
Xenon 
Lamp 
Power supply 
Processing 
Unit 
Xenon Excitation 
Lamp 
Monitor 
Beam 
Splitter 
Chopper 
(shutter) 
1 
Sample 
Emission 
Interface 1+-----' 
D 
PC 
Photomultiplier 
Processing 
unit 
A-D 
Converter 
Electronics system 
Excitation light 
Emission light 
Figure C-1 Internal block diagram ofthe F4500 21. 
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APPENDIX D 
Instrument specifications for the Hitachi F-4500 fluorescence 
spectrophotometer 
Table D-1 Instrument parameters of the F-4500210 
Parameters Specifications 
Light source 150 W Xenon lamp 
Monochromators Excitation: 200 - 600 nm 
Emission: 200 - 900 nm 
Excitation slit width 1.0, 2.5, 5.0, and 10.0 nm 
Emission slit width 1.0, 2.5, 5.0, 10.0, and 20.0 nm 
Scanning speed 15, 60, 240, 1200, 2400, 12000, and 
300000 nm I min 
Wavelength accuracy ± 2.0 nm 
Response 0.004, 0.01 , 0.05, 0.1, 0.5, 2.0, and 8.0 
seconds 
PMT Voltage 400, 700, and 950 V 
194 
> > ~ :J "l) I» -< "l) iil 1/1 m PC2 &0(0' s RMSE Root MOBn SqliBre E/ror iij' Z m SJJ ..... .. . ~ .. .. '21 ' . . , .. .. , . . . . .. .... 0.3 .. . ..... , .. . .. . " .... ., .. .... . 0 .:. . 14 "2- X 
-l 0 m :r 7 17 1~ • • 1 .... co • ) . III III 20 01 ..... . .. So 
" ~24 25 III .... 
-< 0 :::r III (11 
in' 0 16 1210 n 
" 
0.1 . . . " .. .. . . .. . .. .. .... . . !!!. 0-
• . Zl 0 5 19 6' 
-III . • 8 ... 
0 • 2 • ~ • 13 III .... e . 
n 
·SJJ . . .' .. 1 .. ..· . 9. : .. . . , .. . . 0 0 !!!. PC, PCs :J 6' 1/1 iil 
-4roJ ·2000 0 20ll 4(lX) PCJ1 pcJS PCJ9 PCJ3 PCJ7 (11 
-
.... o· ffiC(400-S84,95 ... , x~ 96%,3% Y·expl: 46%,51% FITC(49J.584,95 ... , V&'iabIe: cErrc vfITC 
-" 
0 
III ... 
co Y-mial/Ce ResilWal Valmtion Variance Pri:dicted Y w 
-0- 0.09 .. . , ..... .. . . .. , 11 n Slope Offset Corr . 0 ... 
~ a. 
"" 
0.!II6411 0JD!1S3 0S93182 
:::j 0.9 0.002162 0011195 0S90S00 l: 0 (Q 
n 0.06 .... .. .... .. .. I» 
-
0 ClI a. 05 1/1 c ~ IQ 
I» ;:;: 
- 0.03 co ... , ..... . .. ,' . , . . . .. . :::r 
c 0.3 "l) 
III r-:;' W IQ 
• 
" 
0 0 .... r PCs MoaSlJ(i:d Y I» (JJ :J 
.:. 
PCJll pcJS pcJO PCJ5 pcJO 0.2 0.4 0.6 0.8 1.0 Q. :P III "0 
" ffiC(490-S84,95 ... , Variable: v. To!>1 FlTC(49J·S84,95 ... , (V.I'&', PC~ (FlTC,3) (FlTC.3) 
." 
"0 Q. 0 co 
"" 
< ::I 0 Q. 
~ < ;;' .., co 
... III 
i: ; m ~ PC2 Scores RMSE Root Mean Square Error 400 - . . ., ' l . . .. 0.3 -: .. .. . . .. .. . . 
• 1'6 . 5 
-i 
"" 
'" 
'" :I 
'" .;: 
en 
iij' 
" 
. 9 ' • 13 200 - · · 18 
. 1:9 . 10 02 - ... . . . . . . .. , .. 
...: l4}. 8 20 14 0 -
. 2 25 
• 1112 
. 22 . 7 0.1 ...:: . . .. .. . .. . . .. . . . 
0' 
-en 
0 
.... 
n 
!!!. 
·200 - . . , ' 21' 
1 
. 6 
• 17 . 4 
---
·400 - .. · tS 0 -PCt PCs 
6' 
a .4Iloo .2000 0 2000 4000 PC_01 PC OS PC_09 PC 13 PC~17 , 
o· 
:I Bfl (490·584,95 ... , X·expl: 96%,2% Y·expl: 27%,56% BIL (490.584 ,95 .. . , Variable: cffl v.BFl 
en 
'" 
-.... 0 
~ 
CD 
"T1 
r 
V-variance Residual Validation Variance Predicted Y 
0.09 - ... . . .. 12 .. .. ... ... .. Slope Offset Con . 
0.992044 0004774 0.996014 ; 5 
0.9 - 0991888 0.004944 0.994178 .. ..... . .. .. • ~ 
n 
0 0.06 -
.. . . .. . . . . 
a. 
c 
cc 
0.6 - .. .. . . . . . . . . ... .. . . .. .. .. ! 
; 0.03 - . . . . . . . .. . . . . . ... . ... . .. . .. 
c 
!!!. 
:I 
cc 
"'C 
r 
en 
\ 0.3 - .. .. ... . . . . . .. .. .. ... . .. . .. . .. . . 0 - 0 -
PCs Measured Y 
, 
... 
'" 
PC '00 PC_OS PC~10 PC_ 15 PC~20 02 0.4 0.6 0.8 1.0 
:I Q. Bfl (490·584,95 .. . , Variable: v. Total BIL (490·584,95 .. , (Y·var, PC): (lFl,3) (8Fl,3) 
"T1 
0 
... < CD 
en 
~ 
-i 
:::T 
Cl) 
D> 
j 
600 
300 
PC2 Scores 
: • 2 
· . ' 18 
· . 2 • 8 
· .. . . . . . . ' .. 3 . . •. . . 
· . ' 3 
• 9 · 
. . .......... •. ·13· . . 
• 1:8 • 12 
0.3 
02 
RMSE Rool Mo.n Sq""," Error 
D> 
-< III 
in' 
'C 
0' 
~ 
o 
-300 
5 
• 16 
• :24, 7 
• 15 . 4 
20 . : : .. 11 ... .. 0.1 
III 
0 
~ 
• 1 : 21 
• 6 
n 
!. 
6' 
-600 ...... " ~4 ........ : 
PC1 
o 
PCs 
01 
~ 
0' 
j 
-4000 -2000 4000 PC_Ol PC_OS PC_OS PCJ3 PCJ7 
B493 (490-584,9 ... , Variable: c.B493 v.B493 
o 2000 
9493 (400-584,9 ... , X-exp/: 96%,3% Y-expl: 33%,51% 
III 
CD 
-
Predicled Y Y-variance Residual Validation Variance 
~ 
0 
.. 
12 " ..... . . . . . . . Slope Offset Corr . 0.09 
111 
~ 
ID 
W 
n 
0.988033 0.007180 0.993!m i 0.9 0984896 0.009198 0989700 
0.06 
0 
j 
~. 
C 
IQ 
0.6 ..... i § 
D> 
~ 
Cl) 0.03 . g 
C 0.3 
III 
s· 
IQ • 
'tI 
r 
IJ) 
o PCs o Me<sured Y 
, 
~ 
D> PCJO PCJ5 02 0.4 0.6 0.8 1.0 j 
C. 8493 (400-584,9 ... , VariatJe: v. Tolal 8493 (490-584,9 ... , (Y-vet, PC} (8493,4)(8493,4) 
." 
0 
~ < ID 
.... 
- - - ---- - -
~ 
-t 
:::r 
CD 
AI 
:> 
AI ;;; 
tn 
PC2 Scores , ', ,& RMSE Roel M .. n SqlMre Error 500 - .. .. 
.. '1' .. " . . .. ' " . .. .. 0.3 -: . .. . . ... . . .. . . , . . . . . .. , .... , . . . ... , ... . . 
• 21 . 14 
• 7 , 17 1$ • ~1 
20 0.2 - .. . ... . . . " ... ... . . . . . . , ... , .. """ . 
~i24 25 
0 -
~ » 
;:;: :::I 
':r III 
0 
-< c: !!!. 
-0 fII 
c: ~ ~ 0 m 
-
~ fII 
0 
.... 
-':r 
iij' 
'C 
0' 
-tn 
0 
... 
n 
!!!. 
:!; 6' 
;:;: iil 
:::r 
-0 0' 
c :> 
-
tn 0 CD 
a -... 
co' 0 ... 
... 
." 
:::::j 
n 
1~ , 1210 0.1 --: . . . . ... . ... . ... . ..... . ... .. . .......... 
:23 5 . 19 
, , 2 , 13 , 
-500 - . .. .. . " , .. , .. :. It , , . , . 9. : .. , . . .. 0 -
PCl PCs 
-.wOO -2!00 0 xm 4!XlO PC~01 pcJ15 PC~09 PCJ3 PC~17 , 
FlTC(490-584,95 ... , X-expl: 96%,3% Y-expl: 45%,53% FITC(400-584,95 ... , Yariat>e: cffiC vflTC 
y-v.ri.nce Residual Valid.lien Variance Predicled Y 
0.09 - . . . . . . . .. . . .. .. . . .. . .. ... . . . . . ... . . . . 11 .. . . .. . .. . -. ... . . . SIqle Offset Corr. 
0.995Il34 0.1J03021 0.997514 • • 0.9 - 0993667 0.004154 0.9$469 . . . . , . . . . . . . .. ... 
m 
(") 
!!!. 
t:r 
~ 
III 
-er 
:::I 
fII 
m 
-0' 
~ 
to> 
(") 
0 
:::I 
~, 
n 
0 
0.00 - . .. , . ..... . .. ... . .. - ... . . . . . . . . . . . .. . c: (Q 
:> ~, 
c 
cc 
AI 
0.6 - ........ . ...... . . -,. , . .. ..... . . -.... I» 
-
m 
fII 
; 
C 
tn 
S' 
cc 
0.03 - , .. . ... . , .... ,., ... , .. .. . , . .. . .. .. ... . ~ 
0.3 - . . . , . . " . .. . ... . .. . .... , .. .. .. .... .. . , .. 
-
I 
~ 
;:;: 
':r 
"'0 
"g 
r 
en 
0 -
PCs 
0 -
MeaSlJ(ed Y r en , 
, 
~ 
AI 
:> 
Q. 
." 
n 
~ < CD 
... 
PC_OO PC_OS PC~lO PC J 5 PC~20 01 0.4 0~6 0.6 1,0 
FlTC(490-584,95 ... , V",iatje: v. Telal FITC(400-564,95 ... , (V-var , Pq (FlTC,3) (FlTC,3) 
~ 
» 
III 'C 
:::I 'C Q. CD 
:> 
"11 Q. 
0 n' CD < tn 
~ iil m b. PC2 Scores 400 - .. " . , . , lfi , 5 
-
-I 
~ 
co 
., 
:::J 
., 
-< en 
U;' 
'C 
0' 
-
200 - .. · , ; 
· f6' ... ·9 .' , .13 . , 
, :24 26 1lt 
, 10 
, · 23 , 
0":: 
, 6 
, 
I" 11 
-
, 22: " 
, , 12 
, 21 
-200 - · •. 1 .. . 6. .. . , 
en 
0 
... 
n 
!!!. 
f 6' 
-
iil ~ 
-0 0' 
C :::J 
-
-
• 17 4 
-400 ..:: 
, 
. . 
· . 
. . 
· . 
.. .15 . . , . 
PCl 
-4000 -2doo 0 wOo 4000 
8ft. (490-564,95 ... , X-expl: 96%,1% Y-elCP: 32%,57% 
0 en co a -iD' C' 
~ ~ 
Y-variance Residual Validation Van~nce 
0.09 - .. . . . . . . · . . . . . .. . . . . . .. 
ID 
.., 
r-
n 
0 
0.06 - ... . .... . . , . . , .. . .. . . . . . . . . .... 
:::J 
~, 
C 
cc 
., 
-co 0.03 - .. . . ... . . , , . , . .. ... . ., . ., . .. . 
c 
en 
:j' 
cc 
'lI 
r-
C/l 
0 - \ 
PCs 
, 
~ 
., PC _00 PC _05 PC~10 PCJ5 PC '20 
:::J 
C. 81l (490-564,95 ... , Variable: v. To/al 
.., 
0 
~ < 
U> 
U> 
RMSE Root Mean SqIJ8re Error 
0.3 --: .. . . .. .. .. 
0.2 -: .. . . ... .. . . .. . ... . .. ..... , .. 
0.1 - . . .. , .. . . .. . - . .. . . . . . . 
\ 
0 -
pes 
PC 01 PC _05 PC Jl9 PC 13 PC~17 , 
BIL (400-564,95 ... , Varial:ile: c.BFL v.Efl 
Predicted Y 
12 . . ... . .. , ' .. . Slope Offset Corr. 
0.995692 0.002513 0997644 1 . 5 
0.9 - 0995847 0.002600 0996676 . . .. ., . .. .. 
0.6 - .. . .. .. .. .. . . .. . . .. . . .. . ..... . 
0.3 - .. .. .... . .. ... .... ... . .. ... ., .. . . 
0 -
MesSIJ(ed Y 
0.'2 0.4 0.6 0:6 1.'0 
81l (400-564,95 ... , (Y -var, PC~ (8FL,3) (8FL,3) 
» 
'C 
-g 
:::J 
C. 
i'j' 
co 
en 
~ ; m 
'" -i ~ 
to 
., 
:> 
., 
-< III 
iii' 
't:I 
0' 
-III 
0 
.... 
n 
!!!. 
~ a: 
::+ iil 
~ 
-0 o· 
c :> 
-
III 
0 to 
a -0' jO' 
... 
... III 
... 
'" ... 
n 
0 
:> 
'E' 
ec 
a 
to 
c 
III 
s· 
ec 
"11 {;; 
, 
... 
., 
:> 
Q. 
." (") 
'" < 0 0 
PCl 
600 
300 
o 
.:JOO 
• 1 
-SOo 
-4000 
Scores 
... 
2 18 
: • 8 
• . 23 ....•. 
21 
-2000 o 
9 : 
. .. . . . . . : ... . .. 1J . . : 
• 1~ . 12 
5 
. 6 
15 - 4 
20 .: ~ . !1 . .. 
. ... , . 14 ..... . . . 
PCl 
2000 4000 
6493 (490-584,9 ... , X-expt 96%,3% V-expt 32%,55% 
Y-voriance Residual Validation Variance 
0.09 
0.08 
0.03 . . . . .. . .. .. . •. . . . ..• . .. . •...•. . . • . .••. . 
o 
PCs 
PCJO PCJ5 
8493(490-584,9 ... , Variable: v.Total 
0.3 
RMSE Root Mean Squore Error 
0.2 
0.1 
o 
PCs 
8493 (490-584,9 ... , Vooable: cB493 v 6493 
Predicted Y 
1.2 .... . . . . .. ...... Slope Offset Corr. 
0.997013 0.001817 0998505 ! 0.9 0.993899 0.003346 0997287 
0.6 
0.3 
o 
MeaSli/'ed Y 
0.2 0.4 0.6 0.8 1.0 
6493 (490-584,9 ., (Y-var, PC): (6493,4)(6493,4) 


